# EDGAR Filing Document

**Accession Number:** 0000083246
**File Stem:** 0001104659-23-012467
**Filing Date:** 2023-2
**Character Count:** 242486
**Document Hash:** e4f465014e3ec60aaff52c269a6c078f
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001104659-23-012467.hdr.sgml**: 20230208

**ACCESSION NUMBER**: 0001104659-23-012467

**CONFORMED SUBMISSION TYPE**: FWP

**PUBLIC DOCUMENT COUNT**: 12

**FILED AS OF DATE**: 20230208

**DATE AS OF CHANGE**: 20230208

**SUBJECT COMPANY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** HSBC USA INC /MD/
- **CENTRAL INDEX KEY:** 0000083246
- **STANDARD INDUSTRIAL CLASSIFICATION:** NATIONAL COMMERCIAL BANKS [6021]
- **IRS NUMBER:** 132764867
- **STATE OF INCORPORATION:** MD
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** FWP
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 333-253385
- **FILM NUMBER:** 23597774

**BUSINESS ADDRESS:**
- **STREET 1:** 452 FIFTH AVE
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10018
- **BUSINESS PHONE:** 212-525-5000

**MAIL ADDRESS:**
- **STREET 1:** 452 FIFTH AVENUE
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10018
**FILED BY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** HSBC USA INC /MD/
- **CENTRAL INDEX KEY:** 0000083246
- **STANDARD INDUSTRIAL CLASSIFICATION:** NATIONAL COMMERCIAL BANKS [6021]
- **IRS NUMBER:** 132764867
- **STATE OF INCORPORATION:** MD
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** FWP

**BUSINESS ADDRESS:**
- **STREET 1:** 452 FIFTH AVE
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10018
- **BUSINESS PHONE:** 212-525-5000

**MAIL ADDRESS:**
- **STREET 1:** 452 FIFTH AVENUE
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10018

Filed Pursuant to Rule 433

Registration No. 333-253385

February 8, 2023

FREE WRITING PROSPECTUS

(To Prospectus dated February 23, 2021,

Prospectus Supplement dated February 23, 2021 and

Equity Index Underlying Supplement dated February 23, 2021)

HSBC USA Inc.

Autocallable Barrier Notes with Step-up Premium

Linked to the Least Performing of the S&P 500<sup>®</sup> Index, the Russell 2000<sup>®</sup> Index and the Dow Jones Industrial Average<sup>®</sup> (the "Reference Asset")

Callable quarterly at the principal amount plus the applicable Call Premium on any Call Observation Date on or after February 23, 2024 if the Official Closing Level of each Underlying is at or above its Call Threshold

Call Premium of at least 2.25% per quarter (equivalent to at least 9.00% per annum) (to be determined on the Trade Date)

If the Notes are not called and the Least Performing Underlying declines by more than 10.00% but less than or equal to 25.00% you will receive your principal amount (a zero return)

If the Notes are not called and the Least Performing Underlying declines by more than 25.00%, there is full exposure to declines in the Least Performing Underlying, and you will lose all or a portion of your principal amount

Approximate 5 year maturity, if not called

All payments on the Notes are subject to the credit risk of HSBC USA Inc.

The Autocallable Barrier Notes with Step-up Premium (each a "Note" and collectively the "Notes") offered hereunder will not be listed on any securities exchange or automated quotation system.

Neither the U.S. Securities and Exchange Commission (the "SEC") nor any state securities commission has approved or disapproved of the Notes or passed upon the accuracy or the adequacy of this document, the accompanying prospectus, prospectus supplement or Equity Index Underlying Supplement. Any representation to the contrary is a criminal offense.

We have appointed HSBC Securities (USA) Inc., an affiliate of ours, as the agent for the sale of the Notes. HSBC Securities (USA) Inc. will purchase the Notes from us for distribution to other registered broker-dealers or will offer the Notes directly to investors. In addition, HSBC Securities (USA) Inc. or another of its affiliates or agents may use the pricing supplement to which this document relates in market-making transactions in any Notes after their initial sale. Unless we or our agent inform you otherwise in the confirmation of sale, the pricing supplement to which this document relates is being used in a market-making transaction. See "Supplemental Plan of Distribution (Conflicts of Interest)" on page FWP-11 of this document.

**Investment in the Notes involves certain risks. You should refer to "Risk Factors" beginning on page FWP-7 of this document, page S-1 of the accompanying prospectus supplement and page S-1 of the accompanying Equity Index Underlying Supplement.**

The Estimated Initial Value of the Notes on the Trade Date is expected to be between $910.00 and $960.00 per Note, which will be less than the price to public. The market value of the Notes at any time will reflect many factors and cannot be predicted with accuracy. See "Estimated Initial Value" on page FWP-4 and "Risk Factors" beginning on page FWP-7 of this document for additional information.

---

| | | | |
|:---|:---|:---|:---|
| | Price to Public | Underwriting Discount<sup>(1)</sup> | Proceeds to Issuer |
| &nbsp;&nbsp;&nbsp;Per Note | $1000.00 |  |  |
| &nbsp;&nbsp;&nbsp;Total |  |  |  |

---

 

<sup>1</sup>HSBC USA Inc. or one of our affiliates may pay varying underwriting discounts of up to 2.00% and structuring fees of up to 0.65% per $1,000 Principal Amount in connection with the distribution of the Notes to other registered broker-dealers. In no case will the sum of the underwriting discounts and structuring fees exceed 2.65% per $1,000 Principal Amount. See "Supplemental Plan of Distribution (Conflicts of Interest)" on page FWP-11 of this document.

**The Notes:**

---

| | | |
|:---|:---|:---|
| **Are Not FDIC Insured** | **Are Not Bank Guaranteed** | **May Lose Value** |

---

![](tm235596d11dps_img01.jpg)

**HSBC USA Inc.**

Autocallable Barrier Notes with Step-up Premium

Linked to the Least Performing of the S&P 500<sup>®</sup> Index, the Russell 2000<sup>®</sup> Index and the Dow Jones Industrial Average<sup>®</sup> (the "Reference Asset")

**Indicative Terms<sup>(1)</sup>**

---

| | |
|:---|:---|
| **Principal Amount** | $1000 |
| **Term** | &nbsp;&nbsp;Approximate 5 year maturity, if not called |
| **Reference Asset** | &nbsp;&nbsp;The S&P 500® Index (Ticker: SPX), the Russell 2000® Index (Ticker: RTY) and the Dow Jones Industrial Average® (Ticker: INDU) (each, an "Underlying" and together the "Underlyings"). |
| **Call Feature** | &nbsp;&nbsp;The Notes will be automatically called if the Official Closing Level of each Underlying is at or above its Call Threshold on any Call Observation Date on or after February 23, 2024. In that case, you will receive a payment, per $1,000 Principal Amount, equal to the Principal Amount, plus the applicable Call Premium on the corresponding Call Payment Date.<sup>(2)</sup> |
| **Call Threshold** | &nbsp;&nbsp;For each Underlying on a Call Observation Date, the relevant percentage of the Initial Value of such Underlying applicable on such Call Observation Date as described on page FWP-4 under Call Observation Dates, Call Payment Dates, Call Premiums and Call Threshold |
| **Call Premiums** | &nbsp;&nbsp;at least 2.25% per quarter (equivalent to at least 9.00% per annum) (to be determined on the Trade Date) payable as described under the Call Feature above and on page FWP-4 under Call Observation Dates, Call Payment Dates and Call Premiums |
| **Barrier Value** | With respect to each Underlying, 75.00% of its Initial Value. |
| **Payment at** <br> **Maturity**<br> **per Note** | Unless the Notes are called, for each $1,000 Principal Amount, you will receive a cash payment on the Maturity Date, calculated as follows:<br> **If the Reference Return of the Least Performing Underlying is less than -10.00%, and therefore not called, but greater than or equal to -25.00%:**<br> $1,000 (a zero return)<br> **If the Reference Return of the Least Performing Underlying is less than -25.00%:**<br> $1,000 + ($1,000 × Reference Return of the Least Performing Underlying).<br> If the Notes are not called and the Final Value of the Least Performing Underlying is less than its Barrier Value, you will not receive a Call Premium, and will lose up to 100% of the Principal Amount. |
| **Reference Return** | With respect to each Underlying,<br> <u>Final Value - Initial Value</u><br> Initial Value |
| **Least Performing Underlying** | The Underlying with the lowest Reference Return. |
| **Trade Date** | February 22, 2023 |
| **Pricing Date** | February 22, 2023 |
| **Original Issue Date** | February 27, 2023 |
| **Final Valuation Date** | February 23, 2028 |
| **Maturity Date <sup>(3)</sup>** | February 28, 2028 |
| **CUSIP / ISIN** | 40441XM98 / US40441XM989 |

---

<sup>1</sup> As more fully described starting on page FWP-4.

<sup>2</sup> See page FWP-4 for the Call Observation Dates, Call Payment Dates and Call Premiums.

<sup>3</sup> Subject to adjustment as described under "Additional Terms of the Notes" in the accompanying Equity Index Underlying Supplement.

**The Notes**

The Notes may be suitable for investors who believe that the value of the Underlyings will not decrease significantly over the term of the Notes.

If the Official Closing Level of each Underlying is at or above its Call Threshold on any Call Observation Date beginning on February 23, 2024, your Notes will be called and you will receive a payment equal to 100% of the Principal Amount, together with the applicable Call Premium on the corresponding Call Payment Date.

If the Notes are not called and the Final Value of the Least Performing Underlying is greater than or equal to its Barrier Value, you will receive a Payment at Maturity equal to 100% of the Principal Amount.

If the Notes are not called and the Final Value of the Least Performing Underlying is less than its Barrier Value, you will not receive the Call Premium and you will lose 1% of your principal for every 1% decline of that Least Performing Underlying from its Initial Value.

![](tm235596d11dps_img02.jpg)

**Illustration of Payment Scenarios**

Your payment on the Notes will depend on whether the Notes have been called, including on the Final Valuation Date, and whether the Final Value of the Least Performing Underlying is greater than or equal to its Barrier Value. If your Notes are not called, you will lose some or all of your Principal Amount at maturity if the Final Value of the Least Performing Underlying is less than its Barrier Value. In such a case, your return on the Notes will be negative.<br>

**Information about the Underlyings**

---

| | |
|:---|:---|
| The S&P 500® Index ("SPX") is a market capitalization-weighted index intended to provide a performance benchmark for the large-cap U.S. equity markets. The SPX includes a representative sample of 500 companies in leading industries of the U.S. economy. | ![](tm235596d11dps_img04.jpg) |

---

---

| | |
|:---|:---|
| The Russell 2000® Index ("RTY") is designed to track the performance of the small capitalization segment of the U.S. equity market. All 2,000 stocks are traded on a major U.S. exchange, and the RTY consists of the smallest 2,000 companies included in the Russell 3000® Index. The Russell 3000® Index is composed of the 3,000 largest U.S. companies as determined by market capitalization. | ![](tm235596d11dps_img05.jpg) |

---

---

| | |
|:---|:---|
| The Dow Jones Industrial Average® ("INDU") is a price-weighted index comprised of 30 blue-chip stocks, which represent nine economic sectors including consumer discretionary, consumer staples, communication services, energy, financials, health care, industrials, information technology and materials. | ![](tm235596d11dps_img06.jpg) |

---

The graphs above illustrate the daily performance of SPX from February 7, 2013 through February 7, 2023, the daily performance of RTY from February 7, 2013 through February 7, 2023 and the daily performance of INDU from February 7, 2013 through February 7, 2023. The closing values in the graphs above were obtained from the Bloomberg Professional® Service. Past performance is not necessarily an indication of future results.

For further information on each Underlying, please see "Description of the Reference Asset" beginning on page FWP-10 of this document. We have derived all disclosure regarding each Underlying from publicly available information. Neither HSBC USA Inc. nor any of its affiliates have undertaken any independent review of, or made any due diligence inquiry with respect to, the publicly available information about each Underlying.

![](tm235596d11dps_img07.jpg)

**HSBC USA Inc.**

**Autocallable Barrier Notes with Step-up Premium**

**Linked to the Least Performing of the S&P 500<sup>®</sup> Index, the Russell 2000<sup>®</sup> Index and the Dow Jones Industrial Average<sup>®</sup> (the "Reference Asset")**

This document relates to a single offering of Autocallable Barrier Notes with Step-up Premium. The Notes will have the terms described in this document and the accompanying prospectus, prospectus supplement and Equity Index Underlying Supplement. If the terms of the Notes offered hereby are inconsistent with those described in the accompanying prospectus, prospectus supplement or Equity Index Underlying Supplement, the terms described in this document shall control.

This document relates to an offering of Notes linked to the performance of the Reference Asset. The purchaser of a Note will acquire a senior unsecured debt security of HSBC USA Inc. linked to the Reference Asset as described below. The following key terms relate to the offering of the Notes:

---

| | |
|:---|:---|
| **Issuer:** | HSBC USA Inc. |
| **Principal Amount:** | $1,000 per Note |
| **Reference Asset:** | The S&P 500® Index (Ticker: SPX), the Russell 2000® Index (Ticker: RTY) and the Dow Jones Industrial Average® (Ticker: INDU) (each, an "Underlying" and together the "Underlyings"). |
| **Trade Date:** | February 22, 2023 |
| **Pricing Date:** | February 22, 2023 |
| **Original Issue Date:** | February 27, 2023 |
| **Final Valuation Date:** | February 23, 2028, subject to adjustment as described under "Additional Terms of the Notes-Valuation Dates" in the accompanying Equity Index Underlying Supplement. |
| **Maturity Date:** | 3 business days after the Final Valuation Date, expected to be February 28, 2028. The Maturity Date is subject to adjustment as described under "Additional Terms of the Notes-Coupon Payment Dates, Call Payment Dates and Maturity Date" in the accompanying Equity Index Underlying Supplement. |
| **Call Feature:** | The Notes will be automatically called if the Official Closing Level of each Underlying is at or above its Call Threshold on any Call Observation Date on or after February 23, 2024. In that case, you will receive a payment, per $1,000 Principal Amount, equal to the Principal Amount, plus the applicable Call Premium on the corresponding Call Payment Date. |
| **Payment at Maturity:** | Unless the Notes are automatically called, on the Maturity Date, for each $1,000 Principal Amount, we will pay you the Final Settlement Value. |
| **Final Settlement Value:** | Unless the Notes are automatically called, for each $1,000 Principal Amount, you will receive a cash payment on the Maturity Date, calculated as follows:<br> **If the Reference Return of the Least Performing Underlying is less than -10.00%, and therefore not called, but greater than or equal to -25.00%:**<br> $1,000 (a zero return)<br> **If the Reference Return of the Least Performing Underlying is less than -25.00%:**<br> $1,000 + ($1,000 × Reference Return of the Least Performing Underlying).<br> If the Notes are not called and the Final Value of the Least Performing Underlying is less than its Barrier Value, you will not receive a Call Premium, and will lose up to 100% of the Principal Amount. |
| **Least Performing Underlying:** | The Underlying with the lowest Reference Return. |
| **Reference Return:** | With respect to each Underlying, the quotient, expressed as a percentage, calculated as follows:<br><u>Final Value - Initial Value</u><br>Initial Value |

---

The Call Premiums are at least 2.25% per quarter (equivalent to at least 9.00% per annum) (to be determined on the Trade Date), payable as described below.<br>

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Call Observation Dates,<br>Call Payment Dates,<br>Call Premiums and Call Thresholds:** | **Call Observation Dates** | **Call Payment Dates** | **Call Premiums\*** | **Call Threshold** |
| **Call Observation Dates,<br>Call Payment Dates,<br>Call Premiums and Call Thresholds:** | February 23, 2024 | February 28, 2024 | at least 9.00% | 90% of the Initial Value |
| **Call Observation Dates,<br>Call Payment Dates,<br>Call Premiums and Call Thresholds:** | May 22, 2024 | May 28, 2024 | at least 11.25% | 90% of the Initial Value |
| **Call Observation Dates,<br>Call Payment Dates,<br>Call Premiums and Call Thresholds:** | August 23, 2024 | August 28, 2024 | at least 13.50% | 90% of the Initial Value |
| **Call Observation Dates,<br>Call Payment Dates,<br>Call Premiums and Call Thresholds:** | November 25, 2024 | November 29, 2024 | at least 15.75% | 90% of the Initial Value |
| **Call Observation Dates,<br>Call Payment Dates,<br>Call Premiums and Call Thresholds:** | February 25, 2025 | February 28, 2025 | at least 18.00% | 90% of the Initial Value |
| **Call Observation Dates,<br>Call Payment Dates,<br>Call Premiums and Call Thresholds:** | May 22, 2025 | May 28, 2025 | at least 20.25% | 90% of the Initial Value |
| **Call Observation Dates,<br>Call Payment Dates,<br>Call Premiums and Call Thresholds:** | August 25, 2025 | August 28, 2025 | at least 22.50% | 90% of the Initial Value |
| **Call Observation Dates,<br>Call Payment Dates,<br>Call Premiums and Call Thresholds:** | November 24, 2025 | November 28, 2025 | at least 24.75% | 90% of the Initial Value |
| **Call Observation Dates,<br>Call Payment Dates,<br>Call Premiums and Call Thresholds:** | February 25, 2026 | March 2, 2026 | at least 27.00% | 90% of the Initial Value |
| **Call Observation Dates,<br>Call Payment Dates,<br>Call Premiums and Call Thresholds:** | May 22, 2026 | May 28, 2026 | at least 29.25% | 90% of the Initial Value |
| **Call Observation Dates,<br>Call Payment Dates,<br>Call Premiums and Call Thresholds:** | August 25, 2026 | August 28, 2026 | at least 31.50% | 90% of the Initial Value |
| **Call Observation Dates,<br>Call Payment Dates,<br>Call Premiums and Call Thresholds:** | November 24, 2026 | November 30, 2026 | at least 33.75% | 90% of the Initial Value |
| February 24, 2027 | March 1, 2027 | at least 36.00% | 90% of the Initial Value |  |
| May 25, 2027 | May 28, 2027 | at least 38.25% | 90% of the Initial Value |  |
| August 25, 2027 | August 30, 2027 | at least 40.50% | 90% of the Initial Value |  |
| November 23, 2027 | November 29, 2027 | at least 42.75% | 90% of the Initial Value |  |
| February 23, 2028 | February 28, 2028 | at least 45.00% | 90% of the Initial Value |  |
| (the Final Valuation Date) | (the Maturity Date) |  |  |  |

---

\* To be determined on the Trade Date.

---

| | |
|:---|:---|
|  | The Call Observation Dates and Call Payment Dates are subject to postponement as described under "Additional Terms of the Notes-Valuation Dates" and "Additional Terms of the Notes-Coupon Payment Dates, Call Payment Dates and Maturity Date" in the accompanying Equity Index Underlying Supplement. |
| **Initial Value:** | With respect to each Underlying, its Official Closing Level on the Pricing Date. |
| **Final Value:** | With respect to each Underlying, its Official Closing Level on the Final Valuation Date. |
| **Barrier Value:** | With respect to each Underlying, 75.00% of its Initial Value. |
| **CUSIP / ISIN:** | 40441XM98 / US40441XM989 |
| **Form of Notes:** | Book-Entry |
| **Listing:** | The Notes will not be listed on any securities exchange or quotation system. |
| **Estimated Initial Value:** | The Estimated Initial Value of the Notes is expected to be less than the price you pay to purchase the Notes. The Estimated Initial Value does not represent a minimum price at which we or any of our affiliates would be willing to purchase your Notes in the secondary market, if any, at any time. The Estimated Initial Value will be calculated on the Trade Date and will be set forth in the pricing supplement to which this free writing prospectus relates. See "Risk Factors - The Estimated Initial Value of the Notes, which will be determined by us on the Trade Date, is expected to be less than the price to public and may differ from the market value of the Notes in the secondary market, if any." |

---

 

*The Trade Date, the Pricing Date and the other dates set forth above are subject to change, and will be set forth in the pricing supplement relating to the Notes.*

 

**GENERAL**

This document relates to an offering of Notes linked to the Reference Asset. The purchaser of a Note will acquire a senior unsecured debt security of HSBC USA Inc. We reserve the right to withdraw, cancel or modify this offering and to reject orders in whole or in part. Although the offering of Notes relates to the Reference Asset, you should not construe that fact as a recommendation as to the merits of acquiring an investment linked to the Reference Asset or any security included in any Underlying or as to the suitability of an investment in the Notes.

You should read this document together with the prospectus dated February 23, 2021, the prospectus supplement dated February 23, 2021, and the Equity Index Underlying Supplement dated February 23, 2021. If the terms of the Notes offered hereby are inconsistent with those described in the accompanying prospectus, prospectus supplement or Equity Index Underlying Supplement, the terms described in this document shall control. You should carefully consider, among other things, the matters set forth in "Risk Factors" beginning on page FWP-7 of this document, page S-1 of the prospectus supplement and page S-1 of the Equity Index Underlying Supplement, as the Notes involve risks not associated with conventional debt securities. We urge you to consult your investment, legal, tax, accounting and other advisors before you invest in the Notes. As used herein, references to the "Issuer", "HSBC", "we", "us" and "our" are to HSBC USA Inc.

HSBC has filed a registration statement (including a prospectus, prospectus supplement and Equity Index Underlying Supplement) with the SEC for the offering to which this document relates. Before you invest, you should read the prospectus, prospectus supplement and Equity Index Underlying Supplement in that registration statement and other documents HSBC has filed with the SEC for more complete information about HSBC and this offering. You may get these documents for free by visiting EDGAR on the SEC's web site at www.sec.gov. Alternatively, HSBC Securities (USA) Inc. or any dealer participating in this offering will arrange to send you the prospectus, prospectus supplement and Equity Index Underlying Supplement if you request them by calling toll-free 1-866-811-8049.

You may also obtain:

The Equity Index Underlying Supplement at: [http://www.sec.gov/Archives/edgar/data/83246/000110465921026625/tm217170d5_424b2.htm](http://www.sec.gov/Archives/edgar/data/83246/000110465921026625/tm217170d5_424b2.htm)

The prospectus supplement at: [http://www.sec.gov/Archives/edgar/data/83246/000110465921026609/tm217170d2_424b2.htm](http://www.sec.gov/Archives/edgar/data/83246/000110465921026609/tm217170d2_424b2.htm)

The prospectus at: [http://www.sec.gov/Archives/edgar/data/83246/000110465921026585/tm217170d7_424b3.htm](http://www.sec.gov/Archives/edgar/data/83246/000110465921026585/tm217170d7_424b3.htm)

We are using this document to solicit from you an offer to purchase the Notes. You may revoke your offer to purchase the Notes at any time prior to the time at which we accept your offer by notifying HSBC Securities (USA) Inc. We reserve the right to change the terms of, or reject any offer to purchase, the Notes prior to their issuance. In the event of any material changes to the terms of the Notes, we will notify you.

**PAYMENT ON THE NOTES**

**Call Feature**

If the Official Closing Level of each Underlying is at or above its Call Threshold on any Call Observation Date the Notes will be automatically called, and you will receive a cash payment, per $1,000 Principal Amount, equal to the Principal Amount plus the applicable Call Premium on the corresponding Call Payment Date.

**Call Premium**

If the Notes are called on a Call Observation Date, we will pay the applicable Call Premium on the corresponding Call Payment Date, which will be at least 2.25% per quarter (equivalent to at least 9.00% per annum or at least $22.50 per quarter for each $1,000 Principal Amount) (to be determined on the Trade Date) multiplied by the number of quarters elapsed from the Trade Date to the applicable Call Observation Date that the Notes are called. See "Call Observation Dates, Call Payment Dates and Call Premiums" on FWP-5 for the applicable Call Premiums to be paid on the corresponding Call Payment Dates. For information regarding the record dates applicable to the Call Premiums payable on the Notes, please see the section entitled "Description of Notes-Interest and Principal Payments-Recipients of Interest Payments" beginning on page S-17 in the accompanying prospectus supplement.

**Payment at Maturity**

Unless the Notes are called, on the Maturity Date and for each $1,000 Principal Amount, you will receive a cash payment equal to the Final Settlement Value, determined as follows:

**If the Reference Return of the Least Performing Underlying is less than -10.00%, and therefore not called, but greater than or equal to -25.00%:**

$1,000 (a zero return)

**If the Reference Return of the Least Performing Underlying is less than -25.00%:**

$1,000 + ($1,000 × Reference Return of the Least Performing Underlying).

If the Notes are not automatically called and the Final Value of the Least Performing Underlying is less than its Barrier Value, you will not receive a Call Premium and will lose up to 100% of the Principal Amount.

**Calculation Agent**

We or one of our affiliates will act as calculation agent with respect to the Notes.

**Reference Sponsors**

The reference sponsor of the SPX is S&P Dow Jones Indices LLC. The reference sponsor of the RTY is FTSE Russell. The reference sponsor of the INDU is S&P Dow Jones Indices LLC.

**INVESTOR SUITABILITY**

**The Notes may be suitable for you if:**

You believe that the Official Closing Level of each of the Underlyings will be equal to or greater than its Call Threshold on one of the Call Observation Dates.

You seek a Call Premium based on the performance of the Underlyings, that will be at least 2.25% per quarter (to be determined on the Trade Date) if the Official Closing Level of each Underlying is greater than or equal to its Initial Value on any Call Observation Date.

You are willing to invest in the Notes based on the fact that your maximum potential return is limited to the applicable Call Premium payable on the Notes on a given Call Payment Date.

You do not seek an investment that provides an opportunity to participate in the appreciation of the Underlyings.

You are willing to make an investment that is exposed to the potential downside performance of the Least Performing Underlying on a 1-to-1 basis if the Notes are not called and the Reference Return of the Least Performing Underlying is less than -25.00%.

You are willing to lose up to 100% of the Principal Amount.

You are willing to hold the Notes, which will be automatically called on any Call Observation Date on which the Official Closing Level of each Underlying is at or above its Call Threshold, or you are otherwise willing to hold the Notes to maturity.

You are willing to forgo guaranteed interest payments on the Notes, and the dividends or other distributions paid on the stocks included in the Underlyings.

You do not seek an investment for which there will be an active secondary market.

You are willing to accept the risk and return profile of the Notes versus a conventional debt security with a comparable maturity issued by HSBC or another issuer with a similar credit rating.

You are comfortable with the creditworthiness of HSBC, as Issuer of the Notes.

**The Notes may not be suitable for you if:**

You believe that the Official Closing Level of at least one Underlying will be less than its Call Threshold on each of the Call Observation Dates, and below its Barrier Value on the Final Valuation Date.

You believe that the Call Premium, if any, will not provide you with your desired return.

You are unwilling to invest in the Notes based on the fact that your maximum potential return is limited to the applicable Call Premium payable on the Notes on a given Call Payment Date.

You seek an investment that provides an opportunity to participate in the appreciation of the Underlyings.

You are unwilling to make an investment that is exposed to the potential downside performance of the Least Performing Underlying on a 1-to-1 basis if the Notes are not called and the Reference Return of the Least Performing Underlying is less than -25.00%.

You seek an investment that provides full return of principal at maturity.

You are unable or unwilling to hold Notes that will be automatically called on any Call Observation Date on which the Official Closing Level of each Underlying is at or above its Call Threshold, or you are otherwise unable or unwilling to hold the Notes to maturity.

You prefer to receive guaranteed periodic interest payments on the Notes, or the dividends or other distributions paid on the stocks included in the Underlyings.

You seek an investment for which there will be an active secondary market.

You prefer the lower risk, and therefore accept the potentially lower returns, of conventional debt securities with comparable maturities issued by HSBC or another issuer with a similar credit rating.

You are not willing or are unable to assume the credit risk associated with HSBC, as Issuer of the Notes.

**RISK FACTORS**

We urge you to read the section "Risk Factors" beginning on page S-1 of the accompanying prospectus supplement and page S-1 of the accompanying Equity Index Underlying Supplement. You should understand the risks of investing in the Notes and should reach an investment decision only after careful consideration, with your advisors, of the suitability of the Notes in light of your particular financial circumstances and the information set forth in this document and the accompanying prospectus, prospectus supplement and Equity Index Underlying Supplement.

In addition to the risks discussed below, you should review "Risk Factors" in the accompanying prospectus supplement and Equity Index Underlying Supplement including the explanation of risks relating to the Notes described in the following sections:

"-Risks Relating to All Note Issuances" in the prospectus supplement; and

"-General Risks Related to Indices" in the Equity Index Underlying Supplement.

You will be subject to significant risks not associated with conventional fixed-rate or floating-rate debt securities.

***Risks Relating to the Structure or Features of the Notes***

**The Notes do not guarantee any return of principal and you may lose all of your Principal Amount.**

The Notes do not guarantee any return of principal. The Notes differ from ordinary debt securities in that we will not pay you 100% of the Principal Amount of your Notes if the Notes are not called and the Final Value of the Least Performing Underlying is less than its Barrier Value. In this case, the Payment at Maturity you will be entitled to receive will be less than the Principal Amount and you will lose 1% for each 1% that the Reference Return of the Least Performing Underlying is less than 0.00%. You may lose up to 100% of your investment at maturity. If the Notes are not called, you will not receive any Call Premium.

**You may not receive the Call Premium.**

The Notes may not be called, and in such a case you will not receive the Call Premium. If the Official Closing Level of the Least Performing Underlying on the Final Valuation Date is less than its Barrier Level, we will not pay you the Call Premium at maturity, you will not receive a positive return on the Notes, and you will lose some or all of your principal amount.

**Your return on the Notes is limited to the Principal Amount plus the applicable Call Premium, if any, regardless of any appreciation in the value of any Underlying.**

If the Notes are called, for each $1,000 Principal Amount, you will receive $1,000 at maturity plus the applicable Call Premium, regardless of any appreciation in the value of any Underlying, which may be significant. Accordingly, the return on the Notes may be significantly less than the return on a direct investment in the stocks included in the Underlyings during the term of the Notes.

**The amount payable on the Notes is not linked to the values of the Underlyings at any time other than the Call Observation Dates, including the Final Valuation Date.**

The payments on the Notes will be based on the Official Closing Levels of the Underlyings on the Call Observation Dates, including the Final Valuation Date, subject to postponement for non-trading days and certain Market Disruption Events. If the Notes are not called, even if the value of each Underlying is greater than or equal to its Call Threshold during the term of the Notes other than on the Call Observation Dates but then decreases on each Call Observation Date to a value that is less than its Call Threshold, the return on the Notes may be less, and possibly significantly less, than it would have been had the Notes had been called. Similarly, even if the value of the Least Performing Underlying is greater than or equal to its Barrier Value during the term of the Notes other than on the Final Valuation Date but then decreases on the Final Valuation Date to a value that is less than its Barrier Value, the Payment at Maturity will be less, possibly significantly less, than it would have been had the Payment at Maturity been linked to the value of the Least Performing Underlying prior to such decrease. Although the actual values of the Underlyings on the Maturity Date or at other times during the term of the Notes may be higher than their respective values on the Call Observation Dates, whether the Notes will be called and the Payment at Maturity will be based solely on the Official Closing Levels of the Underlyings on the applicable Call Observation Dates.

**Because the Notes are linked to the performance of the Least Performing Underlying, you are exposed to greater risks of not receiving the Call Premium and sustaining a significant loss on your investment than if the Notes were linked to just one Underlying.**

The risk that you will not receive the Call Premium, or that you will suffer a significant loss on your investment, is greater if you invest in the Notes as opposed to substantially similar securities that are linked to the performance of just one Underlying. With multiple Underlyings, it is more likely that one of the Underlyings will close below its respective Barrier Value on the Final Valuation Date, than if the Notes were linked to only one Underlying. Therefore, it is more likely that you will suffer a significant loss on your investment. In addition, because each Underlying must close above its Call Threshold on a Call Observation Date in order for the Notes to be called, the Notes are less likely to be called than if the Notes were linked to just one Underlying, and you may not receive the Call Premium.

**The Notes may be called prior to the Maturity Date.**

If the Notes are called early, the holding period could be as little as approximately 12 months. There is no guarantee that you would be able to reinvest the proceeds from an investment in the Notes at a comparable return for a similar level of risk in the event the Notes are called prior to the Maturity Date.

**If the Notes are not called, your return will be based on the Reference Return of the Least Performing Underlying.**

If the Notes are not called, in which case you will not receive any Call Premium, your return will be based on the Reference Return of the Least Performing Underlying without regard to the performance of any other Underlying. As a result, you could lose all or some of your initial investment if the Final Value of the Least Performing Underlying is less than its Barrier Value, even if there is an increase in the value of any other Underlying. This could be the case even if any other Underlying increased by an amount greater than the decrease in the Least Performing Underlying.

**Higher Call Premiums or lower Barrier Values are generally associated with Underlyings with greater expected volatility and therefore can indicate a greater risk of loss.**

"Volatility" refers to the frequency and magnitude of changes in the value, of an Underlying. The greater the expected volatility with respect to an Underlying on the Trade Date, the higher the expectation as of the Trade Date that the value of that Underlying could close below its Call Threshold on a Call Observation Date or its Barrier Value on the Final Valuation Date, indicating a higher expected risk of non-payment of any of the Call Premiums or loss on the Notes. This greater expected risk will generally be reflected in a higher Call Premiums than the yield payable on our conventional debt securities with a similar maturity, or in more favorable terms (such as a lower Barrier Value) than for similar securities linked to the performance of an Underlying with a lower expected volatility as of the Trade Date. You should therefore understand that a relatively higher Call Premiums may indicate an increased risk of loss. Further, a relatively lower Barrier Value may not necessarily indicate that the Notes have a greater likelihood of a repayment of principal at maturity. The volatility of an Underlying can change significantly over the term of the Notes. The value of an Underlying for your Notes could fall sharply, which could result in a significant loss of principal. You should be willing to accept the downside market risk of the Least Performing Underlying and the potential to lose some or all of your principal at maturity.

**Since the Notes are linked to the performance of more than one Underlying, you will be fully exposed to the risk of fluctuations in the value of each Underlying.**

Since the Notes are linked to the performance of more than one Underlying, the Notes will be linked to the individual performance of each Underlying. Because the Notes are not linked to a weighted basket, in which the risk is mitigated and diversified among all of the components of a basket, you will be exposed to the risk of fluctuations in the values of the Underlyings to the same degree for each Underlying. For example, in the case of securities linked to a weighted basket, the return would depend on the weighted aggregate performance of the basket components reflected as the basket return. Thus, the depreciation of any basket component could be mitigated by the appreciation of another basket component, as scaled by the weightings of such basket components. However, in the case of these Notes, the individual performance of each of the Underlyings would not be combined to calculate your return and the depreciation of either of the Underlyings would not be mitigated by the appreciation of the other Underlying. Instead, your return would depend on the Least Performing Underlying.

***Risks Relating to the Reference Asset***

**Changes that affect an Underlying may affect the value of an Underlying and the market value of the Notes and the amount you will receive on the Notes and the amount you will receive at maturity.**

The policies of the reference sponsor of an Underlying concerning additions, deletions and substitutions of the stocks included in an Underlying, and the manner in which the reference sponsor takes account of certain changes affecting those stocks, may affect the value of an Underlying. The policies of the reference sponsor with respect to the calculation of an Underlying could also affect the value of an Underlying. The reference sponsor may discontinue or suspend calculation or dissemination of an Underlying. Any such actions could affect the value of an Underlying and the value of and the return on the Notes.

**Small-capitalization risk.** 

The RTY tracks companies that are considered small-capitalization. These companies often have greater stock price volatility, lower trading volume and less liquidity than large-capitalization companies and therefore the level of the RTY may be more volatile than an investment in stocks issued by large-capitalization companies. Stock prices of small-capitalization companies are also more vulnerable than those of large-capitalization companies to adverse business and economic developments, and the stocks of small-capitalization companies may be thinly traded, making it difficult for the RTY to track them. In addition, small-capitalization companies are typically less stable financially than large-capitalization companies and may depend on a small number of key personnel, making them more vulnerable to loss of personnel. Small-capitalization companies are often subject to less analyst coverage and may be in early, and less predictable, periods of their corporate existences. Such companies tend to have smaller revenues, less diverse product lines, smaller shares of their product or service markets, fewer financial resources and less competitive strengths than large-capitalization companies and are more susceptible to adverse developments related to their products.

***General Risk Factors***

**The Notes are subject to the credit risk of HSBC USA Inc.**

The Notes are senior unsecured debt obligations of the Issuer, HSBC, and are not, either directly or indirectly, an obligation of any third party. As further described in the accompanying prospectus supplement and prospectus, the Notes will rank on par with all of the other unsecured and unsubordinated debt obligations of HSBC, except such obligations as may be preferred by operation of law. Any payment to be made on the Notes, including any return of principal at maturity, depends on the ability of HSBC to satisfy its obligations as they come due. As a result, the actual and perceived creditworthiness of HSBC may affect the market value of the Notes and, in the event HSBC were to default on its obligations, you may not receive the amounts owed to you under the terms of the Notes.

**The Notes are not insured or guaranteed by any governmental agency of the United States or any other jurisdiction.**

The Notes are not deposit liabilities or other obligations of a bank and are not insured or guaranteed by the Federal Deposit Insurance Corporation or any other governmental agency or program of the United States or any other jurisdiction. An investment in the Notes is subject to the credit risk of HSBC, and in the event that HSBC is unable to pay its obligations as they become due, you may not receive the full payments due on the Notes.

**The Estimated Initial Value of the Notes, which will be determined by us on the Trade Date, is expected to be less than the price to public and may differ from the market value of the Notes in the secondary market, if any.**

The Estimated Initial Value of the Notes will be calculated by us on the Trade Date and is expected to be less than the price to public. The Estimated Initial Value will reflect our and our affiliates' internal funding rate, which is the borrowing rate paid to issue market-linked securities, as well as the mid-market value of the embedded derivatives in the Notes. This internal funding rate is typically lower than the rate we would use when we issue conventional fixed or floating rate debt securities. As a result of the difference between our internal funding rate and the rate we would use when we issue conventional fixed or floating rate debt securities, the Estimated Initial Value of the Notes may be lower if it were based on the prices at which our fixed or floating rate debt securities trade in the secondary market. In addition, if we were to use the rate we use for our conventional fixed or floating rate debt issuances, we would expect the economic terms of the Notes to be more favorable to you. We will determine the value of the embedded derivatives in the Notes by reference to our or our affiliates' internal pricing models. These pricing models consider certain assumptions and variables, which can include volatility and interest rates. Different pricing models and assumptions could provide valuations for the Notes that are different from our Estimated Initial Value. These pricing models rely in part on certain forecasts about future events, which may prove to be incorrect. The Estimated Initial Value does not represent a minimum price at which we or any of our affiliates would be willing to purchase your Notes in the secondary market (if any exists) at any time.

**The price of your Notes in the secondary market, if any, immediately after the Trade Date is expected to be less than the price to public.**

The price to public takes into account certain costs. These costs, which will be used or retained by us or one of our affiliates, include our affiliates' projected hedging profits (which may or may not be realized) for assuming risks inherent in hedging our obligations under the Notes, the underwriting discount and the costs associated with structuring and hedging our obligations under the Notes. If you were to sell your Notes in the secondary market, if any, the price you would receive for your Notes may be less than the price you paid for them because secondary market prices will not take into account these costs. The price of your Notes in the secondary market, if any, at any time after issuance will vary based on many factors, including the values of the Underlyings and changes in market conditions, and cannot be predicted with accuracy. The Notes are not designed to be short-term trading instruments, and you should, therefore, be able and willing to hold the Notes to maturity. Any sale of the Notes prior to maturity could result in a loss to you.

**If we were to repurchase your Notes immediately after the Original Issue Date, the price you receive may be higher than the Estimated Initial Value of the Notes.** 

Assuming that all relevant factors remain constant after the Original Issue Date, the price at which HSBC Securities (USA) Inc. may initially buy or sell the Notes in the secondary market, if any, and the value that may initially be used for customer account statements, if any, may exceed the Estimated Initial Value on the Trade Date for a temporary period expected to be approximately 6 months after the Original Issue Date. This temporary price difference may exist because, in our discretion, we may elect to effectively reimburse to investors a portion of the estimated cost of hedging our obligations under the Notes and other costs in connection with the Notes that we will no longer expect to incur over the term of the Notes. We will make such discretionary election and determine this temporary reimbursement period on the basis of a number of factors, including the tenor of the Notes and any agreement we may have with the distributors of the Notes. The amount of our estimated costs which we effectively reimburse to investors in this way may not be allocated ratably throughout the reimbursement period, and we may discontinue such reimbursement at any time or revise the duration of the reimbursement period after the Original Issue Date of the Notes based on changes in market conditions and other factors that cannot be predicted.

**You will not have any ownership interest in the stocks included in an Underlying.**

As a holder of the Notes, you will not have any ownership interest in the stocks included in an Underlying, such as rights to vote, dividend payments or other distributions. Because the return on the Notes will not reflect any dividends on those stocks, the Notes may underperform an investment in the stocks included in an Underlying.

**The Notes lack liquidity.**

The Notes will not be listed on any securities exchange or automated quotation system. HSBC Securities (USA) Inc. is not required to offer to purchase the Notes in the secondary market, if any exists. Even if there is a secondary market, it may not provide enough liquidity to allow you to trade or sell the Notes easily. Because other dealers are not likely to make a secondary market for the Notes, the price at which you may be able to trade your Notes is likely to depend on the price, if any, at which HSBC Securities (USA) Inc. is willing to buy the Notes.

**Potential conflicts of interest may exist.**

An affiliate of HSBC has a minority equity interest in the owner of an electronic platform, through which we may make available certain structured investments offering materials. HSBC and its affiliates play a variety of roles in connection with the issuance of the Notes, including acting as calculation agent and hedging our obligations under the Notes. In performing these duties, the economic interests of the calculation agent and other affiliates of ours are potentially adverse to your interests as an investor in the Notes. We will not have any obligation to consider your interests as a holder of the Notes in taking any action that might affect the value of your Notes.

**Uncertain tax treatment.**

For a discussion of the U.S. federal income tax consequences of your investment in a Note, please see the discussion under "U.S. Federal Income Tax Considerations" herein and the discussion under "U.S. Federal Income Tax Considerations" in the accompanying prospectus supplement.

**ILLUSTRATIVE EXAMPLES**

The following table and examples are provided for illustrative purposes only and are hypothetical. They do not purport to be representative of every possible scenario concerning increases or decreases in the value of any Underlying relative to its Initial Value. We cannot predict the Official Closing Level of an Underlying on any Call Observation Date, including the Final Valuation Date. The assumptions we have made in connection with the illustrations set forth below may not reflect actual events. You should not take this illustration or these examples as an indication or assurance of the expected performance of the Underlyings or the return on the Notes.

The table and examples below illustrate how the Call Premium and the Payment at Maturity would be calculated with respect to a $1,000 investment in the Notes, given a range of hypothetical performances of any Underlying. The hypothetical returns on the Notes below are numbers, expressed as percentages, that result from comparing the Payment at Maturity per $1,000 Principal Amount to $1,000. The numbers appearing in the following table and examples may have been rounded for ease of analysis. The following table and examples assume the following:

⏵ Principal Amount: $1,000

⏵ Hypothetical Initial Value of each Underlying\*: 1,000.00

⏵ Hypothetical Call Threshold of each Underlying: 900.00 (90.00% the Initial Value)

⏵ Hypothetical Barrier Value of each Underlying: 750.00 (75.00% of its Hypothetical Initial Value)

⏵ Hypothetical Call Premium: 2.25% per quarter, payable as described on page FWP-4 under Call Observation Dates, Call Payment Dates, Call Premiums and Call Threshold. The actual Call Premium will be determined on the Trade Date and will be at least 9.00% per annum.

<sup>\*</sup> The hypothetical Initial Value of 1,000.00 used in the examples below has been chosen for illustrative purposes only and does not represent the actual Initial Value of any Underlying. The actual Initial Value of each Underlying will be determined on the Pricing Date and set forth in the final pricing supplement to which this free writing prospectus relates.

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Notes Are Called on a Call Observation Date** | **Notes Are Called on a Call Observation Date** | **Notes Are Not Called on Any Call Observation Date** | **Notes Are Not Called on Any Call Observation Date** |
| | **Example 1** | **Example 2** | **Example 3** | **Example 4** |
| Initial Value of each Underlying | 1000.00 | 1000.00 | 1000.00 | 1000.00 |
| Call Threshold of each Underlying | 900.00 | 900.00 | 900.00 | 900.00 |
| Barrier Value of each Underlying | 750.00 | 750.00 | 750.00 | 750.00 |
| **Observation Dates** | **Official Closing Level / Percentage Change of the Least Performing Underlying** | **Official Closing Level / Percentage Change of the Least Performing Underlying** | **Official Closing Level / Percentage Change of the Least Performing Underlying** | **Official Closing Level / Percentage Change of the Least Performing Underlying** |
| &nbsp;&nbsp;&nbsp;1<sup>st</sup> Call Observation Date | 1,200.00 / 20.00%<br>Call Premium: $90.00 | 802.50 / -19.75%<br>Call Premium: $0.00 | 802.50 / -19.75%<br>Call Premium: $0.00 | 675.00 / -32.50%<br>Call Premium: $0.00 |
| &nbsp;&nbsp;&nbsp;2<sup>nd</sup> Call Observation Date to 16<sup>th</sup> Call<br>Observation Date | N/A | Official Closing Level is<br>below the Call Threshold<br>Call Premium: $0.00 | Official Closing Level is<br>below the Call Threshold<br>Call Premium: $0.00 | Official Closing Level is<br>below the Call Threshold<br>Call Premium: $0.00 |
| &nbsp;&nbsp;&nbsp;Final Valuation Date | N/A | 1,200.00 / 20.00%<br>Call Premium: $450.00 | 772.50 / -22.75%<br>Call Premium: $0.00 | 525.00 / -47.50%<br>Call Premium: $0.00 |
| Payment if Notes are Called | $1090.00 | See below | N/A | N/A |
| Payment at Maturity | N/A | $1450.00 | $1000.00 | $1,000 + ($1,000 x -47.50%) = $525.00 |
| Return of the Notes | 9.00% | 45.00% | 0.00% | -47.50% |

---

**Example 1-The Official Closing Level of each Underlying on the first Call Observation Date is greater than or equal to its Call Threshold.**

---

| | | |
|:---|:---|:---|
| &nbsp;&nbsp;**Underlying** | &nbsp;&nbsp;**Initial Value** | &nbsp;&nbsp;**Official Closing Level** |
| &nbsp;&nbsp;SPX | &nbsp;&nbsp;1000.00 | &nbsp;&nbsp;1,250.00 (125.00% of Initial Value) |
| &nbsp;&nbsp;RTY | &nbsp;&nbsp;1000.00 | &nbsp;&nbsp;1,200.00 (120.00% of Initial Value) |
| &nbsp;&nbsp;INDU | &nbsp;&nbsp;1000.00 | &nbsp;&nbsp;1,290.00 (129.00% of Initial Value) |

---

---

| | |
|:---|:---|
| &nbsp;&nbsp;**Payment Upon a Call:** | &nbsp;&nbsp;**$1090.00** |

---

Because the Official Closing Level of each Underlying on the first Call Observation Date is at or above its Call Threshold, the Notes will be called and you will receive $1,090.00 per Note, reflecting the Principal Amount plus the applicable Call Premium, resulting in a 9.00% return on the Notes. No extra payment will be made on account of each Underlying closing above its respective Initial Value.

**Example 2-The Official Closing Level of each Underlying on the final Call Observation Date is greater than or equal to its Call Threshold.**

---

| | | |
|:---|:---|:---|
| &nbsp;&nbsp;**Underlying** | &nbsp;&nbsp;**Initial Value** | &nbsp;&nbsp;**Final Value** |
| &nbsp;&nbsp;SPX | &nbsp;&nbsp;1000.00 | &nbsp;&nbsp;1,250.00 (125.00% of Initial Value) |
| &nbsp;&nbsp;RTY | &nbsp;&nbsp;1000.00 | &nbsp;&nbsp;1,200.00 (120.00% of Initial Value) |
| &nbsp;&nbsp;INDU | &nbsp;&nbsp;1000.00 | &nbsp;&nbsp;1,300.00 (130.00% of Initial Value) |

---

---

| | |
|:---|:---|
| &nbsp;&nbsp;**Payment Upon a Call:** | &nbsp;&nbsp;**$1450.00** |

---

Because the Official Closing Level of each Underlying on the final Call Observation Date is at or above its Call Threshold, the Notes will be called and you will receive $1,450.00 per Note, reflecting the Principal Amount plus the applicable Call Premium, resulting in a 45.00% return on the Notes. No extra payment will be made on account of each Underlying closing above its respective Initial Value.

**Example 3- The Notes are not called and the Final Value of the Least Performing Underlying is greater than or equal to its Barrier Value.**

---

| | | |
|:---|:---|:---|
| &nbsp;&nbsp;**Underlying** | &nbsp;&nbsp;**Initial Value** | &nbsp;&nbsp;**Final Value** |
| &nbsp;&nbsp;SPX | &nbsp;&nbsp;1000.00 | &nbsp;&nbsp;1,150.00 (115.00% of Initial Value) |
| &nbsp;&nbsp;RTY | &nbsp;&nbsp;1000.00 | &nbsp;&nbsp;772.50 (77.25% of Initial Value) |
| &nbsp;&nbsp;INDU | &nbsp;&nbsp;1000.00 | &nbsp;&nbsp;1,100.00 (110.00% of Initial Value) |

---

The RTY is the Least Performing Underlying.

---

| | |
|:---|:---|
| &nbsp;&nbsp;Reference Return of the Least Performing Underlying: | &nbsp;&nbsp;-22.75% |
| &nbsp;&nbsp;**Payment at Maturity:** | &nbsp;&nbsp;**$1000.00** |

---

Because the Final Value of the Least Performing Underlying is less than its Call Threshold but is greater than or equal to the Barrier Value, you will receive $1,000 per Note, reflecting the Principal Amount, resulting in a 0.00% return on the Notes, even though the value of the Least Performing Underlying has declined.

**Example 4-The Notes are not called and the Final Value of the Least Performing Underlying is less than its Barrier Value.**

---

| | | |
|:---|:---|:---|
| &nbsp;&nbsp;**Underlying** | &nbsp;&nbsp;**Initial Value** | &nbsp;&nbsp;**Final Value** |
| &nbsp;&nbsp;SPX | &nbsp;&nbsp;1000.00 | &nbsp;&nbsp;1,100.00 (110.00% of Initial Value) |
| &nbsp;&nbsp;RTY | &nbsp;&nbsp;1000.00 | &nbsp;&nbsp;525.00 (52.50% of Initial Value) |
| &nbsp;&nbsp;INDU | &nbsp;&nbsp;1000.00 | &nbsp;&nbsp;1,050.00 (105.00% of Initial Value) |

---

The RTY is the Least Performing Underlying.

---

| | |
|:---|:---|
| &nbsp;&nbsp;Reference Return of the Least Performing Underlying: | &nbsp;&nbsp;-47.50% |
| &nbsp;&nbsp;**Payment at Maturity:** | &nbsp;&nbsp;**$525.00** |

---

Because the Final Value of the Least Performing Underlying is less than its Barrier Value, you will receive $525.00 per $1,000 Principal Amount, calculated as follows:

Final Settlement Value = $1,000 + ($1,000 x -47.50%) = $525.00

You will not receive a Call Premium, resulting in a -47.50% return on the Notes.

If the Notes are not called and the Final Value of the Least Performing Underlying is less than its Barrier Value, you will be exposed to any decrease in the value of the Least Performing Underlying on a 1:1 basis and could lose up to 100% of your principal at maturity.

**DESCRIPTION OF THE REFERENCE ASSET**

---

| | |
|:---|:---|
| **Description of the SPX** | **Historical Performance of the SPX**  |
| The S&P 500® Index ("SPX") is a market capitalization-weighted index intended to provide a performance benchmark for the large-cap U.S. equity markets. The SPX includes a representative sample of 500 companies in leading industries of the U.S. economy.<br>For more information about the SPX, see "The S&P 500® Index" beginning on page S-55 of the accompanying Equity Index Underlying Supplement. | The following graph sets forth the historical performance of the SPX based on the daily historical closing values from February 7, 2013 through February 7, 2023. We obtained the closing values below from the Bloomberg Professional® service. We have not undertaken any independent review of, or made any due diligence inquiry with respect to, the information obtained from the Bloomberg Professional® service.<br>![](tm235596d11dps_img08.jpg) |
| The historical values of the SPX should not be taken as an indication of future performance, and no assurance can be given as to the Official Closing Level of the SPX on any Call Observation Date, including the Final Valuation Date. | The historical values of the SPX should not be taken as an indication of future performance, and no assurance can be given as to the Official Closing Level of the SPX on any Call Observation Date, including the Final Valuation Date. |

---

---

| | |
|:---|:---|
| **Description of the RTY** | **Historical Performance of the RTY**  |
| The Russell 2000® Index ("RTY") is designed to track the performance of the small capitalization segment of the U.S. equity market. All 2,000 stocks are traded on a major U.S. exchange, and the RTY consists of the smallest 2,000 companies included in the Russell 3000® Index. The Russell 3000® Index is composed of the 3,000 largest U.S. companies as determined by market capitalization.<br>For more information about the RTY, see "The Russell 2000® Index" beginning on page S-45 of the accompanying Equity Index Underlying Supplement. | The following graph sets forth the historical performance of the RTY based on the daily historical closing values from February 7, 2013 through February 7, 2023. We obtained the closing values below from the Bloomberg Professional® service. We have not undertaken any independent review of, or made any due diligence inquiry with respect to, the information obtained from the Bloomberg Professional® service.<br>![](tm235596d11dps_img09.jpg) |
| The historical values of the RTY should not be taken as an indication of future performance, and no assurance can be given as to the Official Closing Level of the RTY on any Call Observation Date, including the Final Valuation Date. | The historical values of the RTY should not be taken as an indication of future performance, and no assurance can be given as to the Official Closing Level of the RTY on any Call Observation Date, including the Final Valuation Date. |

---

---

| | |
|:---|:---|
| **Description of the INDU** | **Historical Performance of the INDU**  |
| The Dow Jones Industrial Average® ("INDU") is a price-weighted index comprised of 30 blue-chip stocks, which represent nine economic sectors including consumer discretionary, consumer staples, communication services, energy, financials, health care, industrials, information technology and materials.<br>For more information about the INDU, see "The Dow Jones Industrial Average®" beginning on page S-10 of the accompanying Equity Index Underlying Supplement. | The following graph sets forth the historical performance of the INDU based on the daily historical closing values from February 7, 2013 through February 7, 2023. We obtained the closing values below from the Bloomberg Professional® service. We have not undertaken any independent review of, or made any due diligence inquiry with respect to, the information obtained from the Bloomberg Professional® service.<br>![](tm235596d11dps_img10.jpg) |
| The historical values of the INDU should not be taken as an indication of future performance, and no assurance can be given as to the Official Closing Level of the INDU on any Call Observation Date, including the Final Valuation Date. | The historical values of the INDU should not be taken as an indication of future performance, and no assurance can be given as to the Official Closing Level of the INDU on any Call Observation Date, including the Final Valuation Date. |

---

 ****

**EVENTS OF DEFAULT AND ACCELERATION**

If the Notes have become immediately due and payable following an Event of Default (as defined in the accompanying prospectus) with respect to the Notes, the calculation agent will determine the accelerated payment due and payable in the same general manner as described in this document except that in such a case, the scheduled trading day immediately preceding the date of acceleration will be used as the Final Valuation Date for purposes of determining the Reference Return of any Underlying, and the accelerated Maturity Date will be three business days after the accelerated Final Valuation Date. If a Market Disruption Event exists with respect to any Underlying on that scheduled trading day, then the accelerated Final Valuation Date for that Underlying will be postponed for up to five scheduled trading days (in the same manner used for postponing the originally scheduled Final Valuation Date). The accelerated Maturity Date will also be postponed by an equal number of business days. For the avoidance of doubt, if no Market Disruption Event exists with respect to an Underlying on the scheduled trading day preceding the date of acceleration, the determination of such Underlying's Reference Return will be made on such date, irrespective of the existence of a Market Disruption Event with respect to any other Underlying occurring on such date.

If the Notes have become immediately due and payable following an Event of Default, you will not be entitled to any additional payments with respect to the Notes. For more information, see "Description of Debt Securities — Senior Debt Securities — Events of Default" in the accompanying prospectus.

**SUPPLEMENTAL PLAN OF DISTRIBUTION (CONFLICTS OF INTEREST)**

We have appointed HSBC Securities (USA) Inc., an affiliate of HSBC, as the agent for the sale of the Notes. Pursuant to the terms of a distribution agreement, HSBC Securities (USA) Inc. will purchase the Notes from HSBC at the price to public less the underwriting discount set forth on the cover page of the pricing supplement to which this document relates, for distribution to other registered broker-dealers or will offer the Notes directly to investors. HSBC Securities (USA) Inc. proposes to offer the Notes at the price to public set forth on the cover page of this document. HSBC USA Inc. or one of our affiliates may pay varying underwriting discounts of up to 2.00% and structuring fees of up to 0.65% per $1,000 Principal Amount in connection with the distribution of the Notes to other registered broker-dealers. In no case will the sum of the underwriting discounts and structuring fees exceed 2.65% per $1,000 Principal Amount.

An affiliate of HSBC has paid or may pay in the future an amount to broker-dealers in connection with the costs of the continuing implementation of systems to support the Notes.

In addition, HSBC Securities (USA) Inc. or another of its affiliates or agents may use the pricing supplement to which this document relates in market-making transactions after the initial sale of the Notes, but is under no obligation to make a market in the Notes and may discontinue any market-making activities at any time without notice.

See "Supplemental Plan of Distribution (Conflicts of Interest)" on page S-83 in the prospectus supplement.

We expect that delivery of the Notes will be made against payment for the Notes on or about the Original Issue Date set forth on the inside cover page of this document, which is more than two business days following the Trade Date. Under Rule 15c6-1 under the Securities Exchange Act of 1934, trades in the secondary market generally are required to settle in two business days, unless the parties to that trade expressly agree otherwise. Accordingly, purchasers who wish to trade the Notes more than two business days prior to the Original Issue Date will be required to specify an alternate settlement cycle at the time of any such trade to prevent a failed settlement, and should consult their own advisors.

**U.S. FEDERAL INCOME TAX CONSIDERATIONS**

There is no direct legal authority as to the proper tax treatment of the Notes, and therefore significant aspects of the tax treatment of the Notes are uncertain as to both the timing and character of any inclusion in income in respect of the Notes. Under one approach, a Note should be treated as a pre-paid executory contract with respect to the Underlyings. We intend to treat the Notes consistent with this approach. Pursuant to the terms of the Notes, you agree to treat the Notes under this approach for all U.S. federal income tax purposes. Subject to the limitations described therein, and based on certain factual representations received from us, in the opinion of our special U.S. tax counsel, Mayer Brown LLP, it is reasonable to treat a Note as a pre-paid executory contract with respect to the Underlyings. Pursuant to this approach, we do not intend to report any income or gain with respect to the Notes prior to their maturity or an earlier sale, call or exchange and we intend to treat any gain or loss upon maturity or an earlier sale, call or exchange as long-term capital gain or loss, provided you have held the Note for more than one year at such time for U.S. federal income tax purposes. If the Notes are held by the same United States holder until maturity, that holder's holding period will generally include the maturity date.

We will not attempt to ascertain whether any of the entities whose stock is included in an Underlying would be treated as a passive foreign investment company ("PFIC") or United States real property holding corporation ("USRPHC"), both as defined for U.S. federal income tax purposes. If one or more of the entities whose stock is included in an Underlying were so treated, certain adverse U.S. federal income tax consequences might apply. You should refer to information filed with the SEC and other authorities by the entities whose stock is included in an Underlying and consult your tax advisor regarding the possible consequences to you if one or more of the entities whose stock is included in any Underlying is or becomes a PFIC or a USRPHC.

Under current law, while the matter is not entirely clear, individual non-U.S. holders, and entities whose property is potentially includible in those individuals' gross estates for U.S. federal estate tax purposes (for example, a trust funded by such an individual and with respect to which the individual has retained certain interests or powers), should note that, absent an applicable treaty benefit, the Notes are likely to be treated as U.S. situs property, subject to U.S. federal estate tax. These individuals and entities should consult their own tax advisors regarding the U.S. federal estate tax consequences of investing in the Notes.

A "dividend equivalent" payment is treated as a dividend from sources within the United States and such payments generally would be subject to a 30% U.S. withholding tax if paid to a non-U.S. holder. Under U.S. Treasury Department regulations, payments (including deemed payments) with respect to equity-linked instruments ("ELIs") that are "specified ELIs" may be treated as dividend equivalents if such specified ELIs reference an interest in an "underlying security," which is generally any interest in an entity taxable as a corporation for U.S. federal income tax purposes if a payment with respect to such interest could give rise to a U.S. source dividend. However, Internal Revenue Service guidance provides that withholding on dividend equivalent payments will not apply to specified ELIs that are not delta-one instruments and that are issued before January 1, 2025. Based on the Issuer's determination that the Notes are not "delta-one" instruments, non-U.S. holders should not be subject to withholding on dividend equivalent payments, if any, under the Notes. However, it is possible that the Notes could be treated as deemed reissued for U.S. federal income tax purposes upon the occurrence of certain events affecting an Underlying or the Notes, and following such occurrence the Notes could be treated as subject to withholding on dividend equivalent payments. Non-U.S. holders that enter, or have entered, into other transactions in respect of an Underlying or the Notes should consult their tax advisors as to the application of the dividend equivalent withholding tax in the context of the Notes and their other transactions. If any payments are treated as dividend equivalents subject to withholding, we (or the applicable paying agent) would be entitled to withhold taxes without being required to pay any additional amounts with respect to amounts so withheld.

For a discussion of the U.S. federal income tax consequences of your investment in a Note, please see the discussion under "U.S. Federal Income Tax Considerations" in the accompanying prospectus supplement.

PROSPECTIVE PURCHASERS OF NOTES SHOULD CONSULT THEIR TAX ADVISORS AS TO THE FEDERAL, STATE, LOCAL, AND OTHER TAX CONSEQUENCES TO THEM OF THE PURCHASE, OWNERSHIP AND DISPOSITION OF NOTES.

---

| | | |
|:---|:---|:---|
| **TABLE OF CONTENTS** |  | &nbsp;&nbsp;<br> You should only rely on the information contained in this document, the accompanying Equity Index Underlying Supplement, prospectus supplement and prospectus. We have not authorized anyone to provide you with information or to make any representation to you that is not contained in this document, the accompanying Equity Index Underlying Supplement, prospectus supplement and prospectus. If anyone provides you with different or inconsistent information, you should not rely on it. This document, the accompanying Equity Index Underlying Supplement, prospectus supplement and prospectus are not an offer to sell these Notes, and these documents are not soliciting an offer to buy these Notes, in any jurisdiction where the offer or sale is not permitted. You should not, under any circumstances, assume that the information in this document, the accompanying Equity Index Underlying Supplement, prospectus supplement and prospectus is correct on any date after their respective dates. <br>**HSBC USA Inc.**<br>**$[ ]** <br> **Autocallable Barrier Notes with Step-up Premium<br> Linked to the Least Performing of <br>the S&P 500<sup>®</sup> Index, <br>the Russell 2000<sup>®</sup> Index and<br>the Dow Jones Industrial Average<sup>®</sup>**<br>**February 8, 2023**<br>**Free Writing Prospectus** |
|  |  | &nbsp;&nbsp;<br> You should only rely on the information contained in this document, the accompanying Equity Index Underlying Supplement, prospectus supplement and prospectus. We have not authorized anyone to provide you with information or to make any representation to you that is not contained in this document, the accompanying Equity Index Underlying Supplement, prospectus supplement and prospectus. If anyone provides you with different or inconsistent information, you should not rely on it. This document, the accompanying Equity Index Underlying Supplement, prospectus supplement and prospectus are not an offer to sell these Notes, and these documents are not soliciting an offer to buy these Notes, in any jurisdiction where the offer or sale is not permitted. You should not, under any circumstances, assume that the information in this document, the accompanying Equity Index Underlying Supplement, prospectus supplement and prospectus is correct on any date after their respective dates. <br>**HSBC USA Inc.**<br>**$[ ]** <br> **Autocallable Barrier Notes with Step-up Premium<br> Linked to the Least Performing of <br>the S&P 500<sup>®</sup> Index, <br>the Russell 2000<sup>®</sup> Index and<br>the Dow Jones Industrial Average<sup>®</sup>**<br>**February 8, 2023**<br>**Free Writing Prospectus** |
| **Free Writing Prospectus** | **Free Writing Prospectus** | &nbsp;&nbsp;<br> You should only rely on the information contained in this document, the accompanying Equity Index Underlying Supplement, prospectus supplement and prospectus. We have not authorized anyone to provide you with information or to make any representation to you that is not contained in this document, the accompanying Equity Index Underlying Supplement, prospectus supplement and prospectus. If anyone provides you with different or inconsistent information, you should not rely on it. This document, the accompanying Equity Index Underlying Supplement, prospectus supplement and prospectus are not an offer to sell these Notes, and these documents are not soliciting an offer to buy these Notes, in any jurisdiction where the offer or sale is not permitted. You should not, under any circumstances, assume that the information in this document, the accompanying Equity Index Underlying Supplement, prospectus supplement and prospectus is correct on any date after their respective dates. <br>**HSBC USA Inc.**<br>**$[ ]** <br> **Autocallable Barrier Notes with Step-up Premium<br> Linked to the Least Performing of <br>the S&P 500<sup>®</sup> Index, <br>the Russell 2000<sup>®</sup> Index and<br>the Dow Jones Industrial Average<sup>®</sup>**<br>**February 8, 2023**<br>**Free Writing Prospectus** |
| General | FWP-5 | &nbsp;&nbsp;<br> You should only rely on the information contained in this document, the accompanying Equity Index Underlying Supplement, prospectus supplement and prospectus. We have not authorized anyone to provide you with information or to make any representation to you that is not contained in this document, the accompanying Equity Index Underlying Supplement, prospectus supplement and prospectus. If anyone provides you with different or inconsistent information, you should not rely on it. This document, the accompanying Equity Index Underlying Supplement, prospectus supplement and prospectus are not an offer to sell these Notes, and these documents are not soliciting an offer to buy these Notes, in any jurisdiction where the offer or sale is not permitted. You should not, under any circumstances, assume that the information in this document, the accompanying Equity Index Underlying Supplement, prospectus supplement and prospectus is correct on any date after their respective dates. <br>**HSBC USA Inc.**<br>**$[ ]** <br> **Autocallable Barrier Notes with Step-up Premium<br> Linked to the Least Performing of <br>the S&P 500<sup>®</sup> Index, <br>the Russell 2000<sup>®</sup> Index and<br>the Dow Jones Industrial Average<sup>®</sup>**<br>**February 8, 2023**<br>**Free Writing Prospectus** |
| Payment on the Notes | FWP-5 | &nbsp;&nbsp;<br> You should only rely on the information contained in this document, the accompanying Equity Index Underlying Supplement, prospectus supplement and prospectus. We have not authorized anyone to provide you with information or to make any representation to you that is not contained in this document, the accompanying Equity Index Underlying Supplement, prospectus supplement and prospectus. If anyone provides you with different or inconsistent information, you should not rely on it. This document, the accompanying Equity Index Underlying Supplement, prospectus supplement and prospectus are not an offer to sell these Notes, and these documents are not soliciting an offer to buy these Notes, in any jurisdiction where the offer or sale is not permitted. You should not, under any circumstances, assume that the information in this document, the accompanying Equity Index Underlying Supplement, prospectus supplement and prospectus is correct on any date after their respective dates. <br>**HSBC USA Inc.**<br>**$[ ]** <br> **Autocallable Barrier Notes with Step-up Premium<br> Linked to the Least Performing of <br>the S&P 500<sup>®</sup> Index, <br>the Russell 2000<sup>®</sup> Index and<br>the Dow Jones Industrial Average<sup>®</sup>**<br>**February 8, 2023**<br>**Free Writing Prospectus** |
| Investor Suitability | FWP-6 | &nbsp;&nbsp;<br> You should only rely on the information contained in this document, the accompanying Equity Index Underlying Supplement, prospectus supplement and prospectus. We have not authorized anyone to provide you with information or to make any representation to you that is not contained in this document, the accompanying Equity Index Underlying Supplement, prospectus supplement and prospectus. If anyone provides you with different or inconsistent information, you should not rely on it. This document, the accompanying Equity Index Underlying Supplement, prospectus supplement and prospectus are not an offer to sell these Notes, and these documents are not soliciting an offer to buy these Notes, in any jurisdiction where the offer or sale is not permitted. You should not, under any circumstances, assume that the information in this document, the accompanying Equity Index Underlying Supplement, prospectus supplement and prospectus is correct on any date after their respective dates. <br>**HSBC USA Inc.**<br>**$[ ]** <br> **Autocallable Barrier Notes with Step-up Premium<br> Linked to the Least Performing of <br>the S&P 500<sup>®</sup> Index, <br>the Russell 2000<sup>®</sup> Index and<br>the Dow Jones Industrial Average<sup>®</sup>**<br>**February 8, 2023**<br>**Free Writing Prospectus** |
| Risk Factors | FWP-7 | &nbsp;&nbsp;<br> You should only rely on the information contained in this document, the accompanying Equity Index Underlying Supplement, prospectus supplement and prospectus. We have not authorized anyone to provide you with information or to make any representation to you that is not contained in this document, the accompanying Equity Index Underlying Supplement, prospectus supplement and prospectus. If anyone provides you with different or inconsistent information, you should not rely on it. This document, the accompanying Equity Index Underlying Supplement, prospectus supplement and prospectus are not an offer to sell these Notes, and these documents are not soliciting an offer to buy these Notes, in any jurisdiction where the offer or sale is not permitted. You should not, under any circumstances, assume that the information in this document, the accompanying Equity Index Underlying Supplement, prospectus supplement and prospectus is correct on any date after their respective dates. <br>**HSBC USA Inc.**<br>**$[ ]** <br> **Autocallable Barrier Notes with Step-up Premium<br> Linked to the Least Performing of <br>the S&P 500<sup>®</sup> Index, <br>the Russell 2000<sup>®</sup> Index and<br>the Dow Jones Industrial Average<sup>®</sup>**<br>**February 8, 2023**<br>**Free Writing Prospectus** |
| Illustrative Examples | FWP-8 | &nbsp;&nbsp;<br> You should only rely on the information contained in this document, the accompanying Equity Index Underlying Supplement, prospectus supplement and prospectus. We have not authorized anyone to provide you with information or to make any representation to you that is not contained in this document, the accompanying Equity Index Underlying Supplement, prospectus supplement and prospectus. If anyone provides you with different or inconsistent information, you should not rely on it. This document, the accompanying Equity Index Underlying Supplement, prospectus supplement and prospectus are not an offer to sell these Notes, and these documents are not soliciting an offer to buy these Notes, in any jurisdiction where the offer or sale is not permitted. You should not, under any circumstances, assume that the information in this document, the accompanying Equity Index Underlying Supplement, prospectus supplement and prospectus is correct on any date after their respective dates. <br>**HSBC USA Inc.**<br>**$[ ]** <br> **Autocallable Barrier Notes with Step-up Premium<br> Linked to the Least Performing of <br>the S&P 500<sup>®</sup> Index, <br>the Russell 2000<sup>®</sup> Index and<br>the Dow Jones Industrial Average<sup>®</sup>**<br>**February 8, 2023**<br>**Free Writing Prospectus** |
| Description of the Reference Asset | FWP-10 | &nbsp;&nbsp;<br> You should only rely on the information contained in this document, the accompanying Equity Index Underlying Supplement, prospectus supplement and prospectus. We have not authorized anyone to provide you with information or to make any representation to you that is not contained in this document, the accompanying Equity Index Underlying Supplement, prospectus supplement and prospectus. If anyone provides you with different or inconsistent information, you should not rely on it. This document, the accompanying Equity Index Underlying Supplement, prospectus supplement and prospectus are not an offer to sell these Notes, and these documents are not soliciting an offer to buy these Notes, in any jurisdiction where the offer or sale is not permitted. You should not, under any circumstances, assume that the information in this document, the accompanying Equity Index Underlying Supplement, prospectus supplement and prospectus is correct on any date after their respective dates. <br>**HSBC USA Inc.**<br>**$[ ]** <br> **Autocallable Barrier Notes with Step-up Premium<br> Linked to the Least Performing of <br>the S&P 500<sup>®</sup> Index, <br>the Russell 2000<sup>®</sup> Index and<br>the Dow Jones Industrial Average<sup>®</sup>**<br>**February 8, 2023**<br>**Free Writing Prospectus** |
| Events of Default and Acceleration | FWP-11 | &nbsp;&nbsp;<br> You should only rely on the information contained in this document, the accompanying Equity Index Underlying Supplement, prospectus supplement and prospectus. We have not authorized anyone to provide you with information or to make any representation to you that is not contained in this document, the accompanying Equity Index Underlying Supplement, prospectus supplement and prospectus. If anyone provides you with different or inconsistent information, you should not rely on it. This document, the accompanying Equity Index Underlying Supplement, prospectus supplement and prospectus are not an offer to sell these Notes, and these documents are not soliciting an offer to buy these Notes, in any jurisdiction where the offer or sale is not permitted. You should not, under any circumstances, assume that the information in this document, the accompanying Equity Index Underlying Supplement, prospectus supplement and prospectus is correct on any date after their respective dates. <br>**HSBC USA Inc.**<br>**$[ ]** <br> **Autocallable Barrier Notes with Step-up Premium<br> Linked to the Least Performing of <br>the S&P 500<sup>®</sup> Index, <br>the Russell 2000<sup>®</sup> Index and<br>the Dow Jones Industrial Average<sup>®</sup>**<br>**February 8, 2023**<br>**Free Writing Prospectus** |
| Supplemental Plan of Distribution (Conflicts of Interest) | FWP-11 | &nbsp;&nbsp;<br> You should only rely on the information contained in this document, the accompanying Equity Index Underlying Supplement, prospectus supplement and prospectus. We have not authorized anyone to provide you with information or to make any representation to you that is not contained in this document, the accompanying Equity Index Underlying Supplement, prospectus supplement and prospectus. If anyone provides you with different or inconsistent information, you should not rely on it. This document, the accompanying Equity Index Underlying Supplement, prospectus supplement and prospectus are not an offer to sell these Notes, and these documents are not soliciting an offer to buy these Notes, in any jurisdiction where the offer or sale is not permitted. You should not, under any circumstances, assume that the information in this document, the accompanying Equity Index Underlying Supplement, prospectus supplement and prospectus is correct on any date after their respective dates. <br>**HSBC USA Inc.**<br>**$[ ]** <br> **Autocallable Barrier Notes with Step-up Premium<br> Linked to the Least Performing of <br>the S&P 500<sup>®</sup> Index, <br>the Russell 2000<sup>®</sup> Index and<br>the Dow Jones Industrial Average<sup>®</sup>**<br>**February 8, 2023**<br>**Free Writing Prospectus** |
| U.S. Federal Income Tax Considerations | FWP-12 | &nbsp;&nbsp;<br> You should only rely on the information contained in this document, the accompanying Equity Index Underlying Supplement, prospectus supplement and prospectus. We have not authorized anyone to provide you with information or to make any representation to you that is not contained in this document, the accompanying Equity Index Underlying Supplement, prospectus supplement and prospectus. If anyone provides you with different or inconsistent information, you should not rely on it. This document, the accompanying Equity Index Underlying Supplement, prospectus supplement and prospectus are not an offer to sell these Notes, and these documents are not soliciting an offer to buy these Notes, in any jurisdiction where the offer or sale is not permitted. You should not, under any circumstances, assume that the information in this document, the accompanying Equity Index Underlying Supplement, prospectus supplement and prospectus is correct on any date after their respective dates. <br>**HSBC USA Inc.**<br>**$[ ]** <br> **Autocallable Barrier Notes with Step-up Premium<br> Linked to the Least Performing of <br>the S&P 500<sup>®</sup> Index, <br>the Russell 2000<sup>®</sup> Index and<br>the Dow Jones Industrial Average<sup>®</sup>**<br>**February 8, 2023**<br>**Free Writing Prospectus** |
|  |  | &nbsp;&nbsp;<br> You should only rely on the information contained in this document, the accompanying Equity Index Underlying Supplement, prospectus supplement and prospectus. We have not authorized anyone to provide you with information or to make any representation to you that is not contained in this document, the accompanying Equity Index Underlying Supplement, prospectus supplement and prospectus. If anyone provides you with different or inconsistent information, you should not rely on it. This document, the accompanying Equity Index Underlying Supplement, prospectus supplement and prospectus are not an offer to sell these Notes, and these documents are not soliciting an offer to buy these Notes, in any jurisdiction where the offer or sale is not permitted. You should not, under any circumstances, assume that the information in this document, the accompanying Equity Index Underlying Supplement, prospectus supplement and prospectus is correct on any date after their respective dates. <br>**HSBC USA Inc.**<br>**$[ ]** <br> **Autocallable Barrier Notes with Step-up Premium<br> Linked to the Least Performing of <br>the S&P 500<sup>®</sup> Index, <br>the Russell 2000<sup>®</sup> Index and<br>the Dow Jones Industrial Average<sup>®</sup>**<br>**February 8, 2023**<br>**Free Writing Prospectus** |
| **Equity Index Underlying Supplement** | **Equity Index Underlying Supplement** | &nbsp;&nbsp;<br> You should only rely on the information contained in this document, the accompanying Equity Index Underlying Supplement, prospectus supplement and prospectus. We have not authorized anyone to provide you with information or to make any representation to you that is not contained in this document, the accompanying Equity Index Underlying Supplement, prospectus supplement and prospectus. If anyone provides you with different or inconsistent information, you should not rely on it. This document, the accompanying Equity Index Underlying Supplement, prospectus supplement and prospectus are not an offer to sell these Notes, and these documents are not soliciting an offer to buy these Notes, in any jurisdiction where the offer or sale is not permitted. You should not, under any circumstances, assume that the information in this document, the accompanying Equity Index Underlying Supplement, prospectus supplement and prospectus is correct on any date after their respective dates. <br>**HSBC USA Inc.**<br>**$[ ]** <br> **Autocallable Barrier Notes with Step-up Premium<br> Linked to the Least Performing of <br>the S&P 500<sup>®</sup> Index, <br>the Russell 2000<sup>®</sup> Index and<br>the Dow Jones Industrial Average<sup>®</sup>**<br>**February 8, 2023**<br>**Free Writing Prospectus** |
| Disclaimer | ii | &nbsp;&nbsp;<br> You should only rely on the information contained in this document, the accompanying Equity Index Underlying Supplement, prospectus supplement and prospectus. We have not authorized anyone to provide you with information or to make any representation to you that is not contained in this document, the accompanying Equity Index Underlying Supplement, prospectus supplement and prospectus. If anyone provides you with different or inconsistent information, you should not rely on it. This document, the accompanying Equity Index Underlying Supplement, prospectus supplement and prospectus are not an offer to sell these Notes, and these documents are not soliciting an offer to buy these Notes, in any jurisdiction where the offer or sale is not permitted. You should not, under any circumstances, assume that the information in this document, the accompanying Equity Index Underlying Supplement, prospectus supplement and prospectus is correct on any date after their respective dates. <br>**HSBC USA Inc.**<br>**$[ ]** <br> **Autocallable Barrier Notes with Step-up Premium<br> Linked to the Least Performing of <br>the S&P 500<sup>®</sup> Index, <br>the Russell 2000<sup>®</sup> Index and<br>the Dow Jones Industrial Average<sup>®</sup>**<br>**February 8, 2023**<br>**Free Writing Prospectus** |
| Risk Factors | S-1 | &nbsp;&nbsp;<br> You should only rely on the information contained in this document, the accompanying Equity Index Underlying Supplement, prospectus supplement and prospectus. We have not authorized anyone to provide you with information or to make any representation to you that is not contained in this document, the accompanying Equity Index Underlying Supplement, prospectus supplement and prospectus. If anyone provides you with different or inconsistent information, you should not rely on it. This document, the accompanying Equity Index Underlying Supplement, prospectus supplement and prospectus are not an offer to sell these Notes, and these documents are not soliciting an offer to buy these Notes, in any jurisdiction where the offer or sale is not permitted. You should not, under any circumstances, assume that the information in this document, the accompanying Equity Index Underlying Supplement, prospectus supplement and prospectus is correct on any date after their respective dates. <br>**HSBC USA Inc.**<br>**$[ ]** <br> **Autocallable Barrier Notes with Step-up Premium<br> Linked to the Least Performing of <br>the S&P 500<sup>®</sup> Index, <br>the Russell 2000<sup>®</sup> Index and<br>the Dow Jones Industrial Average<sup>®</sup>**<br>**February 8, 2023**<br>**Free Writing Prospectus** |
| The DAX® Index | S-8 | &nbsp;&nbsp;<br> You should only rely on the information contained in this document, the accompanying Equity Index Underlying Supplement, prospectus supplement and prospectus. We have not authorized anyone to provide you with information or to make any representation to you that is not contained in this document, the accompanying Equity Index Underlying Supplement, prospectus supplement and prospectus. If anyone provides you with different or inconsistent information, you should not rely on it. This document, the accompanying Equity Index Underlying Supplement, prospectus supplement and prospectus are not an offer to sell these Notes, and these documents are not soliciting an offer to buy these Notes, in any jurisdiction where the offer or sale is not permitted. You should not, under any circumstances, assume that the information in this document, the accompanying Equity Index Underlying Supplement, prospectus supplement and prospectus is correct on any date after their respective dates. <br>**HSBC USA Inc.**<br>**$[ ]** <br> **Autocallable Barrier Notes with Step-up Premium<br> Linked to the Least Performing of <br>the S&P 500<sup>®</sup> Index, <br>the Russell 2000<sup>®</sup> Index and<br>the Dow Jones Industrial Average<sup>®</sup>**<br>**February 8, 2023**<br>**Free Writing Prospectus** |
| The Dow Jones Industrial Average® | S-10 | &nbsp;&nbsp;<br> You should only rely on the information contained in this document, the accompanying Equity Index Underlying Supplement, prospectus supplement and prospectus. We have not authorized anyone to provide you with information or to make any representation to you that is not contained in this document, the accompanying Equity Index Underlying Supplement, prospectus supplement and prospectus. If anyone provides you with different or inconsistent information, you should not rely on it. This document, the accompanying Equity Index Underlying Supplement, prospectus supplement and prospectus are not an offer to sell these Notes, and these documents are not soliciting an offer to buy these Notes, in any jurisdiction where the offer or sale is not permitted. You should not, under any circumstances, assume that the information in this document, the accompanying Equity Index Underlying Supplement, prospectus supplement and prospectus is correct on any date after their respective dates. <br>**HSBC USA Inc.**<br>**$[ ]** <br> **Autocallable Barrier Notes with Step-up Premium<br> Linked to the Least Performing of <br>the S&P 500<sup>®</sup> Index, <br>the Russell 2000<sup>®</sup> Index and<br>the Dow Jones Industrial Average<sup>®</sup>**<br>**February 8, 2023**<br>**Free Writing Prospectus** |
| The EURO STOXX 50® Index | S-12 | &nbsp;&nbsp;<br> You should only rely on the information contained in this document, the accompanying Equity Index Underlying Supplement, prospectus supplement and prospectus. We have not authorized anyone to provide you with information or to make any representation to you that is not contained in this document, the accompanying Equity Index Underlying Supplement, prospectus supplement and prospectus. If anyone provides you with different or inconsistent information, you should not rely on it. This document, the accompanying Equity Index Underlying Supplement, prospectus supplement and prospectus are not an offer to sell these Notes, and these documents are not soliciting an offer to buy these Notes, in any jurisdiction where the offer or sale is not permitted. You should not, under any circumstances, assume that the information in this document, the accompanying Equity Index Underlying Supplement, prospectus supplement and prospectus is correct on any date after their respective dates. <br>**HSBC USA Inc.**<br>**$[ ]** <br> **Autocallable Barrier Notes with Step-up Premium<br> Linked to the Least Performing of <br>the S&P 500<sup>®</sup> Index, <br>the Russell 2000<sup>®</sup> Index and<br>the Dow Jones Industrial Average<sup>®</sup>**<br>**February 8, 2023**<br>**Free Writing Prospectus** |
| The EURO STOXX® Banks Index | S-14 | &nbsp;&nbsp;<br> You should only rely on the information contained in this document, the accompanying Equity Index Underlying Supplement, prospectus supplement and prospectus. We have not authorized anyone to provide you with information or to make any representation to you that is not contained in this document, the accompanying Equity Index Underlying Supplement, prospectus supplement and prospectus. If anyone provides you with different or inconsistent information, you should not rely on it. This document, the accompanying Equity Index Underlying Supplement, prospectus supplement and prospectus are not an offer to sell these Notes, and these documents are not soliciting an offer to buy these Notes, in any jurisdiction where the offer or sale is not permitted. You should not, under any circumstances, assume that the information in this document, the accompanying Equity Index Underlying Supplement, prospectus supplement and prospectus is correct on any date after their respective dates. <br>**HSBC USA Inc.**<br>**$[ ]** <br> **Autocallable Barrier Notes with Step-up Premium<br> Linked to the Least Performing of <br>the S&P 500<sup>®</sup> Index, <br>the Russell 2000<sup>®</sup> Index and<br>the Dow Jones Industrial Average<sup>®</sup>**<br>**February 8, 2023**<br>**Free Writing Prospectus** |
| The FTSE® 100 Index | S-16 | &nbsp;&nbsp;<br> You should only rely on the information contained in this document, the accompanying Equity Index Underlying Supplement, prospectus supplement and prospectus. We have not authorized anyone to provide you with information or to make any representation to you that is not contained in this document, the accompanying Equity Index Underlying Supplement, prospectus supplement and prospectus. If anyone provides you with different or inconsistent information, you should not rely on it. This document, the accompanying Equity Index Underlying Supplement, prospectus supplement and prospectus are not an offer to sell these Notes, and these documents are not soliciting an offer to buy these Notes, in any jurisdiction where the offer or sale is not permitted. You should not, under any circumstances, assume that the information in this document, the accompanying Equity Index Underlying Supplement, prospectus supplement and prospectus is correct on any date after their respective dates. <br>**HSBC USA Inc.**<br>**$[ ]** <br> **Autocallable Barrier Notes with Step-up Premium<br> Linked to the Least Performing of <br>the S&P 500<sup>®</sup> Index, <br>the Russell 2000<sup>®</sup> Index and<br>the Dow Jones Industrial Average<sup>®</sup>**<br>**February 8, 2023**<br>**Free Writing Prospectus** |
| The Hang Seng® Index | S-17 | &nbsp;&nbsp;<br> You should only rely on the information contained in this document, the accompanying Equity Index Underlying Supplement, prospectus supplement and prospectus. We have not authorized anyone to provide you with information or to make any representation to you that is not contained in this document, the accompanying Equity Index Underlying Supplement, prospectus supplement and prospectus. If anyone provides you with different or inconsistent information, you should not rely on it. This document, the accompanying Equity Index Underlying Supplement, prospectus supplement and prospectus are not an offer to sell these Notes, and these documents are not soliciting an offer to buy these Notes, in any jurisdiction where the offer or sale is not permitted. You should not, under any circumstances, assume that the information in this document, the accompanying Equity Index Underlying Supplement, prospectus supplement and prospectus is correct on any date after their respective dates. <br>**HSBC USA Inc.**<br>**$[ ]** <br> **Autocallable Barrier Notes with Step-up Premium<br> Linked to the Least Performing of <br>the S&P 500<sup>®</sup> Index, <br>the Russell 2000<sup>®</sup> Index and<br>the Dow Jones Industrial Average<sup>®</sup>**<br>**February 8, 2023**<br>**Free Writing Prospectus** |
| The Hang Seng China Enterprises Index | S-19 | &nbsp;&nbsp;<br> You should only rely on the information contained in this document, the accompanying Equity Index Underlying Supplement, prospectus supplement and prospectus. We have not authorized anyone to provide you with information or to make any representation to you that is not contained in this document, the accompanying Equity Index Underlying Supplement, prospectus supplement and prospectus. If anyone provides you with different or inconsistent information, you should not rely on it. This document, the accompanying Equity Index Underlying Supplement, prospectus supplement and prospectus are not an offer to sell these Notes, and these documents are not soliciting an offer to buy these Notes, in any jurisdiction where the offer or sale is not permitted. You should not, under any circumstances, assume that the information in this document, the accompanying Equity Index Underlying Supplement, prospectus supplement and prospectus is correct on any date after their respective dates. <br>**HSBC USA Inc.**<br>**$[ ]** <br> **Autocallable Barrier Notes with Step-up Premium<br> Linked to the Least Performing of <br>the S&P 500<sup>®</sup> Index, <br>the Russell 2000<sup>®</sup> Index and<br>the Dow Jones Industrial Average<sup>®</sup>**<br>**February 8, 2023**<br>**Free Writing Prospectus** |
| The KOSPI 200 Index | S-22 | &nbsp;&nbsp;<br> You should only rely on the information contained in this document, the accompanying Equity Index Underlying Supplement, prospectus supplement and prospectus. We have not authorized anyone to provide you with information or to make any representation to you that is not contained in this document, the accompanying Equity Index Underlying Supplement, prospectus supplement and prospectus. If anyone provides you with different or inconsistent information, you should not rely on it. This document, the accompanying Equity Index Underlying Supplement, prospectus supplement and prospectus are not an offer to sell these Notes, and these documents are not soliciting an offer to buy these Notes, in any jurisdiction where the offer or sale is not permitted. You should not, under any circumstances, assume that the information in this document, the accompanying Equity Index Underlying Supplement, prospectus supplement and prospectus is correct on any date after their respective dates. <br>**HSBC USA Inc.**<br>**$[ ]** <br> **Autocallable Barrier Notes with Step-up Premium<br> Linked to the Least Performing of <br>the S&P 500<sup>®</sup> Index, <br>the Russell 2000<sup>®</sup> Index and<br>the Dow Jones Industrial Average<sup>®</sup>**<br>**February 8, 2023**<br>**Free Writing Prospectus** |
| The MSCI Indices | S-24 | &nbsp;&nbsp;<br> You should only rely on the information contained in this document, the accompanying Equity Index Underlying Supplement, prospectus supplement and prospectus. We have not authorized anyone to provide you with information or to make any representation to you that is not contained in this document, the accompanying Equity Index Underlying Supplement, prospectus supplement and prospectus. If anyone provides you with different or inconsistent information, you should not rely on it. This document, the accompanying Equity Index Underlying Supplement, prospectus supplement and prospectus are not an offer to sell these Notes, and these documents are not soliciting an offer to buy these Notes, in any jurisdiction where the offer or sale is not permitted. You should not, under any circumstances, assume that the information in this document, the accompanying Equity Index Underlying Supplement, prospectus supplement and prospectus is correct on any date after their respective dates. <br>**HSBC USA Inc.**<br>**$[ ]** <br> **Autocallable Barrier Notes with Step-up Premium<br> Linked to the Least Performing of <br>the S&P 500<sup>®</sup> Index, <br>the Russell 2000<sup>®</sup> Index and<br>the Dow Jones Industrial Average<sup>®</sup>**<br>**February 8, 2023**<br>**Free Writing Prospectus** |
| The NASDAQ 100 Index® | S-31 | &nbsp;&nbsp;<br> You should only rely on the information contained in this document, the accompanying Equity Index Underlying Supplement, prospectus supplement and prospectus. We have not authorized anyone to provide you with information or to make any representation to you that is not contained in this document, the accompanying Equity Index Underlying Supplement, prospectus supplement and prospectus. If anyone provides you with different or inconsistent information, you should not rely on it. This document, the accompanying Equity Index Underlying Supplement, prospectus supplement and prospectus are not an offer to sell these Notes, and these documents are not soliciting an offer to buy these Notes, in any jurisdiction where the offer or sale is not permitted. You should not, under any circumstances, assume that the information in this document, the accompanying Equity Index Underlying Supplement, prospectus supplement and prospectus is correct on any date after their respective dates. <br>**HSBC USA Inc.**<br>**$[ ]** <br> **Autocallable Barrier Notes with Step-up Premium<br> Linked to the Least Performing of <br>the S&P 500<sup>®</sup> Index, <br>the Russell 2000<sup>®</sup> Index and<br>the Dow Jones Industrial Average<sup>®</sup>**<br>**February 8, 2023**<br>**Free Writing Prospectus** |
| The Nikkei Stock Average | S-34 | &nbsp;&nbsp;<br> You should only rely on the information contained in this document, the accompanying Equity Index Underlying Supplement, prospectus supplement and prospectus. We have not authorized anyone to provide you with information or to make any representation to you that is not contained in this document, the accompanying Equity Index Underlying Supplement, prospectus supplement and prospectus. If anyone provides you with different or inconsistent information, you should not rely on it. This document, the accompanying Equity Index Underlying Supplement, prospectus supplement and prospectus are not an offer to sell these Notes, and these documents are not soliciting an offer to buy these Notes, in any jurisdiction where the offer or sale is not permitted. You should not, under any circumstances, assume that the information in this document, the accompanying Equity Index Underlying Supplement, prospectus supplement and prospectus is correct on any date after their respective dates. <br>**HSBC USA Inc.**<br>**$[ ]** <br> **Autocallable Barrier Notes with Step-up Premium<br> Linked to the Least Performing of <br>the S&P 500<sup>®</sup> Index, <br>the Russell 2000<sup>®</sup> Index and<br>the Dow Jones Industrial Average<sup>®</sup>**<br>**February 8, 2023**<br>**Free Writing Prospectus** |
| The NYSE® FANG+™ Index | S-36 | &nbsp;&nbsp;<br> You should only rely on the information contained in this document, the accompanying Equity Index Underlying Supplement, prospectus supplement and prospectus. We have not authorized anyone to provide you with information or to make any representation to you that is not contained in this document, the accompanying Equity Index Underlying Supplement, prospectus supplement and prospectus. If anyone provides you with different or inconsistent information, you should not rely on it. This document, the accompanying Equity Index Underlying Supplement, prospectus supplement and prospectus are not an offer to sell these Notes, and these documents are not soliciting an offer to buy these Notes, in any jurisdiction where the offer or sale is not permitted. You should not, under any circumstances, assume that the information in this document, the accompanying Equity Index Underlying Supplement, prospectus supplement and prospectus is correct on any date after their respective dates. <br>**HSBC USA Inc.**<br>**$[ ]** <br> **Autocallable Barrier Notes with Step-up Premium<br> Linked to the Least Performing of <br>the S&P 500<sup>®</sup> Index, <br>the Russell 2000<sup>®</sup> Index and<br>the Dow Jones Industrial Average<sup>®</sup>**<br>**February 8, 2023**<br>**Free Writing Prospectus** |
| The PHLX Housing Sector Index | S-41 | &nbsp;&nbsp;<br> You should only rely on the information contained in this document, the accompanying Equity Index Underlying Supplement, prospectus supplement and prospectus. We have not authorized anyone to provide you with information or to make any representation to you that is not contained in this document, the accompanying Equity Index Underlying Supplement, prospectus supplement and prospectus. If anyone provides you with different or inconsistent information, you should not rely on it. This document, the accompanying Equity Index Underlying Supplement, prospectus supplement and prospectus are not an offer to sell these Notes, and these documents are not soliciting an offer to buy these Notes, in any jurisdiction where the offer or sale is not permitted. You should not, under any circumstances, assume that the information in this document, the accompanying Equity Index Underlying Supplement, prospectus supplement and prospectus is correct on any date after their respective dates. <br>**HSBC USA Inc.**<br>**$[ ]** <br> **Autocallable Barrier Notes with Step-up Premium<br> Linked to the Least Performing of <br>the S&P 500<sup>®</sup> Index, <br>the Russell 2000<sup>®</sup> Index and<br>the Dow Jones Industrial Average<sup>®</sup>**<br>**February 8, 2023**<br>**Free Writing Prospectus** |
| The Russell 2000® Index | S-45 | &nbsp;&nbsp;<br> You should only rely on the information contained in this document, the accompanying Equity Index Underlying Supplement, prospectus supplement and prospectus. We have not authorized anyone to provide you with information or to make any representation to you that is not contained in this document, the accompanying Equity Index Underlying Supplement, prospectus supplement and prospectus. If anyone provides you with different or inconsistent information, you should not rely on it. This document, the accompanying Equity Index Underlying Supplement, prospectus supplement and prospectus are not an offer to sell these Notes, and these documents are not soliciting an offer to buy these Notes, in any jurisdiction where the offer or sale is not permitted. You should not, under any circumstances, assume that the information in this document, the accompanying Equity Index Underlying Supplement, prospectus supplement and prospectus is correct on any date after their respective dates. <br>**HSBC USA Inc.**<br>**$[ ]** <br> **Autocallable Barrier Notes with Step-up Premium<br> Linked to the Least Performing of <br>the S&P 500<sup>®</sup> Index, <br>the Russell 2000<sup>®</sup> Index and<br>the Dow Jones Industrial Average<sup>®</sup>**<br>**February 8, 2023**<br>**Free Writing Prospectus** |
| The S&P 100® Index | S-48 | &nbsp;&nbsp;<br> You should only rely on the information contained in this document, the accompanying Equity Index Underlying Supplement, prospectus supplement and prospectus. We have not authorized anyone to provide you with information or to make any representation to you that is not contained in this document, the accompanying Equity Index Underlying Supplement, prospectus supplement and prospectus. If anyone provides you with different or inconsistent information, you should not rely on it. This document, the accompanying Equity Index Underlying Supplement, prospectus supplement and prospectus are not an offer to sell these Notes, and these documents are not soliciting an offer to buy these Notes, in any jurisdiction where the offer or sale is not permitted. You should not, under any circumstances, assume that the information in this document, the accompanying Equity Index Underlying Supplement, prospectus supplement and prospectus is correct on any date after their respective dates. <br>**HSBC USA Inc.**<br>**$[ ]** <br> **Autocallable Barrier Notes with Step-up Premium<br> Linked to the Least Performing of <br>the S&P 500<sup>®</sup> Index, <br>the Russell 2000<sup>®</sup> Index and<br>the Dow Jones Industrial Average<sup>®</sup>**<br>**February 8, 2023**<br>**Free Writing Prospectus** |
| The S&P 500® Index | S-55 | &nbsp;&nbsp;<br> You should only rely on the information contained in this document, the accompanying Equity Index Underlying Supplement, prospectus supplement and prospectus. We have not authorized anyone to provide you with information or to make any representation to you that is not contained in this document, the accompanying Equity Index Underlying Supplement, prospectus supplement and prospectus. If anyone provides you with different or inconsistent information, you should not rely on it. This document, the accompanying Equity Index Underlying Supplement, prospectus supplement and prospectus are not an offer to sell these Notes, and these documents are not soliciting an offer to buy these Notes, in any jurisdiction where the offer or sale is not permitted. You should not, under any circumstances, assume that the information in this document, the accompanying Equity Index Underlying Supplement, prospectus supplement and prospectus is correct on any date after their respective dates. <br>**HSBC USA Inc.**<br>**$[ ]** <br> **Autocallable Barrier Notes with Step-up Premium<br> Linked to the Least Performing of <br>the S&P 500<sup>®</sup> Index, <br>the Russell 2000<sup>®</sup> Index and<br>the Dow Jones Industrial Average<sup>®</sup>**<br>**February 8, 2023**<br>**Free Writing Prospectus** |
| The S&P 500® Low Volatility Index | S-62 | &nbsp;&nbsp;<br> You should only rely on the information contained in this document, the accompanying Equity Index Underlying Supplement, prospectus supplement and prospectus. We have not authorized anyone to provide you with information or to make any representation to you that is not contained in this document, the accompanying Equity Index Underlying Supplement, prospectus supplement and prospectus. If anyone provides you with different or inconsistent information, you should not rely on it. This document, the accompanying Equity Index Underlying Supplement, prospectus supplement and prospectus are not an offer to sell these Notes, and these documents are not soliciting an offer to buy these Notes, in any jurisdiction where the offer or sale is not permitted. You should not, under any circumstances, assume that the information in this document, the accompanying Equity Index Underlying Supplement, prospectus supplement and prospectus is correct on any date after their respective dates. <br>**HSBC USA Inc.**<br>**$[ ]** <br> **Autocallable Barrier Notes with Step-up Premium<br> Linked to the Least Performing of <br>the S&P 500<sup>®</sup> Index, <br>the Russell 2000<sup>®</sup> Index and<br>the Dow Jones Industrial Average<sup>®</sup>**<br>**February 8, 2023**<br>**Free Writing Prospectus** |
| The S&P BRIC 40 Index | S-65 | &nbsp;&nbsp;<br> You should only rely on the information contained in this document, the accompanying Equity Index Underlying Supplement, prospectus supplement and prospectus. We have not authorized anyone to provide you with information or to make any representation to you that is not contained in this document, the accompanying Equity Index Underlying Supplement, prospectus supplement and prospectus. If anyone provides you with different or inconsistent information, you should not rely on it. This document, the accompanying Equity Index Underlying Supplement, prospectus supplement and prospectus are not an offer to sell these Notes, and these documents are not soliciting an offer to buy these Notes, in any jurisdiction where the offer or sale is not permitted. You should not, under any circumstances, assume that the information in this document, the accompanying Equity Index Underlying Supplement, prospectus supplement and prospectus is correct on any date after their respective dates. <br>**HSBC USA Inc.**<br>**$[ ]** <br> **Autocallable Barrier Notes with Step-up Premium<br> Linked to the Least Performing of <br>the S&P 500<sup>®</sup> Index, <br>the Russell 2000<sup>®</sup> Index and<br>the Dow Jones Industrial Average<sup>®</sup>**<br>**February 8, 2023**<br>**Free Writing Prospectus** |
| The S&P MidCap 400® Index | S-68 | &nbsp;&nbsp;<br> You should only rely on the information contained in this document, the accompanying Equity Index Underlying Supplement, prospectus supplement and prospectus. We have not authorized anyone to provide you with information or to make any representation to you that is not contained in this document, the accompanying Equity Index Underlying Supplement, prospectus supplement and prospectus. If anyone provides you with different or inconsistent information, you should not rely on it. This document, the accompanying Equity Index Underlying Supplement, prospectus supplement and prospectus are not an offer to sell these Notes, and these documents are not soliciting an offer to buy these Notes, in any jurisdiction where the offer or sale is not permitted. You should not, under any circumstances, assume that the information in this document, the accompanying Equity Index Underlying Supplement, prospectus supplement and prospectus is correct on any date after their respective dates. <br>**HSBC USA Inc.**<br>**$[ ]** <br> **Autocallable Barrier Notes with Step-up Premium<br> Linked to the Least Performing of <br>the S&P 500<sup>®</sup> Index, <br>the Russell 2000<sup>®</sup> Index and<br>the Dow Jones Industrial Average<sup>®</sup>**<br>**February 8, 2023**<br>**Free Writing Prospectus** |
| The S&P/ASX 200 Index | S-75 | &nbsp;&nbsp;<br> You should only rely on the information contained in this document, the accompanying Equity Index Underlying Supplement, prospectus supplement and prospectus. We have not authorized anyone to provide you with information or to make any representation to you that is not contained in this document, the accompanying Equity Index Underlying Supplement, prospectus supplement and prospectus. If anyone provides you with different or inconsistent information, you should not rely on it. This document, the accompanying Equity Index Underlying Supplement, prospectus supplement and prospectus are not an offer to sell these Notes, and these documents are not soliciting an offer to buy these Notes, in any jurisdiction where the offer or sale is not permitted. You should not, under any circumstances, assume that the information in this document, the accompanying Equity Index Underlying Supplement, prospectus supplement and prospectus is correct on any date after their respective dates. <br>**HSBC USA Inc.**<br>**$[ ]** <br> **Autocallable Barrier Notes with Step-up Premium<br> Linked to the Least Performing of <br>the S&P 500<sup>®</sup> Index, <br>the Russell 2000<sup>®</sup> Index and<br>the Dow Jones Industrial Average<sup>®</sup>**<br>**February 8, 2023**<br>**Free Writing Prospectus** |
| The S&P 500® ESG Index | S-78 | &nbsp;&nbsp;<br> You should only rely on the information contained in this document, the accompanying Equity Index Underlying Supplement, prospectus supplement and prospectus. We have not authorized anyone to provide you with information or to make any representation to you that is not contained in this document, the accompanying Equity Index Underlying Supplement, prospectus supplement and prospectus. If anyone provides you with different or inconsistent information, you should not rely on it. This document, the accompanying Equity Index Underlying Supplement, prospectus supplement and prospectus are not an offer to sell these Notes, and these documents are not soliciting an offer to buy these Notes, in any jurisdiction where the offer or sale is not permitted. You should not, under any circumstances, assume that the information in this document, the accompanying Equity Index Underlying Supplement, prospectus supplement and prospectus is correct on any date after their respective dates. <br>**HSBC USA Inc.**<br>**$[ ]** <br> **Autocallable Barrier Notes with Step-up Premium<br> Linked to the Least Performing of <br>the S&P 500<sup>®</sup> Index, <br>the Russell 2000<sup>®</sup> Index and<br>the Dow Jones Industrial Average<sup>®</sup>**<br>**February 8, 2023**<br>**Free Writing Prospectus** |
| The TOPIX® Index | S-82 | &nbsp;&nbsp;<br> You should only rely on the information contained in this document, the accompanying Equity Index Underlying Supplement, prospectus supplement and prospectus. We have not authorized anyone to provide you with information or to make any representation to you that is not contained in this document, the accompanying Equity Index Underlying Supplement, prospectus supplement and prospectus. If anyone provides you with different or inconsistent information, you should not rely on it. This document, the accompanying Equity Index Underlying Supplement, prospectus supplement and prospectus are not an offer to sell these Notes, and these documents are not soliciting an offer to buy these Notes, in any jurisdiction where the offer or sale is not permitted. You should not, under any circumstances, assume that the information in this document, the accompanying Equity Index Underlying Supplement, prospectus supplement and prospectus is correct on any date after their respective dates. <br>**HSBC USA Inc.**<br>**$[ ]** <br> **Autocallable Barrier Notes with Step-up Premium<br> Linked to the Least Performing of <br>the S&P 500<sup>®</sup> Index, <br>the Russell 2000<sup>®</sup> Index and<br>the Dow Jones Industrial Average<sup>®</sup>**<br>**February 8, 2023**<br>**Free Writing Prospectus** |
| The Swiss Market Index | S-84 | &nbsp;&nbsp;<br> You should only rely on the information contained in this document, the accompanying Equity Index Underlying Supplement, prospectus supplement and prospectus. We have not authorized anyone to provide you with information or to make any representation to you that is not contained in this document, the accompanying Equity Index Underlying Supplement, prospectus supplement and prospectus. If anyone provides you with different or inconsistent information, you should not rely on it. This document, the accompanying Equity Index Underlying Supplement, prospectus supplement and prospectus are not an offer to sell these Notes, and these documents are not soliciting an offer to buy these Notes, in any jurisdiction where the offer or sale is not permitted. You should not, under any circumstances, assume that the information in this document, the accompanying Equity Index Underlying Supplement, prospectus supplement and prospectus is correct on any date after their respective dates. <br>**HSBC USA Inc.**<br>**$[ ]** <br> **Autocallable Barrier Notes with Step-up Premium<br> Linked to the Least Performing of <br>the S&P 500<sup>®</sup> Index, <br>the Russell 2000<sup>®</sup> Index and<br>the Dow Jones Industrial Average<sup>®</sup>**<br>**February 8, 2023**<br>**Free Writing Prospectus** |
| Additional Terms of the Notes | S-86 | &nbsp;&nbsp;<br> You should only rely on the information contained in this document, the accompanying Equity Index Underlying Supplement, prospectus supplement and prospectus. We have not authorized anyone to provide you with information or to make any representation to you that is not contained in this document, the accompanying Equity Index Underlying Supplement, prospectus supplement and prospectus. If anyone provides you with different or inconsistent information, you should not rely on it. This document, the accompanying Equity Index Underlying Supplement, prospectus supplement and prospectus are not an offer to sell these Notes, and these documents are not soliciting an offer to buy these Notes, in any jurisdiction where the offer or sale is not permitted. You should not, under any circumstances, assume that the information in this document, the accompanying Equity Index Underlying Supplement, prospectus supplement and prospectus is correct on any date after their respective dates. <br>**HSBC USA Inc.**<br>**$[ ]** <br> **Autocallable Barrier Notes with Step-up Premium<br> Linked to the Least Performing of <br>the S&P 500<sup>®</sup> Index, <br>the Russell 2000<sup>®</sup> Index and<br>the Dow Jones Industrial Average<sup>®</sup>**<br>**February 8, 2023**<br>**Free Writing Prospectus** |
|  |  | &nbsp;&nbsp;<br> You should only rely on the information contained in this document, the accompanying Equity Index Underlying Supplement, prospectus supplement and prospectus. We have not authorized anyone to provide you with information or to make any representation to you that is not contained in this document, the accompanying Equity Index Underlying Supplement, prospectus supplement and prospectus. If anyone provides you with different or inconsistent information, you should not rely on it. This document, the accompanying Equity Index Underlying Supplement, prospectus supplement and prospectus are not an offer to sell these Notes, and these documents are not soliciting an offer to buy these Notes, in any jurisdiction where the offer or sale is not permitted. You should not, under any circumstances, assume that the information in this document, the accompanying Equity Index Underlying Supplement, prospectus supplement and prospectus is correct on any date after their respective dates. <br>**HSBC USA Inc.**<br>**$[ ]** <br> **Autocallable Barrier Notes with Step-up Premium<br> Linked to the Least Performing of <br>the S&P 500<sup>®</sup> Index, <br>the Russell 2000<sup>®</sup> Index and<br>the Dow Jones Industrial Average<sup>®</sup>**<br>**February 8, 2023**<br>**Free Writing Prospectus** |
| **Prospectus Supplement** | **Prospectus Supplement** | &nbsp;&nbsp;<br> You should only rely on the information contained in this document, the accompanying Equity Index Underlying Supplement, prospectus supplement and prospectus. We have not authorized anyone to provide you with information or to make any representation to you that is not contained in this document, the accompanying Equity Index Underlying Supplement, prospectus supplement and prospectus. If anyone provides you with different or inconsistent information, you should not rely on it. This document, the accompanying Equity Index Underlying Supplement, prospectus supplement and prospectus are not an offer to sell these Notes, and these documents are not soliciting an offer to buy these Notes, in any jurisdiction where the offer or sale is not permitted. You should not, under any circumstances, assume that the information in this document, the accompanying Equity Index Underlying Supplement, prospectus supplement and prospectus is correct on any date after their respective dates. <br>**HSBC USA Inc.**<br>**$[ ]** <br> **Autocallable Barrier Notes with Step-up Premium<br> Linked to the Least Performing of <br>the S&P 500<sup>®</sup> Index, <br>the Russell 2000<sup>®</sup> Index and<br>the Dow Jones Industrial Average<sup>®</sup>**<br>**February 8, 2023**<br>**Free Writing Prospectus** |
| Risk Factors | S-1 | &nbsp;&nbsp;<br> You should only rely on the information contained in this document, the accompanying Equity Index Underlying Supplement, prospectus supplement and prospectus. We have not authorized anyone to provide you with information or to make any representation to you that is not contained in this document, the accompanying Equity Index Underlying Supplement, prospectus supplement and prospectus. If anyone provides you with different or inconsistent information, you should not rely on it. This document, the accompanying Equity Index Underlying Supplement, prospectus supplement and prospectus are not an offer to sell these Notes, and these documents are not soliciting an offer to buy these Notes, in any jurisdiction where the offer or sale is not permitted. You should not, under any circumstances, assume that the information in this document, the accompanying Equity Index Underlying Supplement, prospectus supplement and prospectus is correct on any date after their respective dates. <br>**HSBC USA Inc.**<br>**$[ ]** <br> **Autocallable Barrier Notes with Step-up Premium<br> Linked to the Least Performing of <br>the S&P 500<sup>®</sup> Index, <br>the Russell 2000<sup>®</sup> Index and<br>the Dow Jones Industrial Average<sup>®</sup>**<br>**February 8, 2023**<br>**Free Writing Prospectus** |
| Pricing Supplement | S-12 | &nbsp;&nbsp;<br> You should only rely on the information contained in this document, the accompanying Equity Index Underlying Supplement, prospectus supplement and prospectus. We have not authorized anyone to provide you with information or to make any representation to you that is not contained in this document, the accompanying Equity Index Underlying Supplement, prospectus supplement and prospectus. If anyone provides you with different or inconsistent information, you should not rely on it. This document, the accompanying Equity Index Underlying Supplement, prospectus supplement and prospectus are not an offer to sell these Notes, and these documents are not soliciting an offer to buy these Notes, in any jurisdiction where the offer or sale is not permitted. You should not, under any circumstances, assume that the information in this document, the accompanying Equity Index Underlying Supplement, prospectus supplement and prospectus is correct on any date after their respective dates. <br>**HSBC USA Inc.**<br>**$[ ]** <br> **Autocallable Barrier Notes with Step-up Premium<br> Linked to the Least Performing of <br>the S&P 500<sup>®</sup> Index, <br>the Russell 2000<sup>®</sup> Index and<br>the Dow Jones Industrial Average<sup>®</sup>**<br>**February 8, 2023**<br>**Free Writing Prospectus** |
| Description of Notes | S-14 | &nbsp;&nbsp;<br> You should only rely on the information contained in this document, the accompanying Equity Index Underlying Supplement, prospectus supplement and prospectus. We have not authorized anyone to provide you with information or to make any representation to you that is not contained in this document, the accompanying Equity Index Underlying Supplement, prospectus supplement and prospectus. If anyone provides you with different or inconsistent information, you should not rely on it. This document, the accompanying Equity Index Underlying Supplement, prospectus supplement and prospectus are not an offer to sell these Notes, and these documents are not soliciting an offer to buy these Notes, in any jurisdiction where the offer or sale is not permitted. You should not, under any circumstances, assume that the information in this document, the accompanying Equity Index Underlying Supplement, prospectus supplement and prospectus is correct on any date after their respective dates. <br>**HSBC USA Inc.**<br>**$[ ]** <br> **Autocallable Barrier Notes with Step-up Premium<br> Linked to the Least Performing of <br>the S&P 500<sup>®</sup> Index, <br>the Russell 2000<sup>®</sup> Index and<br>the Dow Jones Industrial Average<sup>®</sup>**<br>**February 8, 2023**<br>**Free Writing Prospectus** |
| Use of Proceeds and Hedging | S-55 | &nbsp;&nbsp;<br> You should only rely on the information contained in this document, the accompanying Equity Index Underlying Supplement, prospectus supplement and prospectus. We have not authorized anyone to provide you with information or to make any representation to you that is not contained in this document, the accompanying Equity Index Underlying Supplement, prospectus supplement and prospectus. If anyone provides you with different or inconsistent information, you should not rely on it. This document, the accompanying Equity Index Underlying Supplement, prospectus supplement and prospectus are not an offer to sell these Notes, and these documents are not soliciting an offer to buy these Notes, in any jurisdiction where the offer or sale is not permitted. You should not, under any circumstances, assume that the information in this document, the accompanying Equity Index Underlying Supplement, prospectus supplement and prospectus is correct on any date after their respective dates. <br>**HSBC USA Inc.**<br>**$[ ]** <br> **Autocallable Barrier Notes with Step-up Premium<br> Linked to the Least Performing of <br>the S&P 500<sup>®</sup> Index, <br>the Russell 2000<sup>®</sup> Index and<br>the Dow Jones Industrial Average<sup>®</sup>**<br>**February 8, 2023**<br>**Free Writing Prospectus** |
| Certain ERISA and Related Considerations | S-56 | &nbsp;&nbsp;<br> You should only rely on the information contained in this document, the accompanying Equity Index Underlying Supplement, prospectus supplement and prospectus. We have not authorized anyone to provide you with information or to make any representation to you that is not contained in this document, the accompanying Equity Index Underlying Supplement, prospectus supplement and prospectus. If anyone provides you with different or inconsistent information, you should not rely on it. This document, the accompanying Equity Index Underlying Supplement, prospectus supplement and prospectus are not an offer to sell these Notes, and these documents are not soliciting an offer to buy these Notes, in any jurisdiction where the offer or sale is not permitted. You should not, under any circumstances, assume that the information in this document, the accompanying Equity Index Underlying Supplement, prospectus supplement and prospectus is correct on any date after their respective dates. <br>**HSBC USA Inc.**<br>**$[ ]** <br> **Autocallable Barrier Notes with Step-up Premium<br> Linked to the Least Performing of <br>the S&P 500<sup>®</sup> Index, <br>the Russell 2000<sup>®</sup> Index and<br>the Dow Jones Industrial Average<sup>®</sup>**<br>**February 8, 2023**<br>**Free Writing Prospectus** |
| U.S. Federal Income Tax Considerations | S-58 | &nbsp;&nbsp;<br> You should only rely on the information contained in this document, the accompanying Equity Index Underlying Supplement, prospectus supplement and prospectus. We have not authorized anyone to provide you with information or to make any representation to you that is not contained in this document, the accompanying Equity Index Underlying Supplement, prospectus supplement and prospectus. If anyone provides you with different or inconsistent information, you should not rely on it. This document, the accompanying Equity Index Underlying Supplement, prospectus supplement and prospectus are not an offer to sell these Notes, and these documents are not soliciting an offer to buy these Notes, in any jurisdiction where the offer or sale is not permitted. You should not, under any circumstances, assume that the information in this document, the accompanying Equity Index Underlying Supplement, prospectus supplement and prospectus is correct on any date after their respective dates. <br>**HSBC USA Inc.**<br>**$[ ]** <br> **Autocallable Barrier Notes with Step-up Premium<br> Linked to the Least Performing of <br>the S&P 500<sup>®</sup> Index, <br>the Russell 2000<sup>®</sup> Index and<br>the Dow Jones Industrial Average<sup>®</sup>**<br>**February 8, 2023**<br>**Free Writing Prospectus** |
| Supplemental Plan of Distribution (Conflicts of Interest) | S-83 | &nbsp;&nbsp;<br> You should only rely on the information contained in this document, the accompanying Equity Index Underlying Supplement, prospectus supplement and prospectus. We have not authorized anyone to provide you with information or to make any representation to you that is not contained in this document, the accompanying Equity Index Underlying Supplement, prospectus supplement and prospectus. If anyone provides you with different or inconsistent information, you should not rely on it. This document, the accompanying Equity Index Underlying Supplement, prospectus supplement and prospectus are not an offer to sell these Notes, and these documents are not soliciting an offer to buy these Notes, in any jurisdiction where the offer or sale is not permitted. You should not, under any circumstances, assume that the information in this document, the accompanying Equity Index Underlying Supplement, prospectus supplement and prospectus is correct on any date after their respective dates. <br>**HSBC USA Inc.**<br>**$[ ]** <br> **Autocallable Barrier Notes with Step-up Premium<br> Linked to the Least Performing of <br>the S&P 500<sup>®</sup> Index, <br>the Russell 2000<sup>®</sup> Index and<br>the Dow Jones Industrial Average<sup>®</sup>**<br>**February 8, 2023**<br>**Free Writing Prospectus** |
|  |  | &nbsp;&nbsp;<br> You should only rely on the information contained in this document, the accompanying Equity Index Underlying Supplement, prospectus supplement and prospectus. We have not authorized anyone to provide you with information or to make any representation to you that is not contained in this document, the accompanying Equity Index Underlying Supplement, prospectus supplement and prospectus. If anyone provides you with different or inconsistent information, you should not rely on it. This document, the accompanying Equity Index Underlying Supplement, prospectus supplement and prospectus are not an offer to sell these Notes, and these documents are not soliciting an offer to buy these Notes, in any jurisdiction where the offer or sale is not permitted. You should not, under any circumstances, assume that the information in this document, the accompanying Equity Index Underlying Supplement, prospectus supplement and prospectus is correct on any date after their respective dates. <br>**HSBC USA Inc.**<br>**$[ ]** <br> **Autocallable Barrier Notes with Step-up Premium<br> Linked to the Least Performing of <br>the S&P 500<sup>®</sup> Index, <br>the Russell 2000<sup>®</sup> Index and<br>the Dow Jones Industrial Average<sup>®</sup>**<br>**February 8, 2023**<br>**Free Writing Prospectus** |
| **Prospectus** | **Prospectus** | &nbsp;&nbsp;<br> You should only rely on the information contained in this document, the accompanying Equity Index Underlying Supplement, prospectus supplement and prospectus. We have not authorized anyone to provide you with information or to make any representation to you that is not contained in this document, the accompanying Equity Index Underlying Supplement, prospectus supplement and prospectus. If anyone provides you with different or inconsistent information, you should not rely on it. This document, the accompanying Equity Index Underlying Supplement, prospectus supplement and prospectus are not an offer to sell these Notes, and these documents are not soliciting an offer to buy these Notes, in any jurisdiction where the offer or sale is not permitted. You should not, under any circumstances, assume that the information in this document, the accompanying Equity Index Underlying Supplement, prospectus supplement and prospectus is correct on any date after their respective dates. <br>**HSBC USA Inc.**<br>**$[ ]** <br> **Autocallable Barrier Notes with Step-up Premium<br> Linked to the Least Performing of <br>the S&P 500<sup>®</sup> Index, <br>the Russell 2000<sup>®</sup> Index and<br>the Dow Jones Industrial Average<sup>®</sup>**<br>**February 8, 2023**<br>**Free Writing Prospectus** |
| About this Prospectus | 1 | &nbsp;&nbsp;<br> You should only rely on the information contained in this document, the accompanying Equity Index Underlying Supplement, prospectus supplement and prospectus. We have not authorized anyone to provide you with information or to make any representation to you that is not contained in this document, the accompanying Equity Index Underlying Supplement, prospectus supplement and prospectus. If anyone provides you with different or inconsistent information, you should not rely on it. This document, the accompanying Equity Index Underlying Supplement, prospectus supplement and prospectus are not an offer to sell these Notes, and these documents are not soliciting an offer to buy these Notes, in any jurisdiction where the offer or sale is not permitted. You should not, under any circumstances, assume that the information in this document, the accompanying Equity Index Underlying Supplement, prospectus supplement and prospectus is correct on any date after their respective dates. <br>**HSBC USA Inc.**<br>**$[ ]** <br> **Autocallable Barrier Notes with Step-up Premium<br> Linked to the Least Performing of <br>the S&P 500<sup>®</sup> Index, <br>the Russell 2000<sup>®</sup> Index and<br>the Dow Jones Industrial Average<sup>®</sup>**<br>**February 8, 2023**<br>**Free Writing Prospectus** |
| Risk Factors | 2 | &nbsp;&nbsp;<br> You should only rely on the information contained in this document, the accompanying Equity Index Underlying Supplement, prospectus supplement and prospectus. We have not authorized anyone to provide you with information or to make any representation to you that is not contained in this document, the accompanying Equity Index Underlying Supplement, prospectus supplement and prospectus. If anyone provides you with different or inconsistent information, you should not rely on it. This document, the accompanying Equity Index Underlying Supplement, prospectus supplement and prospectus are not an offer to sell these Notes, and these documents are not soliciting an offer to buy these Notes, in any jurisdiction where the offer or sale is not permitted. You should not, under any circumstances, assume that the information in this document, the accompanying Equity Index Underlying Supplement, prospectus supplement and prospectus is correct on any date after their respective dates. <br>**HSBC USA Inc.**<br>**$[ ]** <br> **Autocallable Barrier Notes with Step-up Premium<br> Linked to the Least Performing of <br>the S&P 500<sup>®</sup> Index, <br>the Russell 2000<sup>®</sup> Index and<br>the Dow Jones Industrial Average<sup>®</sup>**<br>**February 8, 2023**<br>**Free Writing Prospectus** |
| Where You Can Find More Information | 3 | &nbsp;&nbsp;<br> You should only rely on the information contained in this document, the accompanying Equity Index Underlying Supplement, prospectus supplement and prospectus. We have not authorized anyone to provide you with information or to make any representation to you that is not contained in this document, the accompanying Equity Index Underlying Supplement, prospectus supplement and prospectus. If anyone provides you with different or inconsistent information, you should not rely on it. This document, the accompanying Equity Index Underlying Supplement, prospectus supplement and prospectus are not an offer to sell these Notes, and these documents are not soliciting an offer to buy these Notes, in any jurisdiction where the offer or sale is not permitted. You should not, under any circumstances, assume that the information in this document, the accompanying Equity Index Underlying Supplement, prospectus supplement and prospectus is correct on any date after their respective dates. <br>**HSBC USA Inc.**<br>**$[ ]** <br> **Autocallable Barrier Notes with Step-up Premium<br> Linked to the Least Performing of <br>the S&P 500<sup>®</sup> Index, <br>the Russell 2000<sup>®</sup> Index and<br>the Dow Jones Industrial Average<sup>®</sup>**<br>**February 8, 2023**<br>**Free Writing Prospectus** |
| Special Note Regarding Forward-Looking Statements | 4 | &nbsp;&nbsp;<br> You should only rely on the information contained in this document, the accompanying Equity Index Underlying Supplement, prospectus supplement and prospectus. We have not authorized anyone to provide you with information or to make any representation to you that is not contained in this document, the accompanying Equity Index Underlying Supplement, prospectus supplement and prospectus. If anyone provides you with different or inconsistent information, you should not rely on it. This document, the accompanying Equity Index Underlying Supplement, prospectus supplement and prospectus are not an offer to sell these Notes, and these documents are not soliciting an offer to buy these Notes, in any jurisdiction where the offer or sale is not permitted. You should not, under any circumstances, assume that the information in this document, the accompanying Equity Index Underlying Supplement, prospectus supplement and prospectus is correct on any date after their respective dates. <br>**HSBC USA Inc.**<br>**$[ ]** <br> **Autocallable Barrier Notes with Step-up Premium<br> Linked to the Least Performing of <br>the S&P 500<sup>®</sup> Index, <br>the Russell 2000<sup>®</sup> Index and<br>the Dow Jones Industrial Average<sup>®</sup>**<br>**February 8, 2023**<br>**Free Writing Prospectus** |
| HSBC USA Inc. | 7 | &nbsp;&nbsp;<br> You should only rely on the information contained in this document, the accompanying Equity Index Underlying Supplement, prospectus supplement and prospectus. We have not authorized anyone to provide you with information or to make any representation to you that is not contained in this document, the accompanying Equity Index Underlying Supplement, prospectus supplement and prospectus. If anyone provides you with different or inconsistent information, you should not rely on it. This document, the accompanying Equity Index Underlying Supplement, prospectus supplement and prospectus are not an offer to sell these Notes, and these documents are not soliciting an offer to buy these Notes, in any jurisdiction where the offer or sale is not permitted. You should not, under any circumstances, assume that the information in this document, the accompanying Equity Index Underlying Supplement, prospectus supplement and prospectus is correct on any date after their respective dates. <br>**HSBC USA Inc.**<br>**$[ ]** <br> **Autocallable Barrier Notes with Step-up Premium<br> Linked to the Least Performing of <br>the S&P 500<sup>®</sup> Index, <br>the Russell 2000<sup>®</sup> Index and<br>the Dow Jones Industrial Average<sup>®</sup>**<br>**February 8, 2023**<br>**Free Writing Prospectus** |
| Use of Proceeds | 8 | &nbsp;&nbsp;<br> You should only rely on the information contained in this document, the accompanying Equity Index Underlying Supplement, prospectus supplement and prospectus. We have not authorized anyone to provide you with information or to make any representation to you that is not contained in this document, the accompanying Equity Index Underlying Supplement, prospectus supplement and prospectus. If anyone provides you with different or inconsistent information, you should not rely on it. This document, the accompanying Equity Index Underlying Supplement, prospectus supplement and prospectus are not an offer to sell these Notes, and these documents are not soliciting an offer to buy these Notes, in any jurisdiction where the offer or sale is not permitted. You should not, under any circumstances, assume that the information in this document, the accompanying Equity Index Underlying Supplement, prospectus supplement and prospectus is correct on any date after their respective dates. <br>**HSBC USA Inc.**<br>**$[ ]** <br> **Autocallable Barrier Notes with Step-up Premium<br> Linked to the Least Performing of <br>the S&P 500<sup>®</sup> Index, <br>the Russell 2000<sup>®</sup> Index and<br>the Dow Jones Industrial Average<sup>®</sup>**<br>**February 8, 2023**<br>**Free Writing Prospectus** |
| Description of Debt Securities | 9 | &nbsp;&nbsp;<br> You should only rely on the information contained in this document, the accompanying Equity Index Underlying Supplement, prospectus supplement and prospectus. We have not authorized anyone to provide you with information or to make any representation to you that is not contained in this document, the accompanying Equity Index Underlying Supplement, prospectus supplement and prospectus. If anyone provides you with different or inconsistent information, you should not rely on it. This document, the accompanying Equity Index Underlying Supplement, prospectus supplement and prospectus are not an offer to sell these Notes, and these documents are not soliciting an offer to buy these Notes, in any jurisdiction where the offer or sale is not permitted. You should not, under any circumstances, assume that the information in this document, the accompanying Equity Index Underlying Supplement, prospectus supplement and prospectus is correct on any date after their respective dates. <br>**HSBC USA Inc.**<br>**$[ ]** <br> **Autocallable Barrier Notes with Step-up Premium<br> Linked to the Least Performing of <br>the S&P 500<sup>®</sup> Index, <br>the Russell 2000<sup>®</sup> Index and<br>the Dow Jones Industrial Average<sup>®</sup>**<br>**February 8, 2023**<br>**Free Writing Prospectus** |
| Description of Preferred Stock | 20 | &nbsp;&nbsp;<br> You should only rely on the information contained in this document, the accompanying Equity Index Underlying Supplement, prospectus supplement and prospectus. We have not authorized anyone to provide you with information or to make any representation to you that is not contained in this document, the accompanying Equity Index Underlying Supplement, prospectus supplement and prospectus. If anyone provides you with different or inconsistent information, you should not rely on it. This document, the accompanying Equity Index Underlying Supplement, prospectus supplement and prospectus are not an offer to sell these Notes, and these documents are not soliciting an offer to buy these Notes, in any jurisdiction where the offer or sale is not permitted. You should not, under any circumstances, assume that the information in this document, the accompanying Equity Index Underlying Supplement, prospectus supplement and prospectus is correct on any date after their respective dates. <br>**HSBC USA Inc.**<br>**$[ ]** <br> **Autocallable Barrier Notes with Step-up Premium<br> Linked to the Least Performing of <br>the S&P 500<sup>®</sup> Index, <br>the Russell 2000<sup>®</sup> Index and<br>the Dow Jones Industrial Average<sup>®</sup>**<br>**February 8, 2023**<br>**Free Writing Prospectus** |
| Description of Warrants | 25 | &nbsp;&nbsp;<br> You should only rely on the information contained in this document, the accompanying Equity Index Underlying Supplement, prospectus supplement and prospectus. We have not authorized anyone to provide you with information or to make any representation to you that is not contained in this document, the accompanying Equity Index Underlying Supplement, prospectus supplement and prospectus. If anyone provides you with different or inconsistent information, you should not rely on it. This document, the accompanying Equity Index Underlying Supplement, prospectus supplement and prospectus are not an offer to sell these Notes, and these documents are not soliciting an offer to buy these Notes, in any jurisdiction where the offer or sale is not permitted. You should not, under any circumstances, assume that the information in this document, the accompanying Equity Index Underlying Supplement, prospectus supplement and prospectus is correct on any date after their respective dates. <br>**HSBC USA Inc.**<br>**$[ ]** <br> **Autocallable Barrier Notes with Step-up Premium<br> Linked to the Least Performing of <br>the S&P 500<sup>®</sup> Index, <br>the Russell 2000<sup>®</sup> Index and<br>the Dow Jones Industrial Average<sup>®</sup>**<br>**February 8, 2023**<br>**Free Writing Prospectus** |
| Description of Purchase Contracts | 30 | &nbsp;&nbsp;<br> You should only rely on the information contained in this document, the accompanying Equity Index Underlying Supplement, prospectus supplement and prospectus. We have not authorized anyone to provide you with information or to make any representation to you that is not contained in this document, the accompanying Equity Index Underlying Supplement, prospectus supplement and prospectus. If anyone provides you with different or inconsistent information, you should not rely on it. This document, the accompanying Equity Index Underlying Supplement, prospectus supplement and prospectus are not an offer to sell these Notes, and these documents are not soliciting an offer to buy these Notes, in any jurisdiction where the offer or sale is not permitted. You should not, under any circumstances, assume that the information in this document, the accompanying Equity Index Underlying Supplement, prospectus supplement and prospectus is correct on any date after their respective dates. <br>**HSBC USA Inc.**<br>**$[ ]** <br> **Autocallable Barrier Notes with Step-up Premium<br> Linked to the Least Performing of <br>the S&P 500<sup>®</sup> Index, <br>the Russell 2000<sup>®</sup> Index and<br>the Dow Jones Industrial Average<sup>®</sup>**<br>**February 8, 2023**<br>**Free Writing Prospectus** |
| Description of Units | 33 | &nbsp;&nbsp;<br> You should only rely on the information contained in this document, the accompanying Equity Index Underlying Supplement, prospectus supplement and prospectus. We have not authorized anyone to provide you with information or to make any representation to you that is not contained in this document, the accompanying Equity Index Underlying Supplement, prospectus supplement and prospectus. If anyone provides you with different or inconsistent information, you should not rely on it. This document, the accompanying Equity Index Underlying Supplement, prospectus supplement and prospectus are not an offer to sell these Notes, and these documents are not soliciting an offer to buy these Notes, in any jurisdiction where the offer or sale is not permitted. You should not, under any circumstances, assume that the information in this document, the accompanying Equity Index Underlying Supplement, prospectus supplement and prospectus is correct on any date after their respective dates. <br>**HSBC USA Inc.**<br>**$[ ]** <br> **Autocallable Barrier Notes with Step-up Premium<br> Linked to the Least Performing of <br>the S&P 500<sup>®</sup> Index, <br>the Russell 2000<sup>®</sup> Index and<br>the Dow Jones Industrial Average<sup>®</sup>**<br>**February 8, 2023**<br>**Free Writing Prospectus** |
| Book-Entry Procedures | 35 | &nbsp;&nbsp;<br> You should only rely on the information contained in this document, the accompanying Equity Index Underlying Supplement, prospectus supplement and prospectus. We have not authorized anyone to provide you with information or to make any representation to you that is not contained in this document, the accompanying Equity Index Underlying Supplement, prospectus supplement and prospectus. If anyone provides you with different or inconsistent information, you should not rely on it. This document, the accompanying Equity Index Underlying Supplement, prospectus supplement and prospectus are not an offer to sell these Notes, and these documents are not soliciting an offer to buy these Notes, in any jurisdiction where the offer or sale is not permitted. You should not, under any circumstances, assume that the information in this document, the accompanying Equity Index Underlying Supplement, prospectus supplement and prospectus is correct on any date after their respective dates. <br>**HSBC USA Inc.**<br>**$[ ]** <br> **Autocallable Barrier Notes with Step-up Premium<br> Linked to the Least Performing of <br>the S&P 500<sup>®</sup> Index, <br>the Russell 2000<sup>®</sup> Index and<br>the Dow Jones Industrial Average<sup>®</sup>**<br>**February 8, 2023**<br>**Free Writing Prospectus** |
| Limitations on Issuances in Bearer Form | 39 | &nbsp;&nbsp;<br> You should only rely on the information contained in this document, the accompanying Equity Index Underlying Supplement, prospectus supplement and prospectus. We have not authorized anyone to provide you with information or to make any representation to you that is not contained in this document, the accompanying Equity Index Underlying Supplement, prospectus supplement and prospectus. If anyone provides you with different or inconsistent information, you should not rely on it. This document, the accompanying Equity Index Underlying Supplement, prospectus supplement and prospectus are not an offer to sell these Notes, and these documents are not soliciting an offer to buy these Notes, in any jurisdiction where the offer or sale is not permitted. You should not, under any circumstances, assume that the information in this document, the accompanying Equity Index Underlying Supplement, prospectus supplement and prospectus is correct on any date after their respective dates. <br>**HSBC USA Inc.**<br>**$[ ]** <br> **Autocallable Barrier Notes with Step-up Premium<br> Linked to the Least Performing of <br>the S&P 500<sup>®</sup> Index, <br>the Russell 2000<sup>®</sup> Index and<br>the Dow Jones Industrial Average<sup>®</sup>**<br>**February 8, 2023**<br>**Free Writing Prospectus** |
| U.S. Federal Income Tax Considerations Relating to Debt Securities | 40 | &nbsp;&nbsp;<br> You should only rely on the information contained in this document, the accompanying Equity Index Underlying Supplement, prospectus supplement and prospectus. We have not authorized anyone to provide you with information or to make any representation to you that is not contained in this document, the accompanying Equity Index Underlying Supplement, prospectus supplement and prospectus. If anyone provides you with different or inconsistent information, you should not rely on it. This document, the accompanying Equity Index Underlying Supplement, prospectus supplement and prospectus are not an offer to sell these Notes, and these documents are not soliciting an offer to buy these Notes, in any jurisdiction where the offer or sale is not permitted. You should not, under any circumstances, assume that the information in this document, the accompanying Equity Index Underlying Supplement, prospectus supplement and prospectus is correct on any date after their respective dates. <br>**HSBC USA Inc.**<br>**$[ ]** <br> **Autocallable Barrier Notes with Step-up Premium<br> Linked to the Least Performing of <br>the S&P 500<sup>®</sup> Index, <br>the Russell 2000<sup>®</sup> Index and<br>the Dow Jones Industrial Average<sup>®</sup>**<br>**February 8, 2023**<br>**Free Writing Prospectus** |
| Certain European Union Tax Considerations | 48 | &nbsp;&nbsp;<br> You should only rely on the information contained in this document, the accompanying Equity Index Underlying Supplement, prospectus supplement and prospectus. We have not authorized anyone to provide you with information or to make any representation to you that is not contained in this document, the accompanying Equity Index Underlying Supplement, prospectus supplement and prospectus. If anyone provides you with different or inconsistent information, you should not rely on it. This document, the accompanying Equity Index Underlying Supplement, prospectus supplement and prospectus are not an offer to sell these Notes, and these documents are not soliciting an offer to buy these Notes, in any jurisdiction where the offer or sale is not permitted. You should not, under any circumstances, assume that the information in this document, the accompanying Equity Index Underlying Supplement, prospectus supplement and prospectus is correct on any date after their respective dates. <br>**HSBC USA Inc.**<br>**$[ ]** <br> **Autocallable Barrier Notes with Step-up Premium<br> Linked to the Least Performing of <br>the S&P 500<sup>®</sup> Index, <br>the Russell 2000<sup>®</sup> Index and<br>the Dow Jones Industrial Average<sup>®</sup>**<br>**February 8, 2023**<br>**Free Writing Prospectus** |
| Plan of Distribution (Conflicts of Interest) | 49 | &nbsp;&nbsp;<br> You should only rely on the information contained in this document, the accompanying Equity Index Underlying Supplement, prospectus supplement and prospectus. We have not authorized anyone to provide you with information or to make any representation to you that is not contained in this document, the accompanying Equity Index Underlying Supplement, prospectus supplement and prospectus. If anyone provides you with different or inconsistent information, you should not rely on it. This document, the accompanying Equity Index Underlying Supplement, prospectus supplement and prospectus are not an offer to sell these Notes, and these documents are not soliciting an offer to buy these Notes, in any jurisdiction where the offer or sale is not permitted. You should not, under any circumstances, assume that the information in this document, the accompanying Equity Index Underlying Supplement, prospectus supplement and prospectus is correct on any date after their respective dates. <br>**HSBC USA Inc.**<br>**$[ ]** <br> **Autocallable Barrier Notes with Step-up Premium<br> Linked to the Least Performing of <br>the S&P 500<sup>®</sup> Index, <br>the Russell 2000<sup>®</sup> Index and<br>the Dow Jones Industrial Average<sup>®</sup>**<br>**February 8, 2023**<br>**Free Writing Prospectus** |
| Notice to Canadian Investors | 52 | &nbsp;&nbsp;<br> You should only rely on the information contained in this document, the accompanying Equity Index Underlying Supplement, prospectus supplement and prospectus. We have not authorized anyone to provide you with information or to make any representation to you that is not contained in this document, the accompanying Equity Index Underlying Supplement, prospectus supplement and prospectus. If anyone provides you with different or inconsistent information, you should not rely on it. This document, the accompanying Equity Index Underlying Supplement, prospectus supplement and prospectus are not an offer to sell these Notes, and these documents are not soliciting an offer to buy these Notes, in any jurisdiction where the offer or sale is not permitted. You should not, under any circumstances, assume that the information in this document, the accompanying Equity Index Underlying Supplement, prospectus supplement and prospectus is correct on any date after their respective dates. <br>**HSBC USA Inc.**<br>**$[ ]** <br> **Autocallable Barrier Notes with Step-up Premium<br> Linked to the Least Performing of <br>the S&P 500<sup>®</sup> Index, <br>the Russell 2000<sup>®</sup> Index and<br>the Dow Jones Industrial Average<sup>®</sup>**<br>**February 8, 2023**<br>**Free Writing Prospectus** |
| Notice to EEA Investors | 53 | &nbsp;&nbsp;<br> You should only rely on the information contained in this document, the accompanying Equity Index Underlying Supplement, prospectus supplement and prospectus. We have not authorized anyone to provide you with information or to make any representation to you that is not contained in this document, the accompanying Equity Index Underlying Supplement, prospectus supplement and prospectus. If anyone provides you with different or inconsistent information, you should not rely on it. This document, the accompanying Equity Index Underlying Supplement, prospectus supplement and prospectus are not an offer to sell these Notes, and these documents are not soliciting an offer to buy these Notes, in any jurisdiction where the offer or sale is not permitted. You should not, under any circumstances, assume that the information in this document, the accompanying Equity Index Underlying Supplement, prospectus supplement and prospectus is correct on any date after their respective dates. <br>**HSBC USA Inc.**<br>**$[ ]** <br> **Autocallable Barrier Notes with Step-up Premium<br> Linked to the Least Performing of <br>the S&P 500<sup>®</sup> Index, <br>the Russell 2000<sup>®</sup> Index and<br>the Dow Jones Industrial Average<sup>®</sup>**<br>**February 8, 2023**<br>**Free Writing Prospectus** |
| Notice to UK Investors | 54 | &nbsp;&nbsp;<br> You should only rely on the information contained in this document, the accompanying Equity Index Underlying Supplement, prospectus supplement and prospectus. We have not authorized anyone to provide you with information or to make any representation to you that is not contained in this document, the accompanying Equity Index Underlying Supplement, prospectus supplement and prospectus. If anyone provides you with different or inconsistent information, you should not rely on it. This document, the accompanying Equity Index Underlying Supplement, prospectus supplement and prospectus are not an offer to sell these Notes, and these documents are not soliciting an offer to buy these Notes, in any jurisdiction where the offer or sale is not permitted. You should not, under any circumstances, assume that the information in this document, the accompanying Equity Index Underlying Supplement, prospectus supplement and prospectus is correct on any date after their respective dates. <br>**HSBC USA Inc.**<br>**$[ ]** <br> **Autocallable Barrier Notes with Step-up Premium<br> Linked to the Least Performing of <br>the S&P 500<sup>®</sup> Index, <br>the Russell 2000<sup>®</sup> Index and<br>the Dow Jones Industrial Average<sup>®</sup>**<br>**February 8, 2023**<br>**Free Writing Prospectus** |
| UK Financial Promotion | 54 | &nbsp;&nbsp;<br> You should only rely on the information contained in this document, the accompanying Equity Index Underlying Supplement, prospectus supplement and prospectus. We have not authorized anyone to provide you with information or to make any representation to you that is not contained in this document, the accompanying Equity Index Underlying Supplement, prospectus supplement and prospectus. If anyone provides you with different or inconsistent information, you should not rely on it. This document, the accompanying Equity Index Underlying Supplement, prospectus supplement and prospectus are not an offer to sell these Notes, and these documents are not soliciting an offer to buy these Notes, in any jurisdiction where the offer or sale is not permitted. You should not, under any circumstances, assume that the information in this document, the accompanying Equity Index Underlying Supplement, prospectus supplement and prospectus is correct on any date after their respective dates. <br>**HSBC USA Inc.**<br>**$[ ]** <br> **Autocallable Barrier Notes with Step-up Premium<br> Linked to the Least Performing of <br>the S&P 500<sup>®</sup> Index, <br>the Russell 2000<sup>®</sup> Index and<br>the Dow Jones Industrial Average<sup>®</sup>**<br>**February 8, 2023**<br>**Free Writing Prospectus** |
| Certain ERISA and Related Matters | 55 | &nbsp;&nbsp;<br> You should only rely on the information contained in this document, the accompanying Equity Index Underlying Supplement, prospectus supplement and prospectus. We have not authorized anyone to provide you with information or to make any representation to you that is not contained in this document, the accompanying Equity Index Underlying Supplement, prospectus supplement and prospectus. If anyone provides you with different or inconsistent information, you should not rely on it. This document, the accompanying Equity Index Underlying Supplement, prospectus supplement and prospectus are not an offer to sell these Notes, and these documents are not soliciting an offer to buy these Notes, in any jurisdiction where the offer or sale is not permitted. You should not, under any circumstances, assume that the information in this document, the accompanying Equity Index Underlying Supplement, prospectus supplement and prospectus is correct on any date after their respective dates. <br>**HSBC USA Inc.**<br>**$[ ]** <br> **Autocallable Barrier Notes with Step-up Premium<br> Linked to the Least Performing of <br>the S&P 500<sup>®</sup> Index, <br>the Russell 2000<sup>®</sup> Index and<br>the Dow Jones Industrial Average<sup>®</sup>**<br>**February 8, 2023**<br>**Free Writing Prospectus** |
| Legal Opinions | 57 | &nbsp;&nbsp;<br> You should only rely on the information contained in this document, the accompanying Equity Index Underlying Supplement, prospectus supplement and prospectus. We have not authorized anyone to provide you with information or to make any representation to you that is not contained in this document, the accompanying Equity Index Underlying Supplement, prospectus supplement and prospectus. If anyone provides you with different or inconsistent information, you should not rely on it. This document, the accompanying Equity Index Underlying Supplement, prospectus supplement and prospectus are not an offer to sell these Notes, and these documents are not soliciting an offer to buy these Notes, in any jurisdiction where the offer or sale is not permitted. You should not, under any circumstances, assume that the information in this document, the accompanying Equity Index Underlying Supplement, prospectus supplement and prospectus is correct on any date after their respective dates. <br>**HSBC USA Inc.**<br>**$[ ]** <br> **Autocallable Barrier Notes with Step-up Premium<br> Linked to the Least Performing of <br>the S&P 500<sup>®</sup> Index, <br>the Russell 2000<sup>®</sup> Index and<br>the Dow Jones Industrial Average<sup>®</sup>**<br>**February 8, 2023**<br>**Free Writing Prospectus** |
| Experts | 58 | &nbsp;&nbsp;<br> You should only rely on the information contained in this document, the accompanying Equity Index Underlying Supplement, prospectus supplement and prospectus. We have not authorized anyone to provide you with information or to make any representation to you that is not contained in this document, the accompanying Equity Index Underlying Supplement, prospectus supplement and prospectus. If anyone provides you with different or inconsistent information, you should not rely on it. This document, the accompanying Equity Index Underlying Supplement, prospectus supplement and prospectus are not an offer to sell these Notes, and these documents are not soliciting an offer to buy these Notes, in any jurisdiction where the offer or sale is not permitted. You should not, under any circumstances, assume that the information in this document, the accompanying Equity Index Underlying Supplement, prospectus supplement and prospectus is correct on any date after their respective dates. <br>**HSBC USA Inc.**<br>**$[ ]** <br> **Autocallable Barrier Notes with Step-up Premium<br> Linked to the Least Performing of <br>the S&P 500<sup>®</sup> Index, <br>the Russell 2000<sup>®</sup> Index and<br>the Dow Jones Industrial Average<sup>®</sup>**<br>**February 8, 2023**<br>**Free Writing Prospectus** |

---

### Attached PDF Documents

**Attachment 1:** `tm235596d11dps_fwp.pdf`

Filed Pursuant to Rule 433
Registration No. 333-253385
February 8, 2023
FREE WRITING PROSPECTUS
(To Prospectus dated February 23, 2021,
Prospectus Supplement dated February 23, 2021 and
Equity Index Underlying Supplement dated February 23, 2021)

HSBC USA Inc.

## Autocallable Barrier Notes with Step-up Premium

![img-0.jpeg](img-0.jpeg)

### Linked to the Least Performing of the S&P 500® Index, the Russell 2000® Index and the Dow Jones Industrial Average® (the “Reference Asset”)

- ▶ Callable quarterly at the principal amount plus the applicable Call Premium on any Call Observation Date on or after February 23, 2024 if the Official Closing Level of each Underlying is at or above its Call Threshold
- ▶ Call Premium of at least 2.25% per quarter (equivalent to at least 9.00% per annum) (to be determined on the Trade Date)
- ▶ If the Notes are not called and the Least Performing Underlying declines by more than 10.00% but less than or equal to 25.00% you will receive your principal amount (a zero return)
- ▶ If the Notes are not called and the Least Performing Underlying declines by more than 25.00%, there is full exposure to declines in the Least Performing Underlying, and you will lose all or a portion of your principal amount
- ▶ Approximate 5 year maturity, if not called
- ▶ All payments on the Notes are subject to the credit risk of HSBC USA Inc.

The Autocallable Barrier Notes with Step-up Premium (each a “Note” and collectively the “Notes”) offered hereunder will not be listed on any securities exchange or automated quotation system.

Neither the U.S. Securities and Exchange Commission (the “SEC”) nor any state securities commission has approved or disapproved of the Notes or passed upon the accuracy or the adequacy of this document, the accompanying prospectus, prospectus supplement or Equity Index Underlying Supplement. Any representation to the contrary is a criminal offense.

We have appointed HSBC Securities (USA) Inc., an affiliate of ours, as the agent for the sale of the Notes. HSBC Securities (USA) Inc. will purchase the Notes from us for distribution to other registered broker-dealers or will offer the Notes directly to investors. In addition, HSBC Securities (USA) Inc. or another of its affiliates or agents may use the pricing supplement to which this document relates in market-making transactions in any Notes after their initial sale. Unless we or our agent inform you otherwise in the confirmation of sale, the pricing supplement to which this document relates is being used in a market-making transaction. See “Supplemental Plan of Distribution (Conflicts of Interest)” on page FWP-16 of this document.

**Investment in the Notes involves certain risks. You should refer to “Risk Factors” beginning on page FWP-8 of this document, page S-1 of the accompanying prospectus supplement and page S-1 of the accompanying Equity Index Underlying Supplement.**

The Estimated Initial Value of the Notes on the Trade Date is expected to be between $910.00 and $960.00 per Note, which will be less than the price to public. The market value of the Notes at any time will reflect many factors and cannot be predicted with accuracy. See “Estimated Initial Value” on page FWP-5 and “Risk Factors” beginning on page FWP-8 of this document for additional information.

|  | Price to Public | Underwriting Discount (1) | Proceeds to Issuer |
| --- | --- | --- | --- |
| Per Note | $1,000.00 |  |  |
| Total |  |  |  |

$^{(1)}$ HSBC USA Inc. or one of our affiliates may pay varying underwriting discounts of up to 2.00% and structuring fees of up to 0.65% per $1,000 Principal Amount in connection with the distribution of the Notes to other registered broker-dealers. In no case will the sum of the underwriting discounts and structuring fees exceed 2.65% per $1,000 Principal Amount. See “Supplemental Plan of Distribution (Conflicts of Interest)” on page FWP-16 of this document.

The Notes:

| Are Not FDIC Insured | Are Not Bank Guaranteed | May Lose Value |
| --- | --- | --- |

![img-1.jpeg](img-1.jpeg)

## Indicative Terms$^{(1)}$

| Principal Amount | $1,000 per Note |
| --- | --- |
| Term | Approximate 5 year maturity, if not called |
| Reference Asset | The S&P 500 ® Index (Ticker: SPX), the Russell 2000 ® Index (Ticker: RTY) and the Dow Jones Industrial Average ® (Ticker: INDU) (each, an 'Underlying' and together the 'Underlyings'). |
| Call Feature | The Notes will be automatically called if the Official Closing Level of each Underlying is at or above its Call Threshold on any Call Observation Date on or after February 23, 2024. In that case, you will receive a payment, per $1,000 Principal Amount, equal to the Principal Amount, plus the applicable Call Premium on the corresponding Call Payment Date. (2) |
| Call Threshold | For each Underlying on a Call Observation Date, the relevant percentage of the Initial Value of such Underlying applicable on such Call Observation Date as described on page FWP-5 under Call Observation Dates, Call Payment Dates, Call Premiums and Call Threshold |
| Call Premiums | At least 2.25% per quarter (equivalent to at least 9.00% per annum) (to be determined on the Trade Date) payable as described under the Call Feature above and on page FWP-5 under Call Observation Dates, Call Payment Dates and Call Premiums. |
| Barrier Value | With respect to each Underlying, 75.00% of its Initial Value. |
| Payment at Maturity per Note | Unless the Notes are called, for each $1,000 Principal Amount, you will receive a cash payment on the Maturity Date, calculated as follows: ■ If the Reference Return of the Least Performing Underlying is less than -10.00%, and therefore not called, but greater than or equal to -25.00%: $1,000 (a zero return) ■ If the Reference Return of the Least Performing Underlying is less than -25.00%: $1,000 + ($1,000 × Reference Return of the Least Performing Underlying). If the Notes are not called and the Final Value of the Least Performing Underlying is less than its Barrier Value, you will not receive a Call Premium, and will lose up to 100% of the Principal Amount. |
| Reference Return | With respect to each Underlying, Final Value - Initial Value Initial Value |
| Least Performing Underlying | The Underlying with the lowest Reference Return. |
| Trade Date | February 22, 2023 |
| Pricing Date | February 22, 2023 |
| Original Issue Date | February 27, 2023 |
| Final Valuation Date (3) | February 23, 2028 |
| Maturity Date (3) | February 28, 2028 |
| CUSIP / ISIN | 40441XM98 / US40441XM989 |

$^{(1)}$ As more fully described starting on page FWP-4.

$^{(2)}$ See page FWP-5 for the Call Observation Dates, Call Payment Dates and Call Premiums.

$^{(3)}$ Subject to adjustment as described under 'Additional Terms of the Notes' in the accompanying Equity Index Underlying Supplement.

## The Notes

The Notes may be suitable for investors who believe that the value of the Underlyings will not decrease significantly over the term of the Notes.

If the Official Closing Level of each Underlying is at or above its Call Threshold on any Call Observation Date beginning on February 23, 2024, your Notes will be called and you will receive a payment equal to 100% of the Principal Amount, together with the applicable Call Premium on the corresponding Call Payment Date.

If the Notes are not called and the Final Value of the Least Performing Underlying is greater than or equal to its Barrier Value, you will receive a Payment at Maturity equal to 100% of the Principal Amount.

If the Notes are not called and the Final Value of the Least Performing Underlying is less than its Barrier Value, you will not receive the Call Premium and you will lose 1% of your principal for every 1% decline of that Least Performing Underlying from its Initial Value.

![img-2.jpeg](img-2.jpeg)

FWP-2

## Illustration of Payment Scenarios

Your payment on the Notes will depend on whether the Notes have been called, including on the Final Valuation Date, and whether the Final Value of the Least Performing Underlying is greater than or equal to its Barrier Value. If your Notes are not called, you will lose some or all of your Principal Amount at maturity if the Final Value of the Least Performing Underlying is less than its Barrier Value. In such a case, your return on the Notes will be negative.

![img-3.jpeg](img-3.jpeg)

## Information about the Underlyings

The S&P 500® Index ("SPX") is a market capitalization-weighted index intended to provide a performance benchmark for the large-cap U.S. equity markets. The SPX includes a representative sample of 500 companies in leading industries of the U.S. economy.

The Russell 2000® Index ("RTY") is designed to track the performance of the small capitalization segment of the U.S. equity market. All 2,000 stocks are traded on a major U.S. exchange, and the RTY consists of the smallest 2,000 companies included in the Russell 3000® Index. The Russell 3000® Index is composed of the 3,000 largest U.S. companies as determined by market capitalization.

The Dow Jones Industrial Average® ("INDU") is a price-weighted index comprised of 30 blue-chip stocks, which represent nine economic sectors including consumer discretionary, consumer staples, communication services, energy, financials, health care, industrials, information technology and materials.

![img-4.jpeg](img-4.jpeg)

The graphs above illustrate the daily performance of SPX from February 7, 2013 through February 7, 2023, the daily performance of RTY from February 7, 2013 through February 7, 2023 and the daily performance of INDU from February 7, 2013 through February 7, 2023. The closing values in the graphs above were obtained from the Bloomberg Professional® Service. Past performance is not necessarily an indication of future results.

For further information on each Underlying, please see "Description of the Reference Asset" beginning on page FWP-15 of this document. We have derived all disclosure regarding each Underlying from publicly available information. Neither HSBC USA Inc. nor any of its affiliates have undertaken any independent review of, or made any due diligence inquiry with respect to, the publicly available information about each Underlying.

FWP-3

![img-5.jpeg](img-5.jpeg)

## HSBC USA Inc.

### Autocallable Barrier Notes with Step-up Premium

This document relates to a single offering of Autocallable Barrier Notes with Step-up Premium. The Notes will have the terms described in this document and the accompanying prospectus, prospectus supplement and Equity Index Underlying Supplement. If the terms of the Notes offered hereby are inconsistent with those described in the accompanying prospectus, prospectus supplement or Equity Index Underlying Supplement, the terms described in this document shall control.

This document relates to an offering of Notes linked to the performance of the Reference Asset. The purchaser of a Note will acquire a senior unsecured debt security of HSBC USA Inc. linked to the Reference Asset as described below. The following key terms relate to the offering of the Notes:

| Issuer: | HSBC USA Inc. |
| --- | --- |
| Principal Amount: | $1,000 per Note |
| Reference Asset: | The S&P 500® Index (Ticker: SPX), the Russell 2000® Index (Ticker: RTY) and the Dow Jones Industrial Average® (Ticker: INDU) (each, an “Underlying” and together the “Underlyings”). |
| Trade Date: | February 22, 2023 |
| Pricing Date: | February 22, 2023 |
| Original Issue Date: | February 27, 2023 |
| Final Valuation Date: | February 23, 2028, subject to adjustment as described under “Additional Terms of the Notes-Valuation Dates” in the accompanying Equity Index Underlying Supplement. |
| Maturity Date: | 3 business days after the Final Valuation Date, expected to be February 28, 2028. The Maturity Date is subject to adjustment as described under “Additional Terms of the Notes-Coupon Payment Dates, Call Payment Dates and Maturity Date” in the accompanying Equity Index Underlying Supplement. |
| Call Feature: | If the Official Closing Level of each Underlying is at or above its Call Threshold on any Call Observation Date, the Notes will be automatically called, and you will receive a cash payment, per $1,000 Principal Amount, equal to the Principal Amount plus the applicable Call Premium on the corresponding Call Payment Date. |
| Payment at Maturity: | Unless the Notes are automatically called, on the Maturity Date, for each $1,000 Principal Amount, we will pay you the Final Settlement Value. |
| Final Settlement Value: | Unless the Notes are automatically called, for each $1,000 Principal Amount, you will receive a cash payment on the Maturity Date, calculated as follows: ■ If the Reference Return of the Least Performing Underlying is less than -10.00%, and therefore not called, but greater than or equal to -25.00%: $1,000 (a zero return) ■ If the Reference Return of the Least Performing Underlying is less than -25.00%: $1,000 + ($1,000 × Reference Return of the Least Performing Underlying). If the Notes are not called and the Final Value of the Least Performing Underlying is less than its Barrier Value, you will not receive a Call Premium, and will lose up to 100% of the Principal Amount. |
| Least Performing Underlying: | The Underlying with the lowest Reference Return. |
| Reference Return: | With respect to each Underlying, the quotient, expressed as a percentage, calculated as follows: $$\frac{\text{Final Value} - \text{Initial Value}}{\text{Initial Value}}$$ |

FWP-4

# **Call Observation Dates,  
Call Payment Dates,  
Call Premiums and Call  
Thresholds:**

The Call Premiums are at least 2.25% per quarter (equivalent to at least 9.00% per annum) (to be determined on the Trade Date), payable as described below.

| Call Observation Dates | Call Payment Dates | Call Premiums* | Call Threshold |
| --- | --- | --- | --- |
| February 23, 2024 | February 28, 2024 | at least 9.00% | 90% of the Initial Value |
| May 22, 2024 | May 28, 2024 | at least 11.25% | 90% of the Initial Value |
| August 23, 2024 | August 28, 2024 | at least 13.50% | 90% of the Initial Value |
| November 25, 2024 | November 29, 2024 | at least 15.75% | 90% of the Initial Value |
| February 25, 2025 | February 28, 2025 | at least 18.00% | 90% of the Initial Value |
| May 22, 2025 | May 28, 2025 | at least 20.25% | 90% of the Initial Value |
| August 25, 2025 | August 28, 2025 | at least 22.50% | 90% of the Initial Value |
| November 24, 2025 | November 28, 2025 | at least 24.75% | 90% of the Initial Value |
| February 25, 2026 | March 2, 2026 | at least 27.00% | 90% of the Initial Value |
| May 22, 2026 | May 28, 2026 | at least 29.25% | 90% of the Initial Value |
| August 25, 2026 | August 28, 2026 | at least 31.50% | 90% of the Initial Value |
| November 24, 2026 | November 30, 2026 | at least 33.75% | 90% of the Initial Value |
| February 24, 2027 | March 1, 2027 | at least 36.00% | 90% of the Initial Value |
| May 25, 2027 | May 28, 2027 | at least 38.25% | 90% of the Initial Value |
| August 25, 2027 | August 30, 2027 | at least 40.50% | 90% of the Initial Value |
| November 23, 2027 | November 29, 2027 | at least 42.75% | 90% of the Initial Value |
| February 23, 2028 | February 28, 2028 | at least 45.00% | 90% of the Initial Value |
| (the Final Valuation Date) | (the Maturity Date) |  |  |

\* To be determined on the Trade Date.

The Call Observation Dates and Call Payment Dates are subject to postponement as described under 'Additional Terms of the Notes-Valuation Dates' and 'Additional Terms of the Notes-Coupon Payment Dates, Call Payment Dates and Maturity Date' in the accompanying Equity Index Underlying Supplement.

# **Initial Value:**

With respect to each Underlying, its Official Closing Level on the Pricing Date.

# **Final Value:**

With respect to each Underlying, its Official Closing Level on the Final Valuation Date.

# **Barrier Value:**

With respect to each Underlying, 75.00% of its Initial Value.

# **CUSIP / ISIN:**

40441XM98 / US40441XM989

# **Form of Notes:**

Book-Entry

# **Listing:**

The Notes will not be listed on any securities exchange or quotation system.

# **Estimated Initial Value:**

The Estimated Initial Value of the Notes is expected to be less than the price you pay to purchase the Notes. The Estimated Initial Value does not represent a minimum price at which we or any of our affiliates would be willing to purchase your Notes in the secondary market, if any, at any time. The Estimated Initial Value will be calculated on the Trade Date and will be set forth in the pricing supplement to which this free writing prospectus relates. See 'Risk Factors - The Estimated Initial Value of the Notes, which will be determined by us on the Trade Date, is expected to be less than the price to public and may differ from the market value of the Notes in the secondary market, if any.'

*The Trade Date, the Pricing Date and the other dates set forth above are subject to change, and will be set forth in the pricing supplement relating to the Notes.*

FWP-5

## GENERAL

This document relates to an offering of Notes linked to the Reference Asset. The purchaser of a Note will acquire a senior unsecured debt security of HSBC USA Inc. We reserve the right to withdraw, cancel or modify this offering and to reject orders in whole or in part. Although the offering of Notes relates to the Reference Asset, you should not construe that fact as a recommendation as to the merits of acquiring an investment linked to the Reference Asset or any security included in any Underlying or as to the suitability of an investment in the Notes.

You should read this document together with the prospectus dated February 23, 2021, the prospectus supplement dated February 23, 2021, and the Equity Index Underlying Supplement dated February 23, 2021. If the terms of the Notes offered hereby are inconsistent with those described in the accompanying prospectus, prospectus supplement or Equity Index Underlying Supplement, the terms described in this document shall control. You should carefully consider, among other things, the matters set forth in "Risk Factors" beginning on page FWP-8 of this document, page S-1 of the prospectus supplement and page S-1 of the Equity Index Underlying Supplement, as the Notes involve risks not associated with conventional debt securities. We urge you to consult your investment, legal, tax, accounting and other advisors before you invest in the Notes. As used herein, references to the "Issuer", "HSBC", "we", "us" and "our" are to HSBC USA Inc.

HSBC has filed a registration statement (including a prospectus, prospectus supplement and Equity Index Underlying Supplement) with the SEC for the offering to which this document relates. Before you invest, you should read the prospectus, prospectus supplement and Equity Index Underlying Supplement in that registration statement and other documents HSBC has filed with the SEC for more complete information about HSBC and this offering. You may get these documents for free by visiting EDGAR on the SEC's web site at www.sec.gov. Alternatively, HSBC Securities (USA) Inc. or any dealer participating in this offering will arrange to send you the prospectus, prospectus supplement and Equity Index Underlying Supplement if you request them by calling toll-free 1-866-811-8049.

You may also obtain:

- ▶ The Equity Index Underlying Supplement at: https://www.sec.gov/Archives/edgar/data/83246/000110465921026625/tm217170d5_424b2.htm
- ▶ The prospectus supplement at: https://www.sec.gov/Archives/edgar/data/83246/000110465921026609/tm217170d2_424b2.htm
- ▶ The prospectus at: https://www.sec.gov/Archives/edgar/data/83246/000110465921026585/tm217170d7_424b3.htm

We are using this document to solicit from you an offer to purchase the Notes. You may revoke your offer to purchase the Notes at any time prior to the time at which we accept your offer by notifying HSBC Securities (USA) Inc. We reserve the right to change the terms of, or reject any offer to purchase, the Notes prior to their issuance. In the event of any material changes to the terms of the Notes, we will notify you.

## PAYMENT ON THE NOTES

### Call Feature

If the Official Closing Level of each Underlying is at or above its Call Threshold on any Call Observation Date the Notes will be automatically called, and you will receive a cash payment, per $1,000 Principal Amount, equal to the Principal Amount plus the applicable Call Premium on the corresponding Call Payment Date.

### Call Premium

If the Notes are called on a Call Observation Date, we will pay the applicable Call Premium on the corresponding Call Payment Date, which will be at least 2.25% per quarter (equivalent to at least 9.00% per annum or at least $22.50 per quarter for each $1,000 Principal Amount) (to be determined on the Trade Date) multiplied by the number of quarters elapsed from the Trade Date to the applicable Call Observation Date that the Notes are called. See "Call Observation Dates, Call Payment Dates and Call Premiums" on FWP-5 for the applicable Call Premiums to be paid on the corresponding Call Payment Dates. For information regarding the record dates applicable to the Call Premiums payable on the Notes, please see the section entitled "Description of Notes-Interest and Principal Payments-Recipients of Interest Payments" beginning on page S-17 in the accompanying prospectus supplement.

### Payment at Maturity

Unless the Notes are called, on the Maturity Date and for each $1,000 Principal Amount, you will receive a cash payment equal to the Final Settlement Value, determined as follows:

- ■ If the Reference Return of the Least Performing Underlying is less than -10.00%, and therefore not called, but greater than or equal to -25.00%:

$1,000 (a zero return)

- ■ If the Reference Return of the Least Performing Underlying is less than -25.00%:

$1,000 + ($1,000 × Reference Return of the Least Performing Underlying).

If the Notes are not automatically called and the Final Value of the Least Performing Underlying is less than its Barrier Value, you will not receive a Call Premium and will lose up to 100% of the Principal Amount.

### Calculation Agent

We or one of our affiliates will act as calculation agent with respect to the Notes.

FWP-6

## Reference Sponsors

The reference sponsor of the SPX is S&P Dow Jones Indices LLC. The reference sponsor of the RTY is FTSE Russell. The reference sponsor of the INDU is S&P Dow Jones Indices LLC.

## INVESTOR SUITABILITY

### The Notes may be suitable for you if:

- ▶ You believe that the Official Closing Level of each of the Underlyings will be equal to or greater than its Call Threshold on one of the Call Observation Dates.
- ▶ You seek a Call Premium based on the performance of the Underlyings, that will be at least 2.25% per quarter (to be determined on the Trade Date) if the Official Closing Level of each Underlying is greater than or equal to its Initial Value on any Call Observation Date.
- ▶ You are willing to invest in the Notes based on the fact that your maximum potential return is limited to the applicable Call Premium payable on the Notes on a given Call Payment Date.
- ▶ You do not seek an investment that provides an opportunity to participate in the appreciation of the Underlyings.
- ▶ You are willing to make an investment that is exposed to the potential downside performance of the Least Performing Underlying on a 1-to-1 basis if the Notes are not called and the Reference Return of the Least Performing Underlying is less than -25.00%.
- ▶ You are willing to lose up to 100% of the Principal Amount.
- ▶ You are willing to hold the Notes, which will be automatically called on any Call Observation Date on which the Official Closing Level of each Underlying is at or above its Call Threshold, or you are otherwise willing to hold the Notes to maturity.
- ▶ You are willing to forgo guaranteed interest payments on the Notes, and the dividends or other distributions paid on the stocks included in the Underlyings.
- ▶ You do not seek an investment for which there will be an active secondary market.
- ▶ You are willing to accept the risk and return profile of the Notes versus a conventional debt security with a comparable maturity issued by HSBC or another issuer with a similar credit rating.
- ▶ You are comfortable with the creditworthiness of HSBC, as Issuer of the Notes.

### The Notes may not be suitable for you if:

- ▶ You believe that the Official Closing Level of at least one Underlying will be less than its Call Threshold on each of the Call Observation Dates, and below its Barrier Value on the Final Valuation Date.
- ▶ You believe that the Call Premium, if any, will not provide you with your desired return.
- ▶ You are unwilling to invest in the Notes based on the fact that your maximum potential return is limited to the applicable Call Premium payable on the Notes on a given Call Payment Date.
- ▶ You seek an investment that provides an opportunity to participate in the appreciation of the Underlyings.
- ▶ You are unwilling to make an investment that is exposed to the potential downside performance of the Least Performing Underlying on a 1-to-1 basis if the Notes are not called and the Reference Return of the Least Performing Underlying is less than -25.00%.
- ▶ You seek an investment that provides full return of principal at maturity.
- ▶ You are unable or unwilling to hold Notes that will be automatically called on any Call Observation Date on which the Official Closing Level of each Underlying is at or above its Call Threshold, or you are otherwise unable or unwilling to hold the Notes to maturity.
- ▶ You prefer to receive guaranteed periodic interest payments on the Notes, or the dividends or other distributions paid on the stocks included in the Underlyings.
- ▶ You seek an investment for which there will be an active secondary market.
- ▶ You prefer the lower risk, and therefore accept the potentially lower returns, of conventional debt securities with comparable maturities issued by HSBC or another issuer with a similar credit rating.
- ▶ You are not willing or are unable to assume the credit risk associated with HSBC, as Issuer of the Notes.

FWP-7

## RISK FACTORS

We urge you to read the section 'Risk Factors' beginning on page S-1 of the accompanying prospectus supplement and page S-1 of the accompanying Equity Index Underlying Supplement. You should understand the risks of investing in the Notes and should reach an investment decision only after careful consideration, with your advisors, of the suitability of the Notes in light of your particular financial circumstances and the information set forth in this document and the accompanying prospectus, prospectus supplement and Equity Index Underlying Supplement.

In addition to the risks discussed below, you should review 'Risk Factors' in the accompanying prospectus supplement and Equity Index Underlying Supplement including the explanation of risks relating to the Notes described in the following sections:

- '-General Risks Related to Indices' in the Equity Index Underlying Supplement.

You will be subject to significant risks not associated with conventional fixed-rate or floating-rate debt securities.

### *Risks Relating to the Structure or Features of the Notes*

#### **The Notes do not guarantee any return of principal and you may lose all of your Principal Amount.**

The Notes do not guarantee any return of principal. The Notes differ from ordinary debt securities in that we will not pay you 100% of the Principal Amount of your Notes if the Notes are not called and the Final Value of the Least Performing Underlying is less than its Barrier Value. In this case, the Payment at Maturity you will be entitled to receive will be less than the Principal Amount and you will lose 1% for each 1% that the Reference Return of the Least Performing Underlying is less than 0.00%. You may lose up to 100% of your investment at maturity. If the Notes are not called, you will not receive any Call Premium.

#### **You may not receive the Call Premium.**

The Notes may not be called, and in such a case you will not receive the Call Premium. If the Official Closing Level of the Least Performing Underlying on the Final Valuation Date is less than its Barrier Level, we will not pay you the Call Premium at maturity, you will not receive a positive return on the Notes, and you will lose some or all of your principal amount.

#### **Your return on the Notes is limited to the Principal Amount plus the applicable Call Premium, if any, regardless of any appreciation in the value of any Underlying.**

If the Notes are called, for each $1,000 Principal Amount, you will receive $1,000 at maturity plus the applicable Call Premium, regardless of any appreciation in the value of any Underlying, which may be significant. Accordingly, the return on the Notes may be significantly less than the return on a direct investment in the stocks included in the Underlyings during the term of the Notes.

#### **The amount payable on the Notes is not linked to the values of the Underlyings at any time other than the Call Observation Dates, including the Final Valuation Date.**

The payments on the Notes will be based on the Official Closing Levels of the Underlyings on the Call Observation Dates, including the Final Valuation Date, subject to postponement for non-trading days and certain Market Disruption Events. If the Notes are not called, even if the value of each Underlying is greater than or equal to its Call Threshold during the term of the Notes other than on the Call Observation Dates but then decreases on each Call Observation Date to a value that is less than its Call Threshold, the return on the Notes may be less, and possibly significantly less, than it would have been had the Notes had been called. Similarly, even if the value of the Least Performing Underlying is greater than or equal to its Barrier Value during the term of the Notes other than on the Final Valuation Date but then decreases on the Final Valuation Date to a value that is less than its Barrier Value, the Payment at Maturity will be less, possibly significantly less, than it would have been had the Payment at Maturity been linked to the value of the Least Performing Underlying prior to such decrease. Although the actual values of the Underlyings on the Maturity Date or at other times during the term of the Notes may be higher than their respective values on the Call Observation Dates, whether the Notes will be called and the Payment at Maturity will be based solely on the Official Closing Levels of the Underlyings on the applicable Call Observation Dates.

#### **Because the Notes are linked to the performance of the Least Performing Underlying, you are exposed to greater risks of not receiving the Call Premium and sustaining a significant loss on your investment than if the Notes were linked to just one Underlying.**

The risk that you will not receive the Call Premium, or that you will suffer a significant loss on your investment, is greater if you invest in the Notes as opposed to substantially similar securities that are linked to the performance of just one Underlying. With multiple Underlyings, it is more likely that one of the Underlyings will close below its respective Barrier Value on the Final Valuation Date, than if the Notes were linked to only one Underlying. Therefore, it is more likely that you will suffer a significant loss on your investment. In addition, because each Underlying must close above its Call Threshold on a Call Observation Date in order for the Notes to be called, the Notes are less likely to be called than if the Notes were linked to just one Underlying, and you may not receive the Call Premium.

FWP-8

### **The Notes may be called prior to the Maturity Date.**

If the Notes are called early, the holding period could be as little as approximately 12 months. There is no guarantee that you would be able to reinvest the proceeds from an investment in the Notes at a comparable return for a similar level of risk in the event the Notes are called prior to the Maturity Date.

### **If the Notes are not called, your return will be based on the Reference Return of the Least Performing Underlying.**

If the Notes are not called, in which case you will not receive any Call Premium, your return will be based on the Reference Return of the Least Performing Underlying without regard to the performance of any other Underlying. As a result, you could lose all or some of your initial investment if the Final Value of the Least Performing Underlying is less than its Barrier Value, even if there is an increase in the value of any other Underlying. This could be the case even if any other Underlying increased by an amount greater than the decrease in the Least Performing Underlying.

### **Higher Call Premiums or lower Barrier Values are generally associated with Underlyings with greater expected volatility and therefore can indicate a greater risk of loss.**

'Volatility' refers to the frequency and magnitude of changes in the value, of an Underlying. The greater the expected volatility with respect to an Underlying on the Trade Date, the higher the expectation as of the Trade Date that the value of that Underlying could close below its Call Threshold on a Call Observation Date or its Barrier Value on the Final Valuation Date, indicating a higher expected risk of non-payment of any of the Call Premiums or loss on the Notes. This greater expected risk will generally be reflected in a higher Call Premiums than the yield payable on our conventional debt securities with a similar maturity, or in more favorable terms (such as a lower Barrier Value) than for similar securities linked to the performance of an Underlying with a lower expected volatility as of the Trade Date. You should therefore understand that a relatively higher Call Premiums may indicate an increased risk of loss. Further, a relatively lower Barrier Value may not necessarily indicate that the Notes have a greater likelihood of a repayment of principal at maturity. The volatility of an Underlying can change significantly over the term of the Notes. The value of an Underlying for your Notes could fall sharply, which could result in a significant loss of principal. You should be willing to accept the downside market risk of the Least Performing Underlying and the potential to lose some or all of your principal at maturity.

### **Since the Notes are linked to the performance of more than one Underlying, you will be fully exposed to the risk of fluctuations in the value of each Underlying.**

Since the Notes are linked to the performance of more than one Underlying, the Notes will be linked to the individual performance of each Underlying. Because the Notes are not linked to a weighted basket, in which the risk is mitigated and diversified among all of the components of a basket, you will be exposed to the risk of fluctuations in the values of the Underlyings to the same degree for each Underlying. For example, in the case of securities linked to a weighted basket, the return would depend on the weighted aggregate performance of the basket components reflected as the basket return. Thus, the depreciation of any basket component could be mitigated by the appreciation of another basket component, as scaled by the weightings of such basket components. However, in the case of these Notes, the individual performance of each of the Underlyings would not be combined to calculate your return and the depreciation of either of the Underlyings would not be mitigated by the appreciation of the other Underlying. Instead, your return would depend on the Least Performing Underlying.

### ***Risks Relating to the Reference Asset***

#### **Changes that affect an Underlying may affect the value of an Underlying and the market value of the Notes and the amount you will receive on the Notes and the amount you will receive at maturity.**

The policies of the reference sponsor of an Underlying concerning additions, deletions and substitutions of the stocks included in an Underlying, and the manner in which the reference sponsor takes account of certain changes affecting those stocks, may affect the value of an Underlying. The policies of the reference sponsor with respect to the calculation of an Underlying could also affect the value of an Underlying. The reference sponsor may discontinue or suspend calculation or dissemination of an Underlying. Any such actions could affect the value of an Underlying and the value of and the return on the Notes.

#### **Small-capitalization risk.**

The RTY tracks companies that are considered small-capitalization. These companies often have greater stock price volatility, lower trading volume and less liquidity than large-capitalization companies and therefore the level of the RTY may be more volatile than an investment in stocks issued by large-capitalization companies. Stock prices of small-capitalization companies are also more vulnerable than those of large-capitalization companies to adverse business and economic developments, and the stocks of small-capitalization companies may be thinly traded, making it difficult for the RTY to track them. In addition, small-capitalization companies are typically less stable financially than large-capitalization companies and may depend on a small number of key personnel, making them more vulnerable to loss of personnel. Small-capitalization companies are often subject to less analyst coverage and may be in early, and less predictable, periods of their corporate existences. Such companies tend to have smaller revenues, less diverse product lines, smaller shares of their product or service markets, fewer financial resources and less competitive strengths than large-capitalization companies and are more susceptible to adverse developments related to their products.

FWP-9

# General Risk Factors

## The Notes are subject to the credit risk of HSBC USA Inc.

The Notes are senior unsecured debt obligations of the Issuer, HSBC, and are not, either directly or indirectly, an obligation of any third party. As further described in the accompanying prospectus supplement and prospectus, the Notes will rank on par with all of the other unsecured and unsubordinated debt obligations of HSBC, except such obligations as may be preferred by operation of law. Any payment to be made on the Notes, including any return of principal at maturity, depends on the ability of HSBC to satisfy its obligations as they come due. As a result, the actual and perceived creditworthiness of HSBC may affect the market value of the Notes and, in the event HSBC were to default on its obligations, you may not receive the amounts owed to you under the terms of the Notes.

## The Notes are not insured or guaranteed by any governmental agency of the United States or any other jurisdiction.

The Notes are not deposit liabilities or other obligations of a bank and are not insured or guaranteed by the Federal Deposit Insurance Corporation or any other governmental agency or program of the United States or any other jurisdiction. An investment in the Notes is subject to the credit risk of HSBC, and in the event that HSBC is unable to pay its obligations as they become due, you may not receive the full payments due on the Notes.

## The Estimated Initial Value of the Notes, which will be determined by us on the Trade Date, is expected to be less than the price to public and may differ from the market value of the Notes in the secondary market, if any.

The Estimated Initial Value of the Notes will be calculated by us on the Trade Date and is expected to be less than the price to public. The Estimated Initial Value will reflect our and our affiliates' internal funding rate, which is the borrowing rate paid to issue market-linked securities, as well as the mid-market value of the embedded derivatives in the Notes. This internal funding rate is typically lower than the rate we would use when we issue conventional fixed or floating rate debt securities. As a result of the difference between our internal funding rate and the rate we would use when we issue conventional fixed or floating rate debt securities, the Estimated Initial Value of the Notes may be lower if it were based on the prices at which our fixed or floating rate debt securities trade in the secondary market. In addition, if we were to use the rate we use for our conventional fixed or floating rate debt issuances, we would expect the economic terms of the Notes to be more favorable to you. We will determine the value of the embedded derivatives in the Notes by reference to our or our affiliates' internal pricing models. These pricing models consider certain assumptions and variables, which can include volatility and interest rates. Different pricing models and assumptions could provide valuations for the Notes that are different from our Estimated Initial Value. These pricing models rely in part on certain forecasts about future events, which may prove to be incorrect. The Estimated Initial Value does not represent a minimum price at which we or any of our affiliates would be willing to purchase your Notes in the secondary market (if any exists) at any time.

## The price of your Notes in the secondary market, if any, immediately after the Trade Date is expected to be less than the price to public.

The price to public takes into account certain costs. These costs, which will be used or retained by us or one of our affiliates, include our affiliates' projected hedging profits (which may or may not be realized) for assuming risks inherent in hedging our obligations under the Notes, the underwriting discount and the costs associated with structuring and hedging our obligations under the Notes. If you were to sell your Notes in the secondary market, if any, the price you would receive for your Notes may be less than the price you paid for them because secondary market prices will not take into account these costs. The price of your Notes in the secondary market, if any, at any time after issuance will vary based on many factors, including the values of the Underlyings and changes in market conditions, and cannot be predicted with accuracy. The Notes are not designed to be short-term trading instruments, and you should, therefore, be able and willing to hold the Notes to maturity. Any sale of the Notes prior to maturity could result in a loss to you.

## If we were to repurchase your Notes immediately after the Original Issue Date, the price you receive may be higher than the Estimated Initial Value of the Notes.

Assuming that all relevant factors remain constant after the Original Issue Date, the price at which HSBC Securities (USA) Inc. may initially buy or sell the Notes in the secondary market, if any, and the value that may initially be used for customer account statements, if any, may exceed the Estimated Initial Value on the Trade Date for a temporary period expected to be approximately 6 months after the Original Issue Date. This temporary price difference may exist because, in our discretion, we may elect to effectively reimburse to investors a portion of the estimated cost of hedging our obligations under the Notes and other costs in connection with the Notes that we will no longer expect to incur over the term of the Notes. We will make such discretionary election and determine this temporary reimbursement period on the basis of a number of factors, including the tenor of the Notes and any agreement we may have with the distributors of the Notes. The amount of our estimated costs which we effectively reimburse to investors in this way may not be allocated ratably throughout the reimbursement period, and we may discontinue such reimbursement at any time or revise the duration of the reimbursement period after the Original Issue Date of the Notes based on changes in market conditions and other factors that cannot be predicted.

## You will not have any ownership interest in the stocks included in an Underlying.

As a holder of the Notes, you will not have any ownership interest in the stocks included in an Underlying, such as rights to vote, dividend payments or other distributions. Because the return on the Notes will not reflect any dividends on those stocks, the Notes may underperform an investment in the stocks included in an Underlying.

FWP-10

### **The Notes lack liquidity.**

The Notes will not be listed on any securities exchange or automated quotation system. HSBC Securities (USA) Inc. is not required to offer to purchase the Notes in the secondary market, if any exists. Even if there is a secondary market, it may not provide enough liquidity to allow you to trade or sell the Notes easily. Because other dealers are not likely to make a secondary market for the Notes, the price at which you may be able to trade your Notes is likely to depend on the price, if any, at which HSBC Securities (USA) Inc. is willing to buy the Notes.

### **Potential conflicts of interest may exist.**

An affiliate of HSBC has a minority equity interest in the owner of an electronic platform, through which we may make available certain structured investments offering materials. HSBC and its affiliates play a variety of roles in connection with the issuance of the Notes, including acting as calculation agent and hedging our obligations under the Notes. In performing these duties, the economic interests of the calculation agent and other affiliates of ours are potentially adverse to your interests as an investor in the Notes. We will not have any obligation to consider your interests as a holder of the Notes in taking any action that might affect the value of your Notes.

### **Uncertain tax treatment.**

For a discussion of the U.S. federal income tax consequences of your investment in a Note, please see the discussion under 'U.S. Federal Income Tax Considerations' herein and the discussion under 'U.S. Federal Income Tax Considerations' in the accompanying prospectus supplement.

FWP-11

## ILLUSTRATIVE EXAMPLES

The following table and examples are provided for illustrative purposes only and are hypothetical. They do not purport to be representative of every possible scenario concerning increases or decreases in the value of any Underlying relative to its Initial Value. We cannot predict the Official Closing Level of an Underlying on any Call Observation Date, including the Final Valuation Date. The assumptions we have made in connection with the illustrations set forth below may not reflect actual events. You should not take this illustration or these examples as an indication or assurance of the expected performance of the Underlyings or the return on the Notes.

The table and examples below illustrate how the Call Premium and the Payment at Maturity would be calculated with respect to a $1,000 investment in the Notes, given a range of hypothetical performances of any Underlying. The hypothetical returns on the Notes below are numbers, expressed as percentages, that result from comparing the Payment at Maturity per $1,000 Principal Amount to $1,000. The numbers appearing in the following table and examples may have been rounded for ease of analysis. The following table and examples assume the following:

- Principal Amount: $1,000
- Hypothetical Initial Value of each Underlying*: 1,000.00
- Hypothetical Call Threshold of each Underlying: 900.00 (90.00% the Initial Value)
- Hypothetical Barrier Value of each Underlying: 750.00 (75.00% of its Hypothetical Initial Value)
- Hypothetical Call Premium: 2.25% per quarter, payable as described on page FWP-5 under Call Observation Dates, Call Payment Dates, Call Premiums and Call Threshold. The actual Call Premium will be determined on the Trade Date and will be at least 9.00% per annum.

* The hypothetical Initial Value of 1,000.00 used in the examples below has been chosen for illustrative purposes only and does not represent the actual Initial Value of any Underlying. The actual Initial Value of each Underlying will be determined on the Pricing Date and set forth in the final pricing supplement to which this free writing prospectus relates.

|  | Notes Are Called on a Call Observation Date |  | Notes Are Not Called on Any Call Observation Date |  |
| --- | --- | --- | --- | --- |
|  | Example 1 | Example 2 | Example 3 | Example 4 |
| Initial Value of each Underlying | 1,000.00 | 1,000.00 | 1,000.00 | 1,000.00 |
| Call Threshold of each Underlying | 900.00 | 900.00 | 900.00 | 900.00 |
| Barrier Value of each Underlying | 750.00 | 750.00 | 750.00 | 750.00 |
| Call Observation Dates | Official Closing Level / Percentage Change of the Least Performing Underlying |  |  |  |
| 1 st Call Observation Date | 1,200.00 / 20.00% Call Premium: $90.00 | 802.50 / -19.75% Call Premium: $0.00 | 802.50 / -19.75% Call Premium: $0.00 | 675.00 / -32.50% Call Premium: $0.00 |
| 2 nd Call Observation Date to 16 th Call Observation Date | N/A | Official Closing Level is below the Call Threshold Call Premium: $0.00 | Official Closing Level is below the Call Threshold Call Premium: $0.00 | Official Closing Level is below the Call Threshold Call Premium: $0.00 |
| Final Valuation Date | N/A | 1,200.00 / 20.00% Call Premium: $450.00 | 772.50 / -22.75% Call Premium: $0.00 | 525.00 / -47.50% Call Premium: $0.00 |
| Payment if Notes are Called | $1,090.00 | See below | N/A | N/A |
| Payment at Maturity | N/A | $1,450.00 | $1,000.00 | $1,000 + ($1,000 x -47.50%) = $525.00 |
| Return of the Notes | 9.00% | 45.00% | 0.00% | -47.50% |

FWP-12

Example 1-The Official Closing Level of each Underlying on the first Call Observation Date is greater than or equal to its Call Threshold.

| Underlying | Initial Value | Official Closing Level |
| --- | --- | --- |
| SPX | 1,000.00 | 1,250.00 (125.00% of Initial Value) |
| RTY | 1,000.00 | 1,200.00 (120.00% of Initial Value) |
| INDU | 1,000.00 | 1,290.00 (129.00% of Initial Value) |

Payment Upon a Call: $1,090.00

Because the Official Closing Level of each Underlying on the first Call Observation Date is at or above its Call Threshold, the Notes will be called and you will receive $1,090.00 per Note, reflecting the Principal Amount plus the applicable Call Premium, resulting in a 9.00% return on the Notes. No extra payment will be made on account of each Underlying closing above its respective Initial Value.

Example 2-The Official Closing Level of each Underlying on the final Call Observation Date is greater than or equal to its Call Threshold.

| Underlying | Initial Value | Final Value |
| --- | --- | --- |
| SPX | 1,000.00 | 1,250.00 (125.00% of Initial Value) |
| RTY | 1,000.00 | 1,200.00 (120.00% of Initial Value) |
| INDU | 1,000.00 | 1,300.00 (130.00% of Initial Value) |

Payment Upon a Call: $1,450.00

Because the Official Closing Level of each Underlying on the final Call Observation Date is at or above its Call Threshold, the Notes will be called and you will receive $1,450.00 per Note, reflecting the Principal Amount plus the applicable Call Premium, resulting in a 45.00% return on the Notes. No extra payment will be made on account of each Underlying closing above its respective Initial Value.

Example 3- The Notes are not called and the Final Value of the Least Performing Underlying is greater than or equal to its Barrier Value.

| Underlying | Initial Value | Final Value |
| --- | --- | --- |
| SPX | 1,000.00 | 1,150.00 (115.00% of Initial Value) |
| RTY | 1,000.00 | 772.50 (77.25% of Initial Value) |
| INDU | 1,000.00 | 1,100.00 (110.00% of Initial Value) |

The RTY is the Least Performing Underlying.

Reference Return of the Least Performing Underlying: -22.75%
Payment at Maturity: $1,000.00

Because the Final Value of the Least Performing Underlying is less than its Call Threshold but is greater than or equal to the Barrier Value, you will receive $1,000 per Note, reflecting the Principal Amount, resulting in a 0.00% return on the Notes, even though the value of the Least Performing Underlying has declined.

Example 4-The Notes are not called and the Final Value of the Least Performing Underlying is less than its Barrier Value.

| Underlying | Initial Value | Final Value |
| --- | --- | --- |
| SPX | 1,000.00 | 1,100.00 (110.00% of Initial Value) |
| RTY | 1,000.00 | 525.00 (52.50% of Initial Value) |
| INDU | 1,000.00 | 1,050.00 (105.00% of Initial Value) |

The RTY is the Least Performing Underlying.

Reference Return of the Least Performing Underlying: -47.50%
Payment at Maturity: $525.00

FWP-13

Because the Final Value of the Least Performing Underlying is less than its Barrier Value, you will receive $525.00 per $1,000 Principal Amount, calculated as follows:

$$\text{Final Settlement Value} = \$1,000 + (\$1,000 \times -47.50\%) = \$525.00$$

You will not receive a Call Premium, resulting in a -47.50% return on the Notes.

If the Notes are not called and the Final Value of the Least Performing Underlying is less than its Barrier Value, you will be exposed to any decrease in the value of the Least Performing Underlying on a 1:1 basis and could lose up to 100% of your principal at maturity.

FWP- 14

# DESCRIPTION OF THE REFERENCE ASSET

## Description of the SPX

The S&P 500® Index ('SPX') is a market capitalization-weighted index intended to provide a performance benchmark for the large-cap U.S. equity markets. The SPX includes a representative sample of 500 companies in leading industries of the U.S. economy.

*For more information about the SPX, see 'The S&P 500® Index' beginning on page S-55 of the accompanying Equity Index Underlying Supplement.*

## Historical Performance of the SPX

The following graph sets forth the historical performance of the SPX based on the daily historical closing values from February 7, 2013 through February 7, 2023. We obtained the closing values below from the Bloomberg Professional® service. We have not undertaken any independent review of, or made any due diligence inquiry with respect to, the information obtained from the Bloomberg Professional® service.

![img-0.jpeg](img-0.jpeg)

The historical values of the SPX should not be taken as an indication of future performance, and no assurance can be given as to the Official Closing Level of the SPX on any Call Observation Date, including the Final Valuation Date.

## Description of the RTY

The Russell 2000® Index ('RTY') is designed to track the performance of the small capitalization segment of the U.S. equity market. All 2,000 stocks are traded on a major U.S. exchange, and the RTY consists of the smallest 2,000 companies included in the Russell 3000® Index. The Russell 3000® Index is composed of the 3,000 largest U.S. companies as determined by market capitalization.

*For more information about the RTY, see 'The Russell 2000® Index' beginning on page S-45 of the accompanying Equity Index Underlying Supplement.*

## Historical Performance of the RTY

The following graph sets forth the historical performance of the RTY based on the daily historical closing values from February 7, 2013 through February 7, 2023. We obtained the closing values below from the Bloomberg Professional® service. We have not undertaken any independent review of, or made any due diligence inquiry with respect to, the information obtained from the Bloomberg Professional® service.

![img-1.jpeg](img-1.jpeg)

The historical values of the RTY should not be taken as an indication of future performance, and no assurance can be given as to the Official Closing Level of the RTY on any Call Observation Date, including the Final Valuation Date.

FWP-15

## Description of the INDU

The Dow Jones Industrial Average® (“INDU”) is a price-weighted index comprised of 30 blue-chip stocks, which represent nine economic sectors including consumer discretionary, consumer staples, communication services, energy, financials, health care, industrials, information technology and materials.

*For more information about the INDU, see “The Dow Jones Industrial Average®” beginning on page S-10 of the accompanying Equity Index Underlying Supplement.*

## Historical Performance of the INDU

The following graph sets forth the historical performance of the INDU based on the daily historical closing values from February 7, 2013 through February 7, 2023. We obtained the closing values below from the Bloomberg Professional® service. We have not undertaken any independent review of, or made any due diligence inquiry with respect to, the information obtained from the Bloomberg Professional® service.

![img-2.jpeg](img-2.jpeg)

The historical values of the INDU should not be taken as an indication of future performance, and no assurance can be given as to the Official Closing Level of the INDU on any Call Observation Date, including the Final Valuation Date.

## EVENTS OF DEFAULT AND ACCELERATION

If the Notes have become immediately due and payable following an Event of Default (as defined in the accompanying prospectus) with respect to the Notes, the calculation agent will determine the accelerated payment due and payable in the same general manner as described in this document except that in such a case, the scheduled trading day immediately preceding the date of acceleration will be used as the Final Valuation Date for purposes of determining the Reference Return of any Underlying, and the accelerated Maturity Date will be three business days after the accelerated Final Valuation Date. If a Market Disruption Event exists with respect to any Underlying on that scheduled trading day, then the accelerated Final Valuation Date for that Underlying will be postponed for up to five scheduled trading days (in the same manner used for postponing the originally scheduled Final Valuation Date). The accelerated Maturity Date will also be postponed by an equal number of business days. For the avoidance of doubt, if no Market Disruption Event exists with respect to an Underlying on the scheduled trading day preceding the date of acceleration, the determination of such Underlying’s Reference Return will be made on such date, irrespective of the existence of a Market Disruption Event with respect to any other Underlying occurring on such date.

If the Notes have become immediately due and payable following an Event of Default, you will not be entitled to any additional payments with respect to the Notes. For more information, see “Description of Debt Securities - Senior Debt Securities - Events of Default” in the accompanying prospectus.

## SUPPLEMENTAL PLAN OF DISTRIBUTION (CONFLICTS OF INTEREST)

We have appointed HSBC Securities (USA) Inc., an affiliate of HSBC, as the agent for the sale of the Notes. Pursuant to the terms of a distribution agreement, HSBC Securities (USA) Inc. will purchase the Notes from HSBC at the price to public less the underwriting discount set forth on the cover page of the pricing supplement to which this document relates, for distribution to other registered broker-dealers or will offer the Notes directly to investors. HSBC Securities (USA) Inc. proposes to offer the Notes at the price to public set forth on the cover page of this document. HSBC USA Inc. or one of our affiliates may pay varying underwriting discounts of up to 2.00% and structuring fees of up to 0.65% per $1,000 Principal Amount in connection with the distribution of the Notes to other registered broker-dealers. In no case will the sum of the underwriting discounts and structuring fees exceed 2.65% per $1,000 Principal Amount.

An affiliate of HSBC has paid or may pay in the future an amount to broker-dealers in connection with the costs of the continuing implementation of systems to support the Notes.

In addition, HSBC Securities (USA) Inc. or another of its affiliates or agents may use the pricing supplement to which this document relates in market-making transactions after the initial sale of the Notes, but is under no obligation to make a market in the Notes and may discontinue any market-making activities at any time without notice.

See “Supplemental Plan of Distribution (Conflicts of Interest)” on page S-83 in the prospectus supplement.

We expect that delivery of the Notes will be made against payment for the Notes on or about the Original Issue Date set forth on the inside cover page of this document, which is more than two business days following the Trade Date. Under Rule 15c6-1 under the Securities Exchange Act of 1934, trades in the secondary market generally are required to settle in two business days, unless the parties to that trade expressly agree otherwise. Accordingly, purchasers who wish to trade the Notes more than two business days prior to the Original Issue Date will be required to specify an alternate settlement cycle at the time of any such trade to prevent a failed settlement, and should consult their own advisors.

FWP-16

# U.S. FEDERAL INCOME TAX CONSIDERATIONS

There is no direct legal authority as to the proper tax treatment of the Notes, and therefore significant aspects of the tax treatment of the Notes are uncertain as to both the timing and character of any inclusion in income in respect of the Notes. Under one approach, a Note should be treated as a pre-paid executory contract with respect to the Underlyings. We intend to treat the Notes consistent with this approach. Pursuant to the terms of the Notes, you agree to treat the Notes under this approach for all U.S. federal income tax purposes. Subject to the limitations described therein, and based on certain factual representations received from us, in the opinion of our special U.S. tax counsel, Mayer Brown LLP, it is reasonable to treat a Note as a pre-paid executory contract with respect to the Underlyings. Pursuant to this approach, we do not intend to report any income or gain with respect to the Notes prior to their maturity or an earlier sale, call or exchange and we intend to treat any gain or loss upon maturity or an earlier sale, call or exchange as long-term capital gain or loss, provided you have held the Note for more than one year at such time for U.S. federal income tax purposes. If the Notes are held by the same United States holder until maturity, that holder's holding period will generally include the maturity date.

We will not attempt to ascertain whether any of the entities whose stock is included in an Underlying would be treated as a passive foreign investment company ('PFIC') or United States real property holding corporation ('USRPHC'), both as defined for U.S. federal income tax purposes. If one or more of the entities whose stock is included in an Underlying were so treated, certain adverse U.S. federal income tax consequences might apply. You should refer to information filed with the SEC and other authorities by the entities whose stock is included in an Underlying and consult your tax advisor regarding the possible consequences to you if one or more of the entities whose stock is included in any Underlying is or becomes a PFIC or a USRPHC.

Under current law, while the matter is not entirely clear, individual non-U.S. holders, and entities whose property is potentially includable in those individuals' gross estates for U.S. federal estate tax purposes (for example, a trust funded by such an individual and with respect to which the individual has retained certain interests or powers), should note that, absent an applicable treaty benefit, the Notes are likely to be treated as U.S. situs property, subject to U.S. federal estate tax. These individuals and entities should consult their own tax advisors regarding the U.S. federal estate tax consequences of investing in the Notes.

A 'dividend equivalent' payment is treated as a dividend from sources within the United States and such payments generally would be subject to a 30% U.S. withholding tax if paid to a non-U.S. holder. Under U.S. Treasury Department regulations, payments (including deemed payments) with respect to equity-linked instruments ('ELIs') that are 'specified ELIs' may be treated as dividend equivalents if such specified ELIs reference an interest in an 'underlying security,' which is generally any interest in an entity taxable as a corporation for U.S. federal income tax purposes if a payment with respect to such interest could give rise to a U.S. source dividend. However, Internal Revenue Service guidance provides that withholding on dividend equivalent payments will not apply to specified ELIs that are not delta-one instruments and that are issued before January 1, 2025. Based on the Issuer's determination that the Notes are not 'delta-one' instruments, non-U.S. holders should not be subject to withholding on dividend equivalent payments, if any, under the Notes. However, it is possible that the Notes could be treated as deemed reissued for U.S. federal income tax purposes upon the occurrence of certain events affecting an Underlying or the Notes, and following such occurrence the Notes could be treated as subject to withholding on dividend equivalent payments. Non-U.S. holders that enter, or have entered, into other transactions in respect of an Underlying or the Notes should consult their tax advisors as to the application of the dividend equivalent withholding tax in the context of the Notes and their other transactions. If any payments are treated as dividend equivalents subject to withholding, we (or the applicable paying agent) would be entitled to withhold taxes without being required to pay any additional amounts with respect to amounts so withheld.

For a discussion of the U.S. federal income tax consequences of your investment in a Note, please see the discussion under 'U.S. Federal Income Tax Considerations' in the accompanying prospectus supplement.

PROSPECTIVE PURCHASERS OF NOTES SHOULD CONSULT THEIR TAX ADVISORS AS TO THE FEDERAL, STATE, LOCAL, AND OTHER TAX CONSEQUENCES TO THEM OF THE PURCHASE, OWNERSHIP AND DISPOSITION OF NOTES.

FWP-17

# **TABLE OF CONTENTS**

# **Free Writing Prospectus**

| General | FWP-6 |
| --- | --- |
| Payment on the Notes | FWP-6 |
| Investor Suitability | FWP-7 |
| Risk Factors | FWP-8 |
| Illustrative Examples | FWP-12 |
| Description of the Reference Asset | FWP-15 |
| Events of Default and Acceleration | FWP-16 |
| Supplemental Plan of Distribution (Conflicts of Interest) | FWP-16 |
| U.S. Federal Income Tax Considerations | FWP-17 |

# **Equity Index Underlying Supplement**

| Disclaimer | ii |
| --- | --- |
| Risk Factors | S-1 |
| The DAX® Index | S-8 |
| The Dow Jones Industrial Average® | S-10 |
| The EURO STOXX 50® Index | S-12 |
| The EURO STOXX® Banks Index | S-14 |
| The FTSE® 100 Index | S-16 |
| The Hang Seng® Index | S-17 |
| The Hang Seng China Enterprises Index | S-19 |
| The KOSPI 200 Index | S-22 |
| The MSCI Indices | S-24 |
| The NASDAQ 100 Index® | S-31 |
| The Nikkei Stock Average | S-34 |
| The NYSE® FANG+TM Index | S-36 |
| The PHLX Housing Sector Index | S-41 |
| The Russell 2000® Index | S-45 |
| The S&P 100® Index | S-48 |
| The S&P 500® Index | S-55 |
| The S&P 500® Low Volatility Index | S-62 |
| The S&P BRIC 40 Index | S-65 |
| The S&P MidCap 400® Index | S-68 |
| The S&P/ASX 200 Index | S-75 |
| The S&P 500® ESG Index | S-78 |
| The TOPIX® Index | S-82 |
| The Swiss Market Index | S-84 |
| Additional Terms of the Notes | S-86 |

# **Prospectus Supplement**

| Risk Factors | S-1 |
| --- | --- |
| Pricing Supplement | S-12 |
| Description of Notes | S-14 |
| Use of Proceeds and Hedging | S-55 |
| Certain ERISA and Related Considerations | S-56 |
| U.S. Federal Income Tax Considerations | S-58 |
| Supplemental Plan of Distribution (Conflicts of Interest) | S-83 |

# **Prospectus**

| About this Prospectus | 1 |
| --- | --- |
| Risk Factors | 2 |
| Where You Can Find More Information | 3 |
| Special Note Regarding Forward-Looking Statements | 4 |
| HSBC USA Inc. | 7 |
| Use of Proceeds | 8 |
| Description of Debt Securities | 9 |
| Description of Preferred Stock | 20 |
| Description of Warrants | 25 |
| Description of Purchase Contracts | 30 |
| Description of Units | 33 |
| Book-Entry Procedures | 35 |
| Limitations on Issuances in Bearer Form | 39 |
| U.S. Federal Income Tax Considerations Relating to Debt Securities | 40 |
| Certain European Union Tax Considerations | 48 |
| Plan of Distribution (Conflicts of Interest) | 49 |
| Notice to Canadian Investors | 52 |
| Notice to EEA Investors | 53 |
| Notice to UK Investors | 54 |
| UK Financial Promotion | 54 |
| Certain ERISA and Related Matters | 55 |
| Legal Opinions | 57 |
| Experts | 58 |

You should only rely on the information contained in this document, the accompanying Equity Index Underlying Supplement, prospectus supplement and prospectus. We have not authorized anyone to provide you with information or to make any representation to you that is not contained in this document, the accompanying Equity Index Underlying Supplement, prospectus supplement and prospectus. If anyone provides you with different or inconsistent information, you should not rely on it. This document, the accompanying Equity Index Underlying Supplement, prospectus supplement and prospectus are not an offer to sell these Notes, and these documents are not soliciting an offer to buy these Notes, in any jurisdiction where the offer or sale is not permitted. You should not, under any circumstances, assume that the information in this document, the accompanying Equity Index Underlying Supplement, prospectus supplement and prospectus is correct on any date after their respective dates.

# **HSBC USA Inc.**

**\[ ]**

**Autocallable Barrier Notes with Step-up Premium Linked to the Least Performing of the S&P 500® Index, the Russell 2000® Index and the Dow Jones Industrial Average®**

**February 8, 2023**

**Free Writing Prospectus**